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Abstract 
Over the years, biopolymeric microparticles have been associated with the leaching of the 
internal phase. The present work was aimed at developing a new strategy in negotiating the 
problem of leaching from the microparticles. We hypothesized that gelation of the internal phase 
as organogels (core) and their encapsulation within the alginate microparticles may prevent 
leaching. Organogels were prepared using natural fatty acyl sources and synthetic source. 
Natural sources include vegetable fats (cocoa butter, mango butter), animal fat (lanolin) and fatty 
acid having both plant and animal origin (stearic acid), whereas, synthetic source include the 
mixture of Span 80 and Tween 80. Prior to encapsulation, the physicochemical, thermal and 
mechanical properties of the organogels were characterized in depth. The gelation mechanism 
and crystallization phenomenon during the formation of vegetable fat and stearic acid based 
organogels were critically evaluated. The predicted gelation mechanism in vegetable fat based 
organogels is instantaneous nucleation coupled with one or two dimensional growth of the fat 
crystals. On the other hand, stearate molecules followed heterogeneous nucleation coupled with 
one-dimensional growth during the formation of stearate organogels. The aforementioned 
organogels were encapsulated within the alginate microparticles by ionotropic gelation method. 
Microscopic, XRD and DSC studies confirmed the successful encapsulation of organogels as the 
core material of the developed microparticles. The organogel encapsulated microparticles 
prevented the leaching of the internal phase and improved the drug encapsulation efficiency. 
Presence of semi-solid organogels as the core material facilitated the controlled release of the 
drugs (model drugs: metronidazole and ciprofloxacin in stearate formulations) from the 
microparticles. The developed formulations showed good antimicrobial properties against 
Escherichia coli. The microparticles were found to be biocompatible and mucoadhesive in nature 
when checked against mammalian L929 fibroblast cells and goat’s small intestine, respectively. 
Based on the results, it was concluded that the developed formulations (organogels and 
microparticles) may be used as the controlled drug delivery vehicles for in vivo applications. 
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1 
Chapter 1 
Introduction 
Biopharmaceutics Classification System reports that more than 35 % of the bioactive agents are 
poorly aqueous soluble and/or have technical problems in developing formulations [1-2]. To 
improve the solubility and/or bioavailability, a number of technologies are being adopted. Of 
these, lipid-based formulations have shown promising results in enhancing the bioavailability of 
active ingredients. Encapsulation has been extensively used either to immobilize or carry drugs 
[3], vaccines [4], proteins [5], antigens [6], microbial cells [7], animal cells [8], and food 
flavorants [9]. In cosmetics and pharmaceutical industries, encapsulation technology is one of the 
widely used methods for improving the stability, bioavailability and to enhance the loading 
capacity of the active ingredients. These bioactive ingredients can be directly encapsulated or 
encapsulated via lipid vehicle. In general, vegetable oils are being used as the lipid vehicles. 
Encapsulation of the vegetable oils has been carried out using polymers of either synthetic or 
natural origin. The synthetic polymers include poly- -cyanoacrylate alkyl esters, polyglycolic 
acid, polylactic acid, polylactic glycolic acid and polyvinyl alcohol. Polymers of natural origin 
may be obtained either from plant or animal sources. Plant-derived polymers are largely being 
used. The commonly used plant-derived polymers include alginate, arabic gum, carrageenan, 
cellulose and its derivatives, pectin and starch derivatives. Animal-derived polysaccharides 
include chitosan and pectin, whereas, protein-based polymers include albumin, casein, gelatin, 
silk fibroin, soy proteins and whey protein isolate. 
Vegetable oils have been categorized as essential oils and non-essential oils. In general, essential 
oils are volatile and unstable at room-temperature (25 
o
C), whereas, non-essential oils are non-
volatile and stable at room-temperature. Some of the essential and non-essential oils inherently 
possess antibacterial, antifungal and antiviral properties. These properties tend to change if the 
oils get oxidized and become rancid. These properties of the oils can be preserved by designing 
different formulations. These formulations can also be used for controlled release applications. 
The formulations may either be liquid, semi-solid or solid dosage forms. The oil-based liquid, 
semisolid and solid dosage forms are emulsions, organogels and microparticles, respectively. 
2 
Organogels entrap apolar liquid within a three-dimensional and thermo-reversible gel network. 
The apolar liquid can be either an organic solvent or vegetable oil. Over the last two decades, 
organogels have been explored as drug delivery matrices in pharmaceutical applications and 
saturated/trans fat replacers in food applications. The use of organogel based formulations has 
been increasing, which may be attributed to the easy method of preparation, cost effectiveness, 
inherent long-term stability of these products. The organogels have the capability to carry both 
hydrophilic and lipophilic constituents [10]. In the present study, organogels are prepared using 
non-essential oils such as sunflower oil, sesame oil and soy bean oil. Further, the stable semi-
solid organogels are encapsulated within the alginate microparticles and convert to solid dosage 
forms. 
In general, microparticles are the first choice of dosage forms for the encapsulation of vegetable 
oils. Encapsulation strategies help in converting oils into solid dosage forms and enables 
retention of their activity for longer periods of time. The role of polymers is very important in 
improving the encapsulation efficiency of the vegetable oils. Coating of the microparticles with 
another polymer (complex and composite microparticles) has been mainly used to improve the 
encapsulation efficiency. Better encapsulation efficiency is possible if the wall materials of 
microparticles possess both hydrophilic and hydrophobic nature [11]. But, in general, 
biopolymers are hydrophilic in nature. Hydrophobicity of the biopolymers may be improved by 
complexing the biopolymers with synthetic polymers [11]. But, the process is a tedious and time 
consuming process. Keeping this in mind, we hypothesized that instead of coating/complexing, 
the encapsulation efficiency can be improved by immobilizing the internal phase. Hence, 
attempts were made to encapsulate organogels (immobilized vegetable oils) within the 
microparticles. Alginate was chosen as the representative polymer, as alginate forms porous 
matrix in the microparticles and hence allows the leaching of the internal phase.  
3 
Chapter 2 
Review of Literature 
2.1. Organogels 
Organogels are defined as the semi-solid formulations; which comprises a 3 dimensional (3-D) 
network structure of gelator molecules, and an immobilized apolar liquid [12]. Organogels have 
been synthesized using diverse group of gelators (e.g. low molecular weight organogelators 
(LMOGs) and polymeric organogelators) and organic apolar solvents. During the formation of 
organogels, the gelator molecules form a 3-D architecture either by chemical cross-linking 
(covalent or ionic bonds) or physical entanglement (hydrogen bonds, Van der Waal forces, π-π 
interactions) to immobilize the apolar phase. The formation of organogels via chemical reactions 
are referred as chemical gels [13]. On the other hand, formation of organogels via physical 
entanglement are referred as physical gels [13]. Organogel formation occurs due to the 
interaction of structures that develop due to the 3-D assembly of organogelators. Such 
organogelator structures may be either solid (formed during precipitation of the organogelators 
from the solution in an apolar solvent) or fluid-filled (resulting from the entrapment of the 
aqueous phase within the gelator structures) [13]. The properties of organogels mainly depend on 
the structuring ability of the organogelators and the properties of the incorporated compounds 
(e.g. drugs or bioactives). The structure of the organogel depends on a number of factors, 
namely, the method of gel preparation, the nature of the solvent, gelator and co-gelator, and the 
interactions between the components involved. These structures include, but are not limited to, 
reverse worm-like micelles [14], reverse spherical micelles [15-16], microemulsions [17], 
nanotubes [18], twisted or helical nanofibers [18], fibers [19], gel strands in lamellar form [20], 
and crystal networks [21]. The size and shape of the 3-D structures is dependent on the gelator-
solvent interactions. A comprehensive list of the organogelators used in pharmaceutical 
applications is tabulated in Table 2.1. 
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Table 2.1: List of organogelators used in pharmaceutical applications 
S. No. Class Example Reference 
1. Low molecular weight organogelators 
i. Anthryl and anthraquinone derivative 
organogelators 
2,3-didecycloxytetracene [22] 
Sterol organogelators 
a. ALS organogelators Cholesteryl 4-(2-anthryloxy) 
butanoate 
[10] 
b. A(LS)2  organogelators Diacid monoamides of 
cholesteryl glycinate ammonium 
salts 
[23] 
c. Organometallic cholesterol-based 
organogelators 
Palladium pincer bis (carbene) 
complex 
[24]  
d. Aminoacid-sterol based organogelators Cholesteryl L-phenyl alaninate [25]  
e. Bile acid-steroid organogelators Cholic acid amino-alkylamides [26]  
ii. Gemini organogelators Bis (N-lauroyl-L-lysine ethyl 
ester) oxyl amide 
[27] 
iii. Amino acid type organogelators Phenylalanine derivatives of N-
protected phthaloylhydrazide 
amino acids 
[28] 
iv. Fatty acid organogelators Lecithin, Spans, Tweens 
phytosterols+oryzanol 
compounds, Stearic acid and its 
derivatives 
[29-30] 
v. Sugar-based organogelators derivatives of methyl glycosides 
of 4,6-O-benzylidine 
[31] 
2. Polymeric organogelators Poly(ethylene) [32] 
Amongst the organogelators tabulated in Table 2.1, fatty acyl organogelators have been mostly 
used to immobilize vegetable oils [14, 16, 21]. 
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2.1.1. Mechanism of organogel formation 
In general, three mechanisms of organogel formation have been proposed. The first mechanism 
explains the formation of networked structures with fluid-filled fibers, while the second 
mechanism describes those formed by solid fibers. These two mechanisms involve non-covalent 
intermolecular physical interactions. Most LMOGs form organogels by either of these two 
mechanisms. The significant difference between the fluid-filled matrix and solid matrix 
organogels lies in their kinetic behavior. The fluid matrix-type organogels form a transient, 
dynamic gel structure (worm-like or polymer-like) which undergoes constant remodeling. On the 
other hand, solid matrix organogels are robust and exhibit a stable gel network over the gel’s 
lifetime [13]. Schematic representation of the fluid-filled matrix and solid fiber mechanisms have 
been shown in Figure 2.1. The third mechanism describes the formation of 3-D network of 
crosslinked polymers by covalent and ionic interactions. The process of immobilization of apolar 
solvents within these networked structures has been attributed to surface activity present amongst 
the gelator and solvent molecules. The stability of the organogels is significantly affected by 
composition, properties of the bioactive compounds incorporated and functionality. 
 
Figure 2.1: Schematic representation of: (a) Fluid fiber, (b) Solid fiber, and (c) 
Polymerization mechanism. 
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2.2. Types of vegetable oil-based formulations 
Vegetable oils have been encapsulated by different routes. Figure 2.2 illustrates the different 
strategies being adopted to encapsulate the vegetable oils. The current section is devoted to 
discuss, in brief, the different strategies adopted to encapsulate vegetable oils. 
 
Figure 2.2: Schematic illustration of the encapsulation strategies of the vegetable oils 
2.2.2. Multiple emulsions 
Multiple emulsions have been developed since 1965, for pharmaceutical, cosmetic and food 
applications [33]. Multiple emulsions are three-phase systems, which can be either W/O/W or 
O/W/O-type emulsions (W: water; O: oil) (Figure 2.3a). As compared to O/W/O emulsions, 
W/O/W emulsions have been largely employed for the delivery of bioactive ingredients (Figure 
2.3). In general, W/O/W emulsions are being prepared by phase inversion method either by one-
step emulsification or two-step emulsification [34]. Cournarie et al. (2004) reported that two-step 
emulsification method exhibits higher encapsulation efficiencies as compared to one-step 
emulsification method [35]. The advantages and problems associated with the multiple 
emulsions have been tabulated in Table 2.2. Insulin-loaded W/O/W multiple emulsions showed a 
decrease in the blood glucose level in diabetic rats [36]. The oil phase was either medium-chain 
triglycerides or long-chain triglycerides (fish oil). In an another study, insulin loaded multiple 
emulsions were prepared using soy bean oil or medium-chain triglycerides [37]. Under in vitro 
conditions, the multiple emulsions were found to protect insulin from protease action. The 
release of insulin was found to be swelling-break down mediated. Multiple emulsions have also 
been synthesized using different non-essential oils, viz., canola oil, sesame oil, peanut oil and 
safflower oil [38-40]. 
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Table 2.2: The advantages and problems associated with multiple emulsions. 
Advantages Problems and remedies 
Ability to carry both hydrophilic and hydrophobic 
bioactive ingredients. 
[2, 41] The inherent 
thermodynamic stability 
is the major hurdle of the 
multiple emulsions. The 
stability of the emulsions 
can be improved by 
adding complex forming 
or gelling agents to the 
internal phase. 
[42] 
Prolonged drug release systems. [43] 
W/O/W-type emulsions can be used for drug 
delivery, drug targeting and particularly as 
lymphotropic agents. 
[44] 
Protects the bioactive ingredient from 
gastrointestinal harsh (pH, enzymatic degradation) 
conditions. 
[41] 
Taste/smell masking [45] 
Purity of the vegetable oils alters the stability of the multiple emulsions. W/O/W emulsions may 
be stabilized using low fluidity lipids. Low fluidity lipids possess low melting points and prevent 
the leaching/flow of the internal phase during storage, which in turn, improves the stability of the 
formulations. Multiple emulsions with low fluidity lipids are called as multiple lipid carriers 
[34]. In general, low fluidity lipids are semi-solid at room-temperature. The absorption of 
microcrystalline lipid particles at the W/O interface provides stability to the emulsion system 
[46]. Lee et al. (2011) synthesized multiple lipid carriers using coconut oil (melting point: 28 ºC) 
as the lipid phase [34]. Low fluidity lipid was prepared by adding PEG-30 dipolyhydroxy 
stearate to the molten coconut oil (40 ºC). The external water phase of the multiple emulsions 
was also thickened using either xanthan gum or carbomer or polyvinyl alcohol. The decrease in 
fluid flow and amorphous state of the lipid contributed to the high-drug loading capacity of the 
multiple lipid carriers [43]. 
 
Figure 2.3: Schematic representation of: (a) Multiple emulsion, and (b) Capsules. 
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2.2.3. Capsules 
Capsules are unit dosage containers to carry bioactive agents in the form of either soft capsules 
or hard capsules (Figure 2.3b). Conventionally, soft capsules have been used to carry liquids, 
whereas, hard capsules are used for the delivery of solids (powders and pellets). In general, 
gelatin is the most frequently used polymer to prepare capsules. During preparation of the hard 
capsules, water is used as the plasticizer, whereas, for soft capsules glycerin is used as the 
plasticizer. Presence of glycerin enhances the oxygen permeability and relative humidity in the 
soft capsules [47]. Due to this reason, hard capsules posses lower oxygen permeability over soft 
capsules. Since lipid oxidation is one of the main problems associated with oils, soft capsules are 
not suitable for the encapsulation of the oils. Hence, hard capsules are the preferred choice. To 
improve the oral bioavailability of the poorly water-soluble active ingredients, hard gelatin 
capsules are developed as lipophilic liquid vehicles and semi-solid lipophilic vehicles. 
Encapsulation of the bioactive agents as liquid or semi-solid formulations provides opportunity 
for delivering water insoluble bioactive agents with reproducible absorption and acceptable 
bioavailability. Non-essential oils are being used as excipients during the synthesis of either 
lipophilic liquid vehicles or semi-solid lipophilic vehicles. Non-essential oils are biocompatible 
and have the ability to carry lipophilic drugs. The commonly used non-essential oils are arachis 
oil, castor oil, corn oil, cotton seed oil, olive oil, sesame oil, soy bean oil and sunflower oil [48]. 
But, the encapsulation of the essential oils in the capsules is limited. This may be due to the 
higher lipid oxidation of the essential oils over non-essential oils. As capsules do not provide 
sufficient barrier for the oxygen transfer, essential oils may get rancid after the encapsulation. 
The replacement of gelatin was expected to solve the problem. Gelatin-gum arabic capsules 
showed a protective effect against the oxidation of flax seed oil during storage (25 days) at room-
temperature [49]. Alginate complex capsules containing eucalyptus oil were prepared by 
interfacial insolubilization reaction [50]. The capsules showed 90-92 % of the oil encapsulation 
efficiency. To improve the stabilization of the essential oils, complex capsules and nanocapsules 
have been designed. Alginate nanocapsules were prepared to encapsulate the turmeric oil [51]. 
2.2.4. Nanoparticles 
Nanoscale biopolymeric particles have attracted much attention for the development of new 
formulations for the controlled release systems and to enhance the stability of the essential oils. 
Polymer-based nanoparticles are classified as nanocapsules and nanospheres. They differ from 
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each other in terms of their structure. Nanocapsules possess a polymeric wall encapsulating the 
oil core, whereas, the oil may be conjugated with the polymeric wall or matrix in nanospheres 
(Figure 2.4) [52]. 
 
Figure 2.4: Schematic representation of: (a) Nanocapsules, (b) Nanospheres, and (c) SLNs. 
Turmeric oil has been used in the pharmaceutical formulations for its antibacterial, antifungal, 
anticarcinogenic, antioxidant and antimutagenic properties. But the oil is volatile and insoluble in 
water. Alginate nanocapsules containing turmeric oil prevented the vapourization and enhanced 
the water solubilization potential of the oil [51]. Chitosan nanoparticles (40-80 nm) containing 
oregano oil were synthesized. After encapsulation, the antioxidant and antimicrobial activities of 
the oil were retained. The encapsulation efficiency of the developed nanoparticles was found to 
be 21-47 % at different oil loading ratios [53]. Blends of chitosan/angico gum (10-60 nm) and 
alginate/cashew gum (223–399 nm) were used to encapsulate Lippia sidoides essential oil. 16 to 
77 % of encapsulation efficiency of Lippia sidoides essential oil was achieved when 
chitosan/angico gum nanoparticles were prepared [54]. But these nanoparticles showed poor 
stability and low oil release profiles. These properties (stability and oil release profiles) were 
improved by encapsulating the essential oil within alginate/cashew gum nanoparticles [55]. But 
the encapsulation efficiency of the oil was reduced to 21 to 48 %. Chitosan/angico gum 
naoparticles showed 80 % oil release after 60 h, whereas, alginate/cashew gum nanoparticles 
released 90 % of the encapsulated oil after 45 h. The higher and faster release of the oil from 
alginate/cashew gum was due to the increased hydrophilicity of the nanoparticles as compared to 
the chitosan/angico gum nanoparticles. 
2.2.5. Solid lipid nanoparticles 
Solid lipid nanoparticles (SLNs) are nanoscale sized particles prepared using lipids that are solid 
at room-temperature. The lipid component of the SLNs may be constituted by triacylglycerols or 
waxes. Vegetable oils are encapsulated within the lipid matrix of the nanoparticles (Figure 2.4c). 
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The size range of SLNs varies from 50 nm to 1 µm. SLNs carry the active ingredients either in 
the core or on their wall. They are highly advantageous in carrying lipophilic active components. 
They offer good protection, less leakage, and sustained release of the bioactive agents. AlHaj et 
al. (2010) developed SLNs using hydrogenated palm oil (Softisan 154) and Nigella sativa 
essential oil as the lipid matrix [56]. These SLNs were found to be stable at different storage 
temperatures during the three month study. Artemisia arborescens essential oil was encapsulated 
in SLNs (~223 nm) using Compritol 888 ATO as the lipid [57]. The SLNs were physically 
stable. They have retained the antiviral properties of the oil even after 2 years of storage. SLNs 
(~113 nm) of Compritol 888 ATO were also used to encapsulate the frankincense and myrrh 
essential oil [58]. SLNs containing Zataria multiflora essential oil showed only 38.66 % 
encapsulation efficiency [59]. The physicochemical characterization studies revealed that the oil 
interacted with the lipid matrix of the SLNs. 
2.2.6. Beads and microcapsules/microparticles 
Beads and microparticles have been synthesized to prepare food, pharmaceutical, nutraceutical 
and cosmetic products with high oil content in a reduced product volume. These formulations are 
mainly employed to encapsulate essential oils. Essential oils have been encapsulated for many 
reasons, viz., to prevent oxidation, nutrition, therapeutics, flavoring or aroma (Table 2.3) [60]. 
Though beads and microparticles can carry high amounts of vegetable oils, they suffer with 
oxidation and leaching of oils during synthesis, storage and transportation. In general, vegetable 
oils with either unsaturated or polyunsaturated fatty acids are susceptible to oxidation. Lipid 
oxidation causes rancidity and affects the nutritional and health benefits of the vegetable oils. 
Lipid oxidation is governed by oxygen, heat or light. Storage of wheat bran oil containing 
alginate beads in the dark at 4 ºC proved to be very effective as compared to their storage in the 
presence of light at 25 ºC [61]. Storage of beads under these conditions prevented the oxidative 
degradation of nutritionally important compounds (vitamin E, lutein, zeaxanthin and β-carotene). 
Microparticles made of gum arabic and its ternary mixtures with maltodextrin and whey protein 
isolate presented high protection from oxidation to linseed oil (tested by accelerated Rancimat 
test) [62]. These microparticles showed very high encapsulation efficiencies (> 90 %) of linseed 
oil. To prevent the lipid oxidation and to improve the release parameters of flax seed oil, the oil 
was encapsulated in the wall materials of either chickpea or lentil protein isolate and 
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maltodextrin [63]. As compared to the unencapsulated oil, the encapsulated flax seed oil did not 
undergo oxidation over a period of 25 days, when stored at room-temperature. Apart from 
protection against lipid oxidation, the developed microcapsules showed high encapsulation 
efficiencies of flax seed oil. Flax seed oil encapsulation efficiency was higher in lentil protein 
isolate-maltodextrin microcapsules (~ 88 %) relative to the chickpea isolate-maltodextrin 
microcapsules (~ 86.3 %). 
In addition to the lipid oxidation, leaching of the encapsulated oils is another major concern 
associated with the beads and microparticles. In general, leaching is due to the porous nature of 
the formulations. The oil loading capacity can be enhanced by coating the microparticles with 
another polymer, increasing the polymer concentration and curing time of polymer crosslinking. 
Calcium alginate beads with high palm oil content were achieved by varying the alginate 
concentration, type of alginate and drying properties. Palm oil encapsulation efficiency was 
highest (85 to 90 %) when the beads were prepared using alginate (25 g/L) having high guluronic 
acid (M/G ratio = 0.59, molecular weight ~ 97,000) at 50 % oil loading [60]. Calcium alginate 
beads lost 7 to 10 % of the encapsulated oil when the beads were oven-dried at 70 ºC. In contrast 
to the oven-drying, beads did not lose the encapsulated oil when they were freeze-dried at -55 ºC. 
This shows that the encapsulation of oils was influenced by the process parameters, such as, type 
and concentration of the polymer, amount of oil loading and drying conditions. Encapsulation of 
the oils does not always increase when the polymeric microparticles/beads are coated with 
another polymer. Chitosan-cashew gum beads (2.4 %) showed lower encapsulation efficiency of 
the essential oil (from the leaves of Lippia sidoides) as compared to chitosan beads (4.4 %) [64]. 
During the preparation of chitosan-cashew gum beads, the essential oil was leached out of the 
chitosan beads when they were incubated (30 min) in cashew gum solution. In another 
independent study, encapsulation efficiency of linanlool (monoterpene found in the essential oils 
of plants) was found to be 71 to 75 % in calcium alginate microparticles [65]. Impregnation of 
the alginate layer with modified starch resulted in the reduction of the encapsulation efficiency to 
69 %. However, when linalool was encapsulated along with glycerol and modified starch, the 
encapsulation efficiency was enhanced to 86 %. Glycerol improved the viscosity and emulsion 
stability, which in turn, enhanced the encapsulation efficiency. Blending of modified starch with 
maltodextrin improved the encapsulation efficiency of rosemary essential oil (60.22 %) as 
compared to the modified starch microcapsules (56.79 %) [66]. The efficiency was 45.45 % 
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when modified starch and inulin blend was used. In the same study, it was found that the 
encapsulation efficiency of rosemary oil was lower in the blends of gum arabic: maltodextrin 
(45.45 %) and gum arabic: inulin (29.53 %) microcapsules as compared to gum arabic 
microcapsules (56.83 %). These studies signify that it is important to carefully choose the 
polymer solutions and other components for the encapsulation of oils. 
Effective and efficient encapsulation is possible if the wall materials possess both hydrophilic 
and hydrophobic groups [11]. Such polymers enable the emulsification and stabilization of the 
formulations. In this regard, Sarkar et al. (2013) enhanced the hydrophobicity of gum arabic by 
mixing octenyl succinate derivative for the encapsulation of mint oil [11]. The microcapsules 
with gum arabic and octenyl succinate derivative (encapsulation efficiency: 84.19 %) were better 
than gum arabic microcapsules (encapsulation efficiency: 80.66 %). In another study, gum arabic 
and whey protein mixture was successfully used to encapsulate three different oils, namely, 
sunflower oil, lemon oil and orange oil. The oil encapsulation efficiency was > 80 % for each 
formulation. Microencapsulation of l-menthol was studied in gum arabic and gum arabic: 
modified starch mixture (Commercially available modified starches are CAPSUL and HI-CAP 
100). Higher encapsulation efficiency was achieved when HI-CAP 100 (85 %) was used as 
compared to CAPSUL (79 %) and gum arabic (68 %) [67]. Presence of oil as the internal phase 
helps in enhancing the hydrophobicity of the formulation. This, in turn, helps increasing the 
encapsulation efficiency. 
With the advancement in drug delivery technology, an alternative approach to improve the 
hydrophobicity of the biopolymeric microparticles has been designed. In this approach, the drug 
molecules are dissolved/dispersed in the vegetable oil and the oil is subsequently gellified using 
a gelating agent to form semi-solid organogels. The organogels are dispersed in an aqueous 
solution of biopolymer. Crosslinking of the biopolymer resulted in the formation of organogel 
containing microparticles. Using this approach, vegetable fat-based organogels, animal fat-based 
organogels and polysorbate fatty acyl organogels were encapsulated within alginate 
microparticles [68-70]. The aforementioned approach was independently developed by another 
group of researchers with modification. In this approach, the organogels were dispersed and 
stabilized in an aqueous medium using a stabilizer so as to form gelled oil particles [71]. 
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Table 2.3: Advantages and problems associated with beads and microparticles. 
Advantages  Problems  
Protection from evaporation, leaching and/or 
oxidation of vegetable oils 
[60-61] Involvement of multiple steps 
in the method of preparation. 
Sometimes, this may leads to 
lower the encapsulation 
efficiency 
[72] 
Controlled-release applications [67] 
Easy handling [73] 
Taste/smell masking [73] 
2.3. Preparation methods of microparticles 
The techniques used for the encapsulation of oils are spray drying [67], coacervation [74], 
emulsion extrusion [75], solvent evaporation [76], ionotropic gelation [77], co-axial electrospray 
[78] and supercritical fluid impregnation method [79]. 
2.3.1. Spray drying 
Spray drying is a widely used technique for the encapsulation of oils in microparticles. Spray 
drying involves rapid atomization of the bioactive agent containing solution/emulsion to drying 
medium at high temperature (Figure 2.5a). Temperature is maintained by pumping hot air in the 
direction opposite to the spraying direction of the emulsion. The sudden change in temperature 
leads to the quick evaporation of water and subsequent formation of solid microparticles with the 
entrapment of the core material [80]. The advantages of this method include, easy availability of 
machinery and easy regulation of the microparticle size. The disadvantage associated with this 
method is the use of high temperature for the drying process. Spray drying technology requires 
fine tuned operating conditions and sufficient amount of solution with active ingredient. The 
operating conditions include air inlet temperature, atomization air flow, liquid flow rate, 
aspirator suction velocity and solid concentration [81]. 
Encapsulation efficiency of the microparticles in spray drying is dependent on some key steps 
viz., preparation of the stable oil-in-water emulsion and spraying of the emulsion into small 
droplets on to the drying bed [9]. Spraying of the emulsion to the requisite droplet size and 
drying of the droplets depends on the emulsion properties. Hence, the weight ratio of hydrophilic 
and lipophilic phases, oil droplet size distribution in the emulsion, the dry matter content in the 
emulsion and the viscosity of the emulsion needs to be optimized prior to spray drying. The 
success of spray drying is mainly influenced by the oil droplet size distribution in the emulsion 
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[82]. The choice of polymer is also important as it constitutes the dry matter of the microparticles 
[83]. For spray drying, the carriers should possess emulsion forming abilities with reasonable 
viscosity so as to be pumped and sprayed. The emulsions should not be sticky and hygroscopic 
after drying. Otherwise, it will affect the stability of the microparticles during storage. The main 
carriers for spray drying in food and pharmaceutical industries are polysaccharides, starches, 
gums, celluloses and proteins. These have been used in either alone or in combination. 
 
Figure 2.5: Schematic representation of: (a) Spray drying, and (b) Coacervation methods. 
2.3.2. Coacervation 
Coacervation is a technique that involves the partial desolvation of a homogeneous polymer 
solution into a polymer rich phase (coacervate) and polymer poor phase (coacervation medium) 
by the addition of a desolvating or coacervating agent (Figure 2.5b). During the process of 
encapsulation, the bioactive agent will be encapsulated within the polymer rich phase. 
Coacervation can be achieved in two ways: simple coacervation and complex coacervation. Both 
the techniques are identical to each other, differing only in the phase separation process. 
In simple coacervation, water soluble desolvating agent is added to the polymer solution. 
Desolvating agent separates the aqueous phase from the polymer molecules, which in turn, 
affects the solubility of the polymer molecules. The polymer rich phase gets precipitated as 
spherical droplets. Crosslinking of these spherical droplets results in the formation of stable 
15 
microparticles. Choice of crosslinking agents depends on the type of biopolymer used. In 
general, glutaraldehyde, genipin and calcium salts have been widely used as the crosslinking 
agents. The polymers used in the coacervation process are alginate, chitosan, gelatin, cellulose 
derivatives and proteins [84-90]. Generally used desolvating agents include alcohols (ethanol, 
propanol, isopropanol, tertiary butyl alcohol), acetone and sodium sulfate [91-92]. 
On the other hand, the complex coacervation technique involves complexation between two 
oppositely charged polymers. Complex coacervation involves three basic steps. First step 
involves the formation of three immiscible phases; liquid vehicle, core material and coating 
material. The core material is dispersed in a solution of coating polymeric material. The coating 
material is made immiscible either by adding desolvating agent or salt or incompatible polymer 
or by inducing polymer-polymer interactions or by changing the temperature of the polymer 
solution. The second step involves the deposition of the liquid polymer on the core material. 
Finally, the third step involves the stabilization of the microcapsules by crosslinking, desolvation 
or thermal treatment. In general, protein-polysaccharide complexes (gelatin-pectin, whey 
protein-gum arabic, gelatin-acacia gum, β-lactoglobulin-acacia gum, gelatin-heparin, gelatin-
carboxymethyl guar gum and albumin-alginic acid) are being used in complex coacervation [93-
100]. 
2.3.3. Coaxial electrospray method 
In general, encapsulation of oils and/or bioactive agents is mainly fabricated by emulsification 
processes, spray drying coacervation and solvent extraction methods. These processes involve 
the application of mechanical forces, chemical reagents and thermal treatment which may lead to 
polymer degradation or denaturation or aggregation [101]. These problems are more pronounced 
in protein-based polymers. In most of the cases, the microparticles/nanoparticles synthesized by 
these methods possess broad size distribution. Presence of multiple steps in each process results 
in the decrease in the encapsulation efficiency. Considering the limitations associated with the 
emulsification and other related processes, electrospray method was proposed. 
Single-axial electrospray method was designed initially. The technical advancements lead to the 
transformation of single-axial electrospray method to coaxial electrospray method. Coaxial 
electrospray differs from the single-axial electrospray in the use of a coaxial capillary needle to 
deliver two liquids independently [101]. Coaxial electrospray allows preparation of multilayered 
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particles having sizes ranging from tens of nanometers to hundreds of micrometers. This process 
introduces high electric field between the coaxial capillary needle and the ground (Figure 2.6a). 
The resultant electrical shear stress elongates the shell (polymer) liquid and core (oil) liquid at 
the needle outlet so as to form an inverted triangle shape or “Taylor cone” [102]. At the end of 
the cone, the liquid propels out and breaks into multilayer droplets. It is possible to achieve 100 
% encapsulation efficiency (using this method) due to the precise control over the core-shell 
geometry. This process protects the fragile therapeutic molecules from denaturation and 
aggregation [103]. Coaxial electrospray method was successfully used to encapsulate peppermint 
oil in alginate-pectin microcapsules [78]. 
 
Figure 2.6: Schematic representation of: (a) Co-axial electrospray, and (b) Supercritical 
fluid technology. 
2.3.4. Supercritical fluid technology 
Supercritical fluid technology was developed to minimize the drawbacks associated with the 
traditional encapsulation methods. It is generally preferred for the essential oils which are 
sensitive to high temperature, oxygen and chemicals. For example, oregano oil degrades at ~80 
o
C, so supercritical fluid technology was employed instead of spray drying [79]. Supercritical 
fluid technology is an eco-friendly approach, where, supercritical carbon dioxide (sc-CO2) is 
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used as the green solvent. sc-CO2 possess the properties which are ideal for the encapsulation of 
bioactive agents. The characteristic properties of sc-CO2 are lower viscosity, higher diffusivity, 
lower surface tension, faster process and high solubility of the active compound [79]. This 
technology is also termed as supercritical solvent impregnation. This process has been successful 
in the encapsulation of oil, fragrances and pharmaceutical ingredients etc. 
Schematic sketch of the principle of this technology was shown in Figure 2.6b. The supercritical 
impregnation apparatus consist of a high pressure stainless steel impregnation cell, a magnetic 
stirrer plate, a temperature controlled water bath, a high pressure CO2 pump and a pressure 
transducer. The impregnation cell contains two chambers separated by a mesh. Lower chamber is 
loaded with the essential oil and the upper chamber is loaded with microparticles or matrices in 
which the oil needs to be impregnated. During the assay, the cell is immersed in the water bath 
(40 to 50 
o
C) and CO2 is pumped (10-12 kPa) into the cell after achieving the desired 
temperature. For better impregnation, homogenization is done by using magnetic stirrer. After 
impregnation time (~2 h), the system is depressurized after reducing the temperature of the water 
bath (~10 
o
C). At lower temperature, dissolution of the oil in sc-CO2 is minimized. Slow 
depressurization (0.07–0.15 MPa/min) is preferred over the fast depressurization. Thereafter, 
depressurizing, the oil impregnated microparticles are collected [104]. Heat sensitive lavandin 
(Lavandula hybrida) essential oil and oregano oil were encapsulated in modified starches by this 
method [79, 104]. 
In this study, ionotropic gelation method was chosen to encapsulate vegetable oils and 
organogels. Rationality behind the selection of the method is: 
 Spray drying involves high temperature, which may destabilize the organogels. 
 Coacervation, emulsion extrusion and solvent evaporation methods use organic solvents, 
which are usually non-biocompatible. 
 Co-axial electrospray and supercritical fluid impregnation methods are advanced techniques 
and are not cost-effective. 
2.3.5. Ionotropic gelation/ internal gelation method 
In general, ionotropic gelation method has been extensively employed to prepare alginate 
microparticles [77]. This method is schematically shown in Figure 2.7. The polymer solution is 
mixed with vegetable oil and/or bioactive agent so as to form a primary emulsion. The primary 
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emulsion is slowly added to the bulk oil (may be different from the encapsulated oil) at 4 
o
C, 
under continuous stirring. Under these conditions, the primary emulsion droplets get dispersed in 
the bulk oil phase by forming oil-in-water-in-oil multiple emulsion. Addition of the crosslinker 
to the emulsion facilitates the formation of microparticles by inducing gelation of the polymeric 
layer. The microparticles are collected, washed and dried. After collecting, the microparticles can 
be hardened by incubating in the crosslinker solution. Internal gelation method has been 
employed to encapsulate organogels within alginate microparticles [68-70]. 
 
Figure 2.7: Schematic representation of the ionotroic gelation method. 
Though alginate has been extensively reported in the literature, the main problem associated with 
the alginate microparticles is their porous nature which in turn leads to the leaching of the 
encapsulating agent [105]. This problem was tried to be solved by incorporating the semi-solid 
organogels as the core material of the microparticles.  
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2.4. Research objectives 
To negate the leaching of the internal phase, we propose that the gelation of the internal apolar 
phase may prevent its leaching from the porous alginate microparticles. Based on this 
hypothesis, following objectives were made. 
1. Encapsulation of cocoa butter and mango butter based organogels in alginate microparticles  
2. Encapsulation of lanolin based organogels in alginate microparticles  
3. Encapsulation of stearate organogels in alginate microparticles  
4. Encapsulation of Span 80-Tween 80 based organogels in alginate microparticles 
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Chapter 3 
Materials and methods 
3.1. Materials 
Sodium alginate, stearic acid, calcium carbonate, calcium chloride (fused), potassium dihydrogen 
phosphate, rhodamine B, Span 80, Tween 80 and dialysis tubing (MW cut-off 12 kDa) were 
purchased from Himedia, Mumbai, India. Cocoa butter and mango butter were procured from NV 
Organics (P) Ltd, New Delhi, India. Anhydrous lanolin was procured from Loba Chemie, 
Mumbai, India. Fluoral yellow 088 was purchased from Sigma-Aldrich, Mumbai, India. Glacial 
acetic acid was purchased from MERCK, Mumbai, India. Refined palm oil (Purti Vanaspati Pvt. 
Ltd. West Bengal, India), Refined sesame oil (Tilsona
®
, Recon oil industries Pvt. Ltd., Mumbai, 
India), soy bean oil (Saffola
®
, Marico Pvt. Ltd., Jalgaon, India) and sunflower oil (Fortune 
sunlite
®
, Adani Wilmar Ltd. Gujarat, India) were purchased from the local market. Metronidazole 
(MZ) was a kind gift from Aarthi drugs, Mumbai, India. Fresh goat’s small intestine was 
procured from the local butcher shop. MG63 cell line was procured from NCCS, Pune, India. 
Double distilled water was used throughout the study. All the experiments were performed in 
duplicates. 
3.2. Preparation of formulations 
3.2.1. Preparation of cocoa butter and mango butter-based organogels 
Emulsions of cocoa butter and mango butter were prepared by hot emulsification method [12]. 
Accurately weighed cocoa butter and span 80 were melted at 45 °C using a temperature 
controlled water-bath. The above mixture was homogenized for 5 min at 1200 rpm (45 °C) using 
an overhead stirrer (RQ-126/D, Remi Motors Ltd, India). Gelatin solution (20% w/w, 45 °C) was 
added drop-by-drop to the mixture and homogenized for another 15 min at the same temperature. 
The hot homogenized emulsion was put into culture bottles (10 ml) and incubated at room-
temperature (25 
o
C) for 30 min to induce gelation. Similarly, mango butter based formulations 
were also made. Drug loaded organogels were prepared by dissolving 0.5 % (w/w) 
metronidazole in the emulsion. The stable organogels were stored at 4 °C for further analysis. 
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3.2.2. Preparation of lanolin-based organogels 
Ten grams of lanolin was liquified at 55 °C. 0.1 g of SMO (1% w/w) was added to the molten 
lanolin and was homogenized at 1500 rpm using an over-head stirrer. This was followed by the 
drop-wise addition of double distilled water to the above mixture with continuous 
homogenization. The homogenization was continued till 15 min after the addition of water. The 
amount of double distilled water was varied so as to obtain semi-solid formulations having 
various proportions of lanolin and water. Metronidazole was used as the model drug. Drug 
containing formulations were prepared by dispersing drug (1 % (w/w)) in lanolin. The rest of the 
procedure was same. 
3.2.3 Preparation of stearate organogels 
Sesame oil and soy bean oil organogels were prepared using stearic acid as the organogelator 
[106]. Stearic acid was dissolved in either sesame oil or soy bean oil at 70 ºC in 15 ml vials. The 
hot stearic acid solution was cooled down to room–temperature (25 oC). This resulted in the 
formation of either cloudy suspension or organogel. To determine the critical gelation 
concentration (CGC) of stearic acid, the concentration of stearic acid was varied from 1 % (w/w) 
to 25 % (w/w). Drug containing organogels were prepared by dispersing ciprofloxacin (0.5 % 
w/w) in the hot stearic acid solution. 
3.2.4. Preparation of Span 80-Tween 80 organogels 
5.25 g of the surfactant mixture (Span 80: Tween 80 ratio of 1:2 w/w) and 1.25 g of sunflower 
oil were mixed to form a homogenous solution at room-temperature. To this, 3.25 g of water was 
added drop-by-drop with continuous mixing at 500 rpm. The homogeneous mixture was allowed 
to settle at room-temperature to form organogel. The prepared organogel was labeled as ‘OG’ 
and used for further studies. To prepare the drug containing organogels, 1 % (w/w) 
metronidazole was dispersed in water and the drug containing water was used for the preparation 
of the organogels. The metronidazole containing organogels were labeled as OGMZ. 
3.2.5. Preparation of microparticles 
The microparticles were synthesized by modified double emulsion method or internal gelation 
method [107]. Briefly, 0.5 g of sodium alginate was dissolved in 20 g of water, kept on stirring at 
250 rpm at room-temperature. After complete dissolution of the sodium alginate, 0.4 g calcium 
carbonate was added and homogenized at 250 rpm. Then, a mixture of 0.5 g of span 80 and 5 g 
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of internal phase was added and further homogenized for 15 min to form an oil-in-water 
emulsion. The internal phase was either vegetable oil or organogel. The emulsion was further 
homogenized in an ice-bath for 10 min to form a thick emulsion. The thick emulsion, so 
obtained, was transferred to 60 ml of ice-cold sunflower oil (external phase) and homogenized 
for 5 min at 250 rpm to form a double emulsion. After the homogenization, 5 ml of acidified oil 
(4.5 ml sunflower oil + 0.5 ml glacial acetic acid) was added to the external phase of the double 
emulsion (which is under stirring) to induce ionic crosslinking and gelation of the alginate layer 
to form microparticles. The microparticles were washed with 0.5M calcium chloride solution 
containing 1 % (v/v) Tween 80, followed by washing with water. The microparticles without any 
internal phase (i.e. organogel or vegetable oil) were labeled as blank microparticles. Drug 
containing microparticles were also prepared as described above, but the internal phases of 
microparticles were changed with drug containing internal phases. 
3.3. Characterization of the formulations 
3.3.1. Microscopic studies 
Microstructure of the formulations was observed using an upright bright-field microscope (Leica 
DM750 equipped with ICC50 HD camera, Germany), phase contrast microscope (Primo vert Carl 
Zeiss GMBH, Germany), fluorescence microscope (FM) (Carl-zeiss-HBO 50) with ProgRes 
capture 2.8 software, polarized light microscope (Leica DMLP attached with Leica DFC 295 
camera) and confocal laser scanning microscope (FV1000 confocal microscope, Olympus, USA). 
For fluorescence microscopy, rhodamine dye solution in water was used as the aqueous phase for 
the preparation of samples. The microparticles for confocal laser scanning microscopy were 
prepared by dissolving fluoral yellow 088 (0.1 % w/w) dye in either organogels or palm oil. The 
dye containing organogels and palm oil were used for the preparation of the microparticles. The 
chromophore (fluoral yellow 088) containing microparticles were excited at 405 nm and the 
fluorescence was observed at 515 nm [108]. The microparticles were sputter coated with platinum 
before the study. Size distribution of the emulsion droplets was analyzed using National 
instrument vision assistant (NI vision assistant-2010, US) software [12]. The near circular 
particles were chosen for the particle size analysis (Heywood circularity factor= 0.9 to 1.1). On an 
average, 1000 microparticles were considered for the size distribution analysis. 
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3.3.2. Gelation kinetics of stearate organogels 
The gelation kinetics was studied by visible spectroscopy. Absorbance of the molten gels was 
measured at 550 and 575 nm for sesame oil and soy bean oil based organogels, respectively. The 
chosen wavelengths were the absorption maxima of the pure sesame oil and soy bean oil. The 
absorbance of the molten organogels was recorded for 15 min at an interval of 15 sec during the 
cooling process. The weight of organogels was kept constant (3 g) for all the gels. 
3.3.3. Molecular characterization studies 
The physico-chemical nature of the formulations was studied by X-ray diffraction (XRD) and 
Fourier transform infrared (FTIR) spectroscopic studies. X-ray diffractometer (Pananalytical, X-
Pert Pro; Almelo, Netharlands) was used to study the morphology of the formulations in their 
native state. Formulations were spread evenly over a glass plate and then subjected to X-ray 
analysis. X-rays of 1.54 Å were generated by a CuKα source. The diffraction was measured in the 
2θ range of 5º to 50º. 
FTIR spectra of the formulations were obtained using FTIR spectroscope (Alpha-E, Bruker, 
Germany), operated in the attenuated total reflectance (ATR) mode. Spectral analysis was 
performed in the range of 4,000 to 500 cm
-1
 at a resolution of 4 cm
-1
. 
3.3.4. DSC studies 
The thermal properties of the formulations were examined using differential scanning calorimeter 
(DSC-200 F3 MAIA, Netzsch, Germany). Accurately weighed formulations were taken in 
aluminum crucibles with pierced aluminium lids. The experiment was performed at a scanning 
rate of 2 K/min under inert atmosphere, created using N2 gas. The results were analyzed using the 
Netzsch-proteus software. 
3.3.4. Mechanical analysis 
Mechanical properties of the formulations were determined using a static mechanical tester 
(Stable Microsystems, TA-HD plus, U.K.). In order to determine the strength, visco-elastic 
nature and spreadability of the formulations, different experiments were conducted. Table 3.1 
summarizes the details of the texture studies. 
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Table 3.1: Details of texture analysis studies. 
Type of 
study 
Type of fixture Testing conditions Mode of 
study Pre test 
speed 
(mm/sec) 
Test speed 
(mm/sec) 
Post test 
speed 
(mm/sec) 
Cyclic 
compression 
P/3, 30mm diameter 
cylindrical probe 
1.0 1.0 1.0 Button 
mode (30 
mm) 
Stress 
relaxation 
HDP/SR 
spreadabilityrig with 
45° conical perspex 
probe 
1.0 1.0  1.0 Auto 
force (5 
g, 5 mm) 
Spreadability HDP/SR spreadability 
rig with 45° conical 
perspex probe  
10 1.0 1.0 Auto 
force (5 
g, 20 
mm) 
Based on the compression results, following parameters were predicted: (i) Hardness or firmness 
(N) – The maximum peak force during the 1st penetration cycle, (ii) Cohesiveness – The ratio of 
force area during the 2
nd
 cycle to that of the 1
st
 cycle, (iii) Adhesiveness – The negative force 
area during the 1
st
 cycle and (iv) Springiness - The ratio of time of 2
nd
 cycle to the 1
st
 cycle. 
Gumminess is the multiplication of hardness and cohesiveness. 
3.3.5. Viscosity studies 
Rheological behavior of the prepared formulations were analyzed using a rotational cone (angle= 
5.4°; diameter= 30 mm) and plate viscometer (BOHLIN VISCO-88, Malvern, U.K.). A gap of 
0.15 mm was maintained between the cone and the plate throughout the study. Viscosity of all 
the formulations was measured under variable shear rates ranging from 13 sec
-1
 to 95 sec
-1 
at 
room-temperature (25 
o
C) [109-110]. 
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3.3.6. Leaching and swelling studies of the microparticles 
Leaching studies were conducted both qualitatively and quantitatively. The qualitative 
measurement was done by placing 0.5 g of the microparticles on Whatmann filter paper (#1, 
Sartorius) and subsequently incubating the samples at room-temperature for 1 h [68, 111]. In 
another study, the leachate was quantified by soaking 0.1 g (W1) of microparticles in 1.0 g (W2) 
of water for 1.0 h at room-temperature in microcentrifuge tubes [112]. After incubation, the 
tubes were centrifuged at 10,000 rpm for 2 min (MC-02, SPINWIN, Tarsons). The pellet (W3) 
and the supernatant (W4) were weighed separately and dried at 55 ºC for 48 h. Subsequently, the 
dried pellet (W5) and supernatant (W6) were weighed again. Swelling power (equation 1) and % 
leaching (equation 2) of the microparticles were calculated using the following equations. 
3
5
Swelling power = 
W
W
  (1) 
6
1
% leaching = 100
W
W
   (2) 
3.3.7. Drug encapsulation efficiency of the microparticles 
The microparticles (1.0 g) were triturated in 10 ml of acetone for 15 min at room-temperature. 
The mixture was transferred to a volumetric flask and incubated for 6.0 h (37 ºC) to achieve drug 
equilibration. Thereafter, the mixture was filtered using Whatmann (#1) filter paper and the 
filtrate was analyzed at 321 nm using UV-visible spectrophotometer (UV-3200, LabIndia, India). 
The drug encapsulation efficiency was represented as % drug encapsulation efficiency (% DEE) 
(equation 3). 
Practical loading
% DEE = 100
Theoritical loading
    (3) 
3.3.8. In vitro biocompatibility studies 
Biocompatibility of the formulations was carried out using L929 fibroblast cell line by “test on 
extract method” as per the reported literature [113]. In gist, leachant of 1 g of the formulation in 
50 ml of phosphate buffer saline (pH 7.2) was used for the study. The formulations were put in 
the dialysis bags, dipped in the phosphate buffer and subsequently incubated at 37 °C for 24 h. 
The leachate was sterilized using syringe filter. 1×10
4 
cells were seeded in each well of the 96 
26 
well plate containing DMEM and 10 % FBS. 10 μl and 20 μl of the filtered leachate was then 
added to the wells and was incubated in CO2 incubator (5 % CO2) and maintained at 37 °C for 24 
h. Thereafter, the viability of the cells was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay. The complete medium was used as negative control. 
3.3.9. Mucoadhesivity studies 
Mucoadhesivity studies were conducted using freshly excised goat intestine (ileum). The 
intestine (2 cm x 2 cm) was cut and adhered to a glass slide using acrylate adhesive such that the 
inner lumen was exposed. The dried microparticles were placed gently on the exposed mucosal 
surface for 5 min. The glass slides were subsequently kept vertically in the USP (United States 
Pharmacopeia) disintegration baskets (EI tablet disintegration apparatus, India) containing 900 
ml of phosphate buffer (pH 7.4). The retention time of the microparticles on the mucosal surface 
was checked over a period of 36 h. 
3.3.10. In vitro drug release studies 
For drug release study, two-compartment modified Franz diffusion cell (receptor and donor) was 
used [12]. Precisely weighed 2 g of the emulsion gels were placed in the donor and the 
compartments were separated by a pre-activated dialysis membrane. On the other hand, donor 
chamber for the microparticles consists of dialysis bag loaded with 1 g of microparticles. 
Receptor compartment contained 50 ml receptor fluid. Donor chamber/dialysis bag was kept in 
contact with the receptor fluid, and it was kept on stirring at 100 rpm (37 °C). The receptor fluid 
was replaced every 15 min in the first 1 h and subsequently every 30 min up to 9 h. The replaced 
fluid spectrophotometrically analyzed at 321 nm using UV-visible spectrophotometer [12]. 
Attempts were also made to predict the drug release pattern by fitting the data in different drug 
kinetic models. 
The antimicrobial activity of the formulated gels was tested against Escherichia coli (NCIM 
5051) by well diffusion method. 100 µl of 2x10
5
 CFU/ml bacterial cells was spread over the 
autoclaved nutrient agar plates. In each plate, uniform sized wells were made using 9.0 mm 
borer. The formulations were placed gently in the wells and incubated at 37 ºC for overnight (12 
h). The antimicrobial activity of the formulations was compared with Metrogyl
®
 (metronidazole 
containing marketed formulation). After incubation, the zone of inhibition against bacteria was 
measured using a ruler. 
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3.3.11. Statistical analysis 
Statistical analysis of the results was performed by one way ANOVA using Microsoft excel
®
 
2007 software. 
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Chapter 4 
Encapsulation of cocoa butter and mango butter 
based organogels in alginate microparticles 
Abstract 
Water-in-oil (fat) type cocoa butter (CB) and mango butter (MB) gels were prepared using 
gelatin solution (20 % (w/w)) by hot emulsification method. Stable CB and MB gels were 
formed until the aqueous proportion has reached to 70 % (w/w) and 35 % (w/w), respectively. 
Amongst the stable CB and MB formulations, gels with 10 % (w/w) and 35 % (w/w) aqueous 
fraction were chosen for further studies. The gels were characterized by microscopy, X-ray 
diffraction (XRD), differential scanning calorimetric (DSC) and mechanical studies. Drug 
(metronidazole) release kinetics indicated that the drug was released from planar matrices in 
either Fickian (mango butter organogels) or non-Fickian diffusion (cocoa butter organogels). The 
drug loaded gels showed good antimicrobial activity against E. coli. Amongst the characterized 
gels, formulations with 35 % (w/w) aqueous fraction were encapsulated within the alginate 
microparticles by ionotropic gelation method. Palm oil (cocoa butter equivalent) containing 
alginate microparticles were synthesized for comparative studies. The difference in the 
microstructure of the palm oil and organogel containing microparticles was elucidated by 
confocal microscopy. Encapsulation of the organogels was confirmed by XRD and DSC studies. 
Leaching of palm oil was noticed in palm oil containing microparticles but leaching of fats was 
less from the organogel containing microparticles. Difference in leaching properties has affected 
the drug encapsulation efficiency and in vitro drug release behavior. Super case II mode of drug 
delivery was shown by the microparticles with good antimicrobial action against E. coli. The 
developed formulations showed good biocompatibility and mucoadhesive nature. Based on the 
results, the developed formulations may be used as controlled delivery vehicles. 
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Graphical abstract 
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Part A: Preparation and characterization of cocoa butter and 
mango butter based organogels 
 
 
 
 
 
 
 
Overview 
Aqueous gelatin solution (20 % w/w) containing water-in-oil (fat) type cocoa butter (CB) and 
mango butter (MB) gels were prepared by hot emulsification method. Stable CB and MB gels 
were formed until the aqueous proportion has reached to 70 % (w/w) and 35 % (w/w), 
respectively. Amongst the stable CB and MB formulations, gels with 10 % (w/w) and 35 % 
(w/w) aqueous fraction were chosen for further studies. The results were analyzed in comparison 
with pure CB and MB. XRD and DSC melting profiles suggested the formation of unstable 
polymorphic forms (α and β`) of fats in the gels. The crystal size and solid fat content analyses 
suggested that the aqueous phase might have hindered the transformation of unstable 
polymorphic forms to stable polymorphic form (β) in the gels. This has improved the softness of 
the gels. As per Avrami analysis of the DSC thermograms, fat crystals were formed by 
instantaneous nucleation and have either uni- or bi-dimensional growth. Drug release kinetics 
suggested that the drug was released from planar matrices in either Fickian (mango butter 
organogels) or non-Fickian diffusion (cocoa butter organogels). Pure CB and MB also showed 
antimicrobial activity due to the presence of polyphenols. Metronidazole loaded gels showed 
better antimicrobial activity as compared to Metrogyl
®
 (marketed formulation). 
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4.1. Introduction 
The development of new materials and/or new technological approaches has grown in importance 
against the use of traditional materials. Agroindustrial residues are unconventional and alternative 
sources towards food, pharmaceutical and cosmetic industries. The fat sources that have been 
used in such industries include sesame oil, soy bean oil, olive oil, cocoa butter, shea butter etc. 
Among these, cocoa butter stands out as one of the best material because of its peculiar physico-
chemical characteristics. 
Theobroma oil or cocoa butter is extracted from the beans of Theobroma cacao L. It is a pale 
yellow vegetable fat rich in stearic and palmitic acids. Unsaturated fatty acids constitute about 40 
% of the total fatty acid content. The polyphenols present in cocoa butter confers health benefits 
due to the presence of phyto-antioxidants [114]. Cocoa butter remains as solid at room 
temperature and melts at body temperature. This property makes it a special material and has been 
extensively explored in food (as chocolates), pharmaceuticals (as suppository bases and topical 
bases) and cosmetics (because of excellent emollient properties) applications [115]. Because of its 
wide range of applications, the availability of cocoa butter in large quantities has become a great 
concern at the industrial level. To cater the needs of the world, Theobroma cacao L (the only 
commercial producer of cocoa butter) has been cultivated in countries such as Ivory Coast, 
Ghana, Nigeria, Cameroon, Brazil, Ecuador, Indonesia and Malaysia [116]. Hence, much of the 
work has been carried out to find alternatives for cocoa butter. 
Cocoa butter alternatives are identified as cocoa butter equivalents (palm oil, shea butter, kukum 
butter, illipe butter, mango butter), cocoa butter replacers (soy bean oil, rape seed oil, cotton seed 
oil, ground nut oil) and cocoa butter substitutes (coconut oil, palm kernel oil) [117]. The physico-
chemical nature of the cocoa butter equivalents is similar to cocoa butter and can be used without 
altering the properties of cocoa butter. In this regard, mango butter (MB) was chosen as the cocoa 
butter equivalent because of its similar fatty acid profile as that of cocoa butter [1]. Fatty acid 
profile of mango butter in comparison with cocoa butter has been provided in Table 4.1. The fatty 
acids in cocoa butter and mango butter exist in 4 to 6 polymorphic states [1]. Mango (Mangifera 
indica L.) trees are grown naturally or cultivated in tropical and subtropical countries, mainly for 
the fruit pulp. In general, mango seeds are discarded as the agroindustrial waste. But, mango seed 
kernel is rich source of fat and can be used to extract mango butter [118]. The fatty acid content 
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of mango butter is similar to cocoa butter but contains higher amount of unsaturated fatty acids 
[1]. Just like cocoa butter, mango butter is also solid at room temperature and melts at body 
temperature. 
Table 4.1: Fatty acid profile of cocoa butter and mango butter [1]. 
Fatty acid Cocoa butter 
(% w/w) 
Mango butter 
(% w/w) 
Saturated fatty acids
* 
  
     Palmitic acid 24.0 9.0 
      Stearic acid 35.0 39.0 
      Arachidic acid 1.0 2.5 
      Behenic acid -- 1.0 
      Lignoceric acid -- 0.5 
Unsaturated fatty acids
* 
  
      Oleic acid 36.0 41.0 
      Linoleic acid 3.0 6.0 
      Linolenic acid 1.0 1.0 
* Approximate values 
Often gelatin is used to improve the processing of the emulsion when low fat or during high 
aqueous phase volume is needed [119]. Gelatin improves the stability of the emulsions by 
preventing coalescence of the dispersed aqueous phase. In addition to these properties, gelatin gel 
has a melting point of ~32 ºC which results in the fat-like behavior [119]. Cocoa butter and 
gelatin have been used for preparing bases. In general, cocoa butter is insoluble in water/body 
fluids due to its high fatty acid content. To improve the compatibility and to reduce the high 
calorie content, researchers have been trying to develop water-in-oil (cocoa butter) organogels 
[120]. These organogels can be used as suppositories or chocolates. In this chapter, cocoa butter 
organogels were prepared using 20 % (w/w) aqueous gelatin solution. To check whether mango 
butter formulations can behave similar to that of cocoa butter formulations or not, mango butter 
organogels were prepared and their properties were compared with cocoa butter organogels. 
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4.2. Materials and methods 
Experimental details for the preparation and characterization of the organogels are explained in 
the chapter 3.2.1. Organogels were characterized (chapter 3.3) by bright field microscopy, polar 
microscopy, XRD, DSC and mechanical studies. In vitro drug delivery and antimicrobial studies 
were also performed. 
4.3. Results and discussion 
4.3.1. Preparation of the organogels 
The molten fats appeared as pale yellow translucent liquids. Addition of gelatin solution resulted 
in the formation of milky white emulsions. Appearance of milky white color without any phase 
separation is an indication to the formation of emulsions [121]. After incubation at room-
temperature, the emulsions which failed to flow under gravity, upon inversion of the vials, were 
regarded as organogels [122]. The stability of the organogels was dependent on the type of the 
vegetable fat used. During preparation, cocoa butter organogels were able to accommodate 70 % 
(w/w) aqueous gelatin solution. On the other hand, only 35 % (w/w) gelatin solution was 
accommodated within the mango butter based organogels. An increase in the aqueous proportion 
beyond 70 % and 35 % for cocoa butter and mango butter formulations, respectively, resulted in 
the phase separation. The pictographs of the cocoa butter and mango butter organogels have been 
shown in Figure 4.1 and 4.2, respectively. The difference in the gelation properties of the 
vegetable fats can be attributed to the variation in the fatty acid compositions. The total 
unsaturated fatty acid content in cocoa butter is in the range of 36 to 43 %, whereas, in mango 
butter it is in the range of 43 to 59 % [1]. Literature suggests that the crystallization efficiency of 
the fats depends on the proportion of the unsaturated fatty acids present [123]. This may be 
associated with molecular geometry of the fatty acids. The tetrahedran bond angles of carbon 
enable the saturated fatty acids to arrange in linear and stack-wise fashion. On the other hand, 
presence of double bonds (unsaturation) in carbon linkages lead to the bending of the fatty acyl 
molecules [123]. These molecules do not stack well and lead to weak intermolecular interactions, 
which, in turn, affect the crystallization process. As mango butter possess higher amount of 
unsaturated fatty acids than cocoa butter, the crystallization efficiency was found to be lower. The 
organogels were stored at 4 ºC and were stable for more than 12 months. Since mango butter 
formed stable organogels up to MG35; CG10, MG10, CG35 and MG35 were chosen as the 
representative formulations for further characterization. 
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Figure 4.1: Cocoa butter based emulsion gels: (a) CG10, (b) CG20, (c) CG30, (d) CG35, (e) 
CG40, (f) CG50, (g) CB60, (h) CG70, (i) CG80, and (j) CG90. 
 
Figure 4.2: Mango butter based emulsion gels: (a) MG10, (b) MG20, (c) MG30, (d) MG35, 
(e) MG40 (f) MG50, (g) MG60, (h) MG70, (i) MG80, and (j) MG90. 
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4.3.2. Microscopic studies 
The microstructure of the organogels showed evenly dispersed circular droplets of aqueous phase 
in the fat matrix (Figure 4.3). An increase in the droplet size was noticed with increase in the 
aqueous phase. Prevention of the droplets coalescence was responsible for the formation of such 
spatially arranged distinct droplets. Similar kinds of microstructures have been previously 
reported [124-125]. At higher water to fat ratio in cocoa butter organogels (> 70 % (w/w) aqueous 
phase) and mango butter organogels (> 35 % (w/w) aqueous phase), crystallization of fats was not 
sufficient to prevent droplet coalescence. Hence, larger and non-uniform droplets were observed 
in the unstable organogels (Figure 4.4). Formation of water-in-oil emulsion was confirmed by 
dilution test [126]. Both kinds of organogels showed uniform dispersion within the oil phase and 
showed phase separation in water (Figure 4.5). This indicated the formation of water-in-oil type 
of emulsions. 
Polarized light micrographs of the organogels showed the presence of continuous crystalline 
network (Figure 4.6). Aqueous phase was dispersed as dark circles in the bright colored fat 
matrices of CG10 and MG10 (representative organogels). The continuous crystalline network 
stabilized the emulsion by physically locking the dispersed phase [126]. Bright field micrographs 
of the molten organogels showed dispersed water droplets within the fat continuous phase (Figure 
4.3). Light micrographs of cocoa butter emulsions showed by Norton et al. (2012) also contained 
similar kind of microstructure [119]. Presence of fat around the water droplets imparts 
microbiological and physical stability to the organogels. The probability of microbial growth 
within the water droplets is minimized by completely isolating the aqueous phase from the 
environment. This helps in imparting microbial stability to the organogels. The presence of 
emulsifiers affects the network crystallization. Hence, high percentage of gelatin (20 % (w/w)) 
solution was used in the study. High gelatin concentration enhances the rate of adsorption of the 
gelatin at the newly formed fat-droplet interface. Rapid gelatin adsorption enhances the gelatin 
membrane formation thereby resulting in the decrease of the interfacial tension [120]. Lower 
interfacial tension prevented the coalescence of the droplets during homogenization process and 
resulted in the formation of smaller droplets. In general, a narrow size distribution was observed 
in the formulations with lower aqueous proportion as compared to the formulations with higher 
proportions of the aqueous phase (Figure 4.3e). CG10 and MG10 were having a narrow size 
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distribution as compared to CG35 and MG35, respectively. The mean size of the droplets (d32) 
was calculated using the following equation: 
3 2
32 i i i id n d n d     (4.1) 
where, ni is the number of droplets with diameter di. 
 
Figure 4.3: Pictographs of: (a) CG10, (b) CG35, (c) MG10, and (d) MG35; Dispersed size 
distribution analysis: (e) % frequency, and (f) Cumulative % frequency. 
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Figure 4.4: Micrographs of the unstable emulsion gels: (a) CG80, (b) CG90, (c) MG40, and 
(d) MG50. 
The mean size of the droplets varied in the order of CG10 (15.2 μm) < CG35 (17.5 μm) < MG10 
(19.63 μm) < MG35 (41.05 μm). The differences in the mean droplet size of the organogels with 
same water to fat ratio can be explained by the differences in the fatty acid composition of cocoa 
butter and mango butter. In general, long chain saturated fatty acids behave as solid at the fat-
droplet interface and the unsaturated fatty acids behave as liquid. Since, the rate of crystallization 
of the unsaturated fatty acids at the fat-droplet interface is slower compared to the rate of 
crystallization of the saturated fatty acids [127], coalescence of the droplets might have lead to the 
formation of the larger droplets in mango butter based organogels. Stearic hindrances associated 
with the unsaturated fatty acids slows down the crystallization rate [127]. The average diameter 
(davg) of the droplets was calculated from Figure 4.3f (shown as dotted lines). The diameter of the 
50 % population of the droplets was considered as davg. The davg values were in close proximity of 
the d32 values. 
38 
 
Figure 4.5: Dilution test: (a) CG10 in water (left), and oil (right); (b) CG35 in water (left), 
and oil (right); (c) MG10 in water (left), and oil (right); and MG35 in (left), and oil (right). 
 
Figure 4.6: Polarized micrographs of: (a) CG10, and (b) MG10. 
4.3.3. Molecular interaction studies 
The XRD profiles of the organogels and the vegetable fats have been shown in Figure 4.7. 
Literature suggests that cocoa butter and mango butter exist in four to six polymorphic forms [1, 
128]. The characteristic peaks (d-values: 3.79Å, 4.2Å) corresponding to α polymeric state were 
not found in the XRD profiles of the vegetable fats and their corresponding organogels [129]. 
Four characteristic d-values (3.7Å, 3.94Å, 4.58Å and 5.42Å), corresponding to the β polymorphic 
state of the fatty acids, were observed both in the vegetable fats and their organogels [129]. Peaks 
at 19.3º and 16.3º 2θ corresponded to the d-values of 4.58Å and 5.42Å, respectively [129-130]. 
These peaks were conserved in both kind of organogels. This indicated that the stable 
polymorphic state (β) was retained by the organogels. But their peak intensity was lowered as 
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compared to the peaks of pure cocoa butter and mango butter. This suggested that the number of 
fatty acids present in β polymorphic state might have been reduced and transformed to the other 
polymorphic states. The presence of peak at 2θ 23.2º (d-value: 3.83Å) indicated the presence of 
β`2 and β`1 polymorphic forms [129]. These peaks were retained in all the organogels and their 
intensity was not significantly changed. In general, β`2 and β`1 polymorphic states are 
intermediary polymorphic states during the conversion of α polymorphic fatty acids to the stable 
β polymorphic fatty acids [131-132]. Since wide angle X-ray scattering was performed, the peaks 
below 5
o 2θ were not observed. Hence, confirmation for the existence of α polymorphic state 
could not be estabilished. In general, tempering of the fats at high temperature leads to the 
polymorphic transition [133]. Keeping this in mind, organogels were prepared by melting the fats 
at 45 ºC, so as to minimize the tempering effects. As a result, minimal changes in the 
polymorphic state of the organogels were observed. 
Though the position of the peaks and the d-value of the β polymorphic state were not significantly 
changed, the full width half maximum (FWHM) values of the organogels were altered (Table 
4.2). The change in the FWHM values can be correlated to the change in the crystallinity of the 
organogels. The change in the crystallinity was determined by calculating the crystal size (D) 
using Debey-Scherrer equation [134]. 
cos
K
D

 
    (4.2) 
where, K is the Scherrer constant or shape factor, 0.89 (as shape of the crystallite is unknown); λ is the CuKα 
wavelength i.e., 1.54 Å; β is the full width at half maximum (FWHM) of the diffraction peak in radians and θ is the 
Braggs diffraction angle. 
The crystal size was determined using the β polymorphic peak (19.3º 2θ), since it had the 
maximum intensity. The crystal size of cocoa butter was reduced with the incorporation of gelatin 
solution within the organogels (Table 4.2). The decrease in the crystal size can be attributed to the 
presence of heterogeneous system (fat and water mixture) within the organogels [135]. During 
crystallization, the crystal growth of cocoa butter might have been hindered by the presence of 
heterogeneous system [135]. This lead to the formation of smaller crystal sizes in the organogels. 
The changes in crystal size suggested that the crystallinity of the organogels was also changed. 
XRD patterns of the cocoa butter, mango butter and their corresponding organogels (hump-like 
structures at ~20º) suggested predominantly amorphous nature. Amorphousity of the organogels 
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was dependent on the proportion of the aqueous gelatin solution and liquid triacylglycerols. 
Change in crystal size of the fats can be correlated to the amorphousity of the gels [136]. 
Crystallinity of the cocoa butter and the mango butter gels was found to be in the order of cocoa 
butter > CG10 > CG35 and mango butter > MG10 > MG35, respectively. Higher crystallinity of 
the cocoa butter based organogels was due to the presence of higher amount of saturated fatty 
acids in cocoa butter as compared to mango butter. 
 
Figure 4.7: XRD profiles of: (a) cocoa butter based gels, and (b) mango butter based gels; 
and FTIR spectra of: (c) Gels, and (d) Gels with drug (metronidazole). 
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Table 4.2: XRD parameters of the cocoa butter, mango butter and organogels. 
Sample FWHM of peak at 19.3º 2θ Crystal size (D), nm 
Cocoa butter 0.14 61.11 
CG10 0.22 38.9 
CG35 0.25 33.68 
Mango butter 0.16 53.5 
MG10 0.22 38.9 
MG35 0.26 32.71 
Figure 4.7c and 4.7d shows the FTIR spectra of the organogels and the organogels with 
metronidazole, respectively. The vegetable fats and the organogels had very similar spectra with 
minor variations. This may be explained by the presence of similar fatty acid profile in cocoa 
butter and mango butter. Very strong stretching peaks of C-H or C=H bonds at ~2800 to 3000 
cm
-1
, ~725 cm
-1
 and ~1450 cm
-1
 were observed, indicating the presence of the saturated and the 
unsaturated fatty acyl chains (tails) of triacylglycerides [137]. The head of the triacylglyceride 
molecules is generally identified by ester linkages. Vibrations of O-C=O ester bond was 
observed at 1150 and 1750 cm
-1 
[137]. Position of these peaks was not altered with the addition 
of the aqueous gelatin solution. The characteristic amide (N-H) bands of gelatin at 1650 cm
-1
 and 
1542 cm
-1
 was seen in CG35 and MG35 gels (indicated by arrows) [138]. These peaks were 
absent in pure cocoa butter and mango butter. CG10 and MG10 also did not show the N-H peaks 
which may be attributed to the presence of the aqueous portion at lower concentration in these 
formulations. The peak corresponding to O-H stretching vibration of water molecules at ~3500 
cm
-1
 was stronger in CG35 and MG35 as compared to CG10 and MG10 indicating an increase in 
the hydrogen bonding as the proportion of the aqueous phase was increased [139]. Metronidazole 
spectrum was characterized by the  presence of OH stretching vibrations at 3219 cm
-1
, C=CH 
stretching vibrations at 3101 cm
-1
, NO2 and NO stretching vibrations at 1535 cm
-1
 and C-OH and 
C-O stretching vibrations at 1074 cm
-1 
[140]. Since metronidazole was completely dissolved in 
the gelatin solution, the peaks corresponding to the drug were not observed in the organogels. 
Absence of new peaks and shift in the peaks of the formulations indicated that there were no 
interactions amongst the drug and the formulation components. 
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4.3.4. DSC studies 
Heating DSC curves showed four and five endotherms in cocoa butter and mango butter based 
organogels over the temperature range of 10 ºC to 40 ºC, respectively (Figure 4.8a and 4.8b). 
Presence of more than one endotherm indicated the existence of the fats in different polymorphic 
states. Pure cocoa butter and mango butter yielded a sharp endotherm at 36.7 ºC and 38.4 ºC, 
respectively, corresponding to the β polymorphic state [141]. The peak intensity of the β state’s 
endotherm was decreased with the addition of aqueous phase. Simultaneously, considerable 
enhancement in the peak intensities of the other polymorphic forms (α and β`) was noticed. 
Presence of peaks at ~20 ºC indicated the existence of α polymorphic state of triacylglycerols in 
the organogels [141]. Next to the α-polymorphic peaks, peak corresponding to the β` 
polymorphism was observed. Pure fats showed a broad endotherm of β` polymorphic 
triacylglycerols with two overlapping endothermic peaks (β`2 and β`1 states) (indicated by arrows 
in Figure 4.8a and 4.8b) [129]. Incorporation of water showed distinct endothermic β`2 and β`1 
polymorphic peaks in the organogels. This indicated that the presence of water might have slowed 
down the polymorphic transformation (from α to β) of fats. The extent of overlapping of β`2 and 
β`1 states was higher in cocoa butter based organogels, whereas, separate endotherms were 
noticed in mango butter based organogels. Thermal profiles of CG10 and CG35 showed 
overlapping endotherms of β`2 and β`1 (as that of cocoa butter) and an extra peak of α 
polymorphic state (unlike cocoa butter). On the contrary, MG10 and MG35 showed separate 
endotherms of α, β`2 and β`1 polymorphic states (unlike mango butter). The melting endotherm of 
β was not prominent in the organogels as compared to the pure fats. In addition to the 
aforementioned peaks (corresponding to α, β` and β polymorphic states), an additional peak at 
very low temperatures (< 15 ºC) was noticed in pure mango butter and its corresponding 
organogels. This peak was due to the sub- α or γ polymorphic triacylglycerols [129]. The cocoa 
butter based organogels did not show any such a peak. This may be explained by the merging of 
the endotherms of γ and α polymorphic triacylglycerols. 
Since different polymorphic states were existing, the amount of fat (cocoa butter and mango 
butter) present in those forms was calculated as solid fat content (SFC) in the organogels [1]. 
% *100t
m
H
SFC
H



  (4.3) 
where, ΔHt is the change in enthalpy at time t and ΔHm is the change in enthalpy during total melting. 
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Figure 4.8: Melting endotherms of: (a) cocoa butter organogels, and (b) mango butter 
organogels; Isosolid diagrams of (c) cocoa butter gels, and (b) mango butter gels; and (e) 
SFC of the gels. 
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Table 4.3: Melting analysis of the cocoa butter (CB), mango butter (MB) and their gels. 
Sample Polymorphic state 
 
Α β`2 β`1 β 
T(ºC) ΔH(J/g) SFC T(ºC) ΔH(J/g) SFC T(ºC) ΔH(J/g) SFC T(ºC) ΔH(J/g) SFC 
CB 10.9 1.5 2.0 26.8 4.7 6.4 30.9 0.53 0.71 36.7 66.7 90.8 
CG10 18.2 36.3 45.2 25.1 3.3 5.2 31.1 12.6 25.8 35.3 9.1 11.4 
CG35 17.3 31.8 68.4 25.2 1.8 3.8 30.8 7.6 16.4 35.6 5.3 11.3 
Sample Polymorphic state 
 
1 ~ sub α or γ 2~ α 3 ~ β`2 4 ~ β`1 5 ~ β 
T(ºC) ΔH (J/g) SFC T (ºC) ΔH (J/g) SFC T (ºC) ΔH (J/g) SFC T (ºC) ΔH (J/g) SFC T (ºC) ΔH (J/g) SFC 
MB 11.1 5.4 3.5 19.9 0.6 1.2 25.5 3.8 7.6 29.6 1.4 0.4 38.0 41.4 83.7 
MG10 15 37.1 79.3 20.1 3.2 6.9 24.4 1.6 3.5 27.0 3.5 7.4 31.9 1.4 2.9 
MG35 11.1 5.3 20.9 18.3 6.7 26.4 24.0 3.6 13.9 28.6 9.7 38.1 33.4 0.2 0.6 
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The change in the enthalpy during the endothermic events was calculated by integrating the 
area under the peak [142-143]. The peak temperatures (T) of the endotherms, change in 
enthalpies (ΔH) and SFC associated with the corresponding endotherms (polymorphic states) 
have been tabulated in Table 4.3. SFC of the β polymorphic state was higher in pure cocoa 
butter and mango butter, whereas, SFC of the α and β` polymorphic states was increased in the 
organogels. Figure 4.8c shows the SFC profiles of the organogels at different temperatures. 
Melting points of α and β` polymorphic states of mango butter were found to be lower than 
cocoa butter whereas, melting point of the β polymorphic state was found to be higher than 
cocoa butter. This suggested that the pure mango butter was softer than cocoa butter at low 
temperatures but retained more number of solids at higher temperatures. This was due to the 
presence of the higher oleic acid content which might have a “dilution effect” on the saturated 
fatty acids thereby increasing the softness of mango butter [1]. On the other hand, mango 
butter contains longer chain fatty acids such as behenic and lignoceric acids. These fatty acids 
contributed to the induction of the stable β polymorphic state, which resulted in the higher 
melting point of mango butter. 
SFC content of cocoa butter and mango butter was drastically decreased when water was 
added. There was no significant difference in the rate of decrease in SFC of CG10 and CG35, 
but it was significant in MG10 and MG35. MG35 lost almost ~80 % of the SFC below 15 °C. 
This may be the reason that mango butter could not form stable organogels beyond 35 % 
(w/w) aqueous phase. This indicated that the organogels became softer than the pure fats and 
their thermal stability was greatly influenced. To measure the compatibility of the emulsion 
gel components and their effects on the gel softening, isosolid diagrams were drawn (Figure 
4.8d and 4.8e). 
In general, isosolid diagrams links the points of different samples with equal solid content in 
weight fraction-temperature graphs. As a matter of fact, if the isosolid lines are parallel and 
approximately horizontal to each other, then the components are said to be compatible to each 
other [1]. Isosolid diagrams suggested that the mango butter organogels were softer than the 
cocoa butter organogels. This may be explained by the lower melting points of the mango 
butter organogels than the cocoa butter organogels at the equal SFC. Sudden decrease in the 
melting points of the isosolid lines was observed when 10 % (w/w) of gelatin solution was 
added to either cocoa butter or mango butter. The decrease in the melting temperature 
indicated softening of the organogels. The results suggested that the softening effect was more 
pronounced when 10 % (w/w) aqueous phase was added to cocoa butter and mango butter. 
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Upon further addition of aqueous phase (35 % w/w), no significant softening effect was 
observed which resulted in almost parallel lines. The isosolid lines of the mango butter 
organogels were more parallel to each other than the cocoa butter organogels. This indicated 
that the softening was continuing in cocoa butter organogels but a plateau phase was reached 
in mango butter organogels. Since the isosolid lines were not horizontal and parallel to each 
other up to the 90 % solid fraction, the gel components (butter and gelatin solution) seemed to 
be not compatible with each other. But the compatibility was improved when the aqueous 
portion was raised to 35 % (w/w). 100 % compatibility amongst the fat (cocoa butter and 
mango butter) and aqueous phase cannot be expected due to the thermodynamic instability 
amongst them. But the compatibility of the fat and the aqueous phase was improved when 
higher amount of gelatin (20 % w/w) solution was added. Comparatively, the components of 
the mango butter organogels were more compatible than the cocoa butter organogels. This can 
be explained by the fact that the isosolid lines were more parallel and horizontal to each other 
in mango butter organogels. This may be due to the presence of the higher amount of 
unsaturated fatty acids in mango butter. Disordered packing of unsaturated fatty acids might 
have allowed the incorporation of the aqueous phase in the organogels and subsequent 
improvement of the compatibility of the fat and the aqueous phases. 
Crystallization studies 
Isothermal crystallization studies of the organogels were performed by holding them at 60 ºC 
for 10 min (to eliminate the crystal memory of the fats) and subsequently cooled to 10 ºC at 1 
ºC/min, followed by holding at 10 ºC for 1 h. The crystallization exotherms of cocoa butter 
and mango butter organogels can be divided into three exothermal events (Figure 4.9a and 
4.9b). The first exotherm (~19 ºC) was not distinctly separated but exist as a shoulder peak of 
the second exotherm at ~22.5 ºC. The intensity of the shoulder peak was reduced when water 
was added to the fats. The third exotherm was recorded during the isothermal stage that spans 
over a wide time range. These kind of exothermic events were similar to the fat mixtures of 
cocoa butter [141, 143]. Crystallization of the fats started at 22.5 ºC and continued up to 10 ºC 
leading to a broad exotherm. Evolution of this kind of exotherm is a characteristic feature of 
hexagonal packing of triacylglycerol chains in α form [141]. Literature suggests that the 
progressive crystallization of triacylglycerides arrange themselves from liquid crystalline to 
double-chain length (2L) organization in α form [141]. The first exothermic peak (shoulder 
peak) corresponded to the crystallization of the high-melting saturated fatty acids [141]. The 
second (major) exothermic event was due to the transformation of monounsaturated fatty 
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acids [141]. During crystallization, a steep increase of the second exotherm at 15.4 ºC and 
15.1 ºC was noticed in cocoa butter and mango butter organogels, respectively. Based on these 
events, it can be inferred that the saturated fatty acids acted like seed crystals for the 
transformation of the liquid crystalline fat. Since the crystal growth of the saturated fatty acids 
was coinciding with the transformation of the unsaturataed fatty acids, the first exotherm in 
DSC thermogram existed as the shoulder peak. The transformation of the fatty acids continued 
even during the isothermal stage. Crystallization at 10 ºC suggested the transformation of the 
liquid crystalline fatty acids into α polymorphic state [129]. Since the crystallization at 10 ºC 
resulted in a broad exotherm, it was expected that some of the α polymorphic fatty acids might 
have converted to β` polymorphic state (found in DSC melting and XRD profiles as well) 
[129, 141]. Overall, the peak positions did not change, but the enthalpies associated with the 
exotherms of organogels were changed due to the difference in the peak intensities. The 
overall crystallization enthalpies of the pure fats and the organogels have been provided in 
Table 4.4. Based on the difference in crystallization enthalpies, Avrami equation (equation 4) 
was used to predict the nucleation and crystal growth in organogels [142]. 
1ln ln ln ln
1 t
k n t
X
        
  (4.4) 
where, X is the fraction of the crystals formed at time t during crystallization, k is the crystallization rate constant 
(measure of crystallization) which depends on the crystallization temperature and n is the Avrami exponent. 
Avrami exponent determines the dimensionality of crystallization. Crystal fraction (X) at a given time was 
calculated by the ratio of partial enthalpy (ΔHx) to the total crystallization enthalpy (ΔHc). 
Figures 9c and 9d indicate that the crystal formation was very rapid during the early stages of 
the crystallization. Subsequently, the rate of formation was slowed and ultimately reached a 
stationary phase. The shape of the curves (X vs. time) illustrates the crystallization mechanism 
of the substance [144]. The shape of the curves did not change, indicating that the 
crystallization mechanism was not affected by the incorporation of the aqueous phase [144]. 
To better understand the crystallization mechanism, the crystal fraction (X) was used to 
calculate the Avrami parameters (n and k). Crystallization data of the organogels showed good 
fitting (R
2 
> 0.95) to the Avrami equation (Figure 4.9e and 4.9f). The Avrami parameters 
calculated from the fit curves have been given in Table 4.4. n values were found to be in the 
range of 0.9 to 1.5. This suggested the occurrence of instantaneous nucleation during the 
crystallization process [129]. n values below 2 suggest that the nucleation rate was very rapid 
at the beginning, but decreased as the time progressed (as predicted by X vs. time curves) 
[142]. n values indicated needle-like growth of the crystals along one or two dimensions. 
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Formation of the spherulitic crystals were reported by the growth of the small needle like 
crystals during suspension crystallization with agitation [145]. Since static crystallization (no 
agitation) was studied in DSC, needle-like crystals might have not aggregated to spherulites. 
 
Figure 4.9: Crystallization exotherms of: (a) cocoa butter gels, and (b) mango butter 
gels; Crystal fraction of (c) cocoa butter gels, and (d) mango butter gels; and Avrami 
analysis of (e) cocoa butter gels, and (f) mango butter gels. 
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Table 4.4: Avrami analysis of the DSC exotherms. 
Sample ΔHc(J/g) n k X 10
-3
 (min) t1/2 (min) 
Cocoa butter 2.28 0.94 103.0 7.56 
CG10 1.55 1.26 42.7 9.10 
CG35 0.96 1.63 19.5 8.88 
Mango butter 1.94 1.05 82.0 7.65 
MG10 1.41 1.32 24.1 12.68 
MG35 0.94 1.45 17.1 12.85 
On the other hand, high k values (Table 4.4) suggested rapid crystallization in cocoa butter, 
followed by mango butter and the organogels, respectively. Rate of crystallization was 
influenced by the presence of water. CG10 and MG10 were having higher rate of 
crystallization as compared to CG35 and MG35, respectively. Presence of aqueous phase 
might have prevented the growth of the crystals in quick time. Increase in the crystallization 
time might also have lead to the change in dimensionality of the growing crystals [142]. 
Hence, n values suggested the possibility of two dimensional growth of the crystals. Change 
in the crystallization times was determined by calculating the half-time of the crystallization 
(t1/2). Since k is dependent on nucleation, crystal growth and temperature, it can be directly 
related to the half-time of crystallization (t1/2). 
 1/2 0.693
n
t k   (4.5) 
t1/2 is a function of both n and k. It provides information about the time taken to form 50 % of 
the crystals. The t1/2 values were lower in pure fats as compared to the organogels (Table 4.4). 
This indicated that the rate of crystallization was highest in cocoa butter and mango butter 
followed by CG10, CG35, MG10 and MG35 under the experimental conditions. As the rate of 
fat crystallization was slower in organogels with higher water proportions, water droplets 
coalescence has lead to the formation of unstable organogels. Higher crystallization rates in 
cocoa butter organogels facilitated the cocoa butter to tolerate high amounts of water. Since 
rate of crystallization was slower in mango butter organogels, the water droplets might have 
coalesced prior to the fat crystallization. Hence, stable cocoa butter organogels were formed 
even at high proportion of water (70 % (w/w)) as compared to the mango butter organogels 
(35 % (w/w)). 
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4.3.5. Mechanical analysis 
During the cyclic uni-axial compression test, fracturing of pure cocoa butter and mango butter 
(shown by an arrow in Figure 4.10a and 4.10b) indicated the brittle nature of the pure fats. 
Fracture points were also seen during the second cycle of compression in the pure fats. 
Organogels, except CG10, did not show fracture points. This indicated a decrease in the 
brittleness with the addition of the aqueous phase. Higher brittleness can be attributed to the 
higher cohesive strength of the pure fats (Table 4.5). The triacylglycerols in pure fats are 
tightly packed either in double or triple chain length structures [146]. This kind of orientation 
favors ordered arrangement of the triacylglycerols and imparts higher cohesive strength [146]. 
Presence of aqueous phase might have disturbed the orientation of the triacylglycerols which 
resulted in the decrease in the cohesiveness, hardness and gumminess of the organogels (Table 
4.5). This indicated that the organogels became softer with the incorporation of the aqueous 
phase (as predicted during melting studies). Increase in the softness might have enhanced the 
adhesive nature and spreadability of the organogels. Interestingly, adhesiveness of the cocoa 
butter and mango butter organogels was enhanced when lower amount of aqueous phase was 
added but a reverse trend was observed when higher amount of aqueous phase was added. 
Presence of gelatin in the aqueous phase might be responsible for the enhancement in the 
adhesive nature of the organogels but at higher amounts of gelatin, the intermolecular 
attraction (cohesive interactions) between the gelatin molecules might have dominated the 
adhesive forces [147]. Increase in the spreadable nature of the organogels was confirmed by 
spreadability studies (Figure 4.10c and 4.10d). Application of force during spreadability test 
did not result in the syneresis of water. Since the water droplets were physically locked within 
the fat continuous phase (evident from the microscopic studies), syneresis did not occur, 
which in turn, imparted physical stability to the organogels. CG35 and MG35 showed higher 
spreadability than CG10, MG10 followed by cocoa butter and mango butter. Increase in the 
softness may be associated with the spreadability of the organogels. During cyclic 
compression studies, springiness of the organogels did not vary significantly. This indicated 
that the elastic nature of the pure fats was not altered in the organogels. To confirm this and to 
critically evaluate the viscoelastic properties of the organogels, stress relaxation studies were 
conducted. 
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Figure 4.10: Compression cycle of: (a) CB and (b) MB-based gels; Spreadability of:  (c) 
CB and (d) MB-based gels; and Stress relaxation of: (e) CB and (f) MB-based gels. 
 
Figure 4.11: Normalized force vs. time (modified Peleg’s analysis). 
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Table 4.5: Mechanical properties of CB, MB and organogels. 
Sample Hardness 
(N) 
Cohesiveness Adhesiveness 
(N.sec) 
Springiness Gumminess 
(N) 
Spreadability 
(N.sec)
 -1
 
CB 11.33 0.42 1.99 1.00 4.79 0.23 
CG10 10.87 0.23 4.44 1.00 2.56 0.31 
CG35 3.72  0.13 2.99 1.01 2.0 0.44 
MB 4.87 0.57 2.17 1.00 2.76 2.51 
MG10 3.04 0.47 2.21 1.00 1.43 5.78 
MG35 1.92 0.37 0.74 1.00 0.71 6.44 
The stress relaxation profiles of the organogels have been shown in Figure 4.10e and 4.10f. 
The firmness (F0) and the residual force (Fr) were higher in cocoa butter and mango butter as 
compared to the organogels. F0 and Fr decreased with the increase in the aqueous phase. This 
was due to the decrease in the SFC of the organogels. The stress relaxation profiles of the 
organogels followed an exponential decay function. The force decay with respect to time 
(F(t)) during the relaxation of the organogels was analyzed by fitting the data in modified 
Peleg’s equation [148]. 
 0
1 2
0
( )F F t t
k k t
F

    (4.6) 
where, F0 is the maximum force attained after loading; k1 and k2 represent the initial rate and extent of the 
relaxation, respectively. 
Normalized stress relaxation data from modified Peleg’s equation yielded a straight line with 
good fitting (R
2
 > 0.995) (Figure 4.11). Curve analysis indicated that the initial rate of 
relaxation (k1) was decreased with the increase in the proportion of the aqueous phase but the 
extent of relaxation (k2) did not vary significantly in both kind of organogels (Table 4.6). 
Though k2 (slope) represents the total relaxation behavior of the formulations, almost similar 
values were obtained. To find the viscoelastic nature and to know the stress relaxation 
behavior, asymptotic residual force was calculated from the stress relaxation curve (F
*
) [149]. 
*
0
rFF
F
    (4.7) 
Where, Fr is the residual force after relaxation and F0 is the maximum force attained prior to the relaxation. 
53 
For viscoelastic materials, F
* 
lies in the range of 0.0 to 1.0. ‘F*’ value close to 1.0 indicates 
that the material is an elastic material. There was a reduction in the F
*
 values with the 
decrease in the SFC of the organogels. This indicated that the elastic nature of the cocoa 
butter and mango butter decreased with the increase in the aqueous phase. Cocoa butter and 
mango butter organogels have shown F
*
 values in the range of 0 to 1, suggesting that the 
developed organogels were viscoelastic in nature. % relaxation was calculated using equation 
8. 
0
0
% e *100r
F F
r laxation
F
 
  
 
  (4.8) 
Mango butter organogels showed more relaxation more than cocoa butter organogels (Table 
4.6). Since mango butter organogels were amorphous than the cocoa butter organogels (as per 
XRD studies), relaxation of the mango butter organogels was more than the cocoa butter 
organogels. 
Table 4.6: Textural parameters of the gels from stress relaxation studies after modified 
Peleg’s analysis. 
Samples F0 (N) Fr (N) k1 k2 F
* 
% relaxation 
CB 71.37 21.09 0.036 0.001 0.29 78.45 
CG10 58.17 15.03 0.031 0.016 0.26 74.16 
CG35 35.98 8.42 0.015 0.001 0.24 76.60 
MB 4.39 0.74 0.041 0.017 0.17 95.17 
MG10 2.15 0.26 0.013 0.017 0.12 87.74 
MG35 1.85 0.08 0.005 0.017 0.04 93.60 
4.3.6. In vitro drug delivery studies 
In vitro drug delivery studies were carried out in phosphate buffer (pH 7.2) (Figure 4.12a). 
The release of the drug was higher from MGM35 (52.78 %) followed by CGM35 (23.24 %), 
CGM10 (18.34 %) and MGM10 (10.83 %), respectively. Organogels with higher aqueous 
phase showed higher drug release than the others. The results suggested that the mango butter 
organogels released more drug than the cocoa butter organogels of similar composition. This 
may be due to the amorphous nature of the mango butter organogels compared to the cocoa 
butter organogels (predicted by XRD studies). Presence of higher amount of liquid 
triacylglycerols in mango butter organogels might have contributed to the higher release of 
54 
the drug. To understand the drug release kinetcis, the drug release data was fit in different 
drug release kinetics models (Figure 4.13). The best fit model was found to be Weibull model 
(Table 4.7). This indicated that the developed formulations were homogeneous planar matrix 
type delivery vehicles [150]. The ‘n’ value (Fickian value) was calculated from the 
Korsemeyer-Peppas (KP) model. The ‘n’ values indicated that the release of the drugs was 
diffusion mediated. The diffusion of the drug from the cocoa butter organogels followed non-
Fickian diffusion while it was Fickian diffusion from the mango butter organogels (Table 
4.7). 
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Figure 4.12: Drug release from the gels: (a) CPDR vs. time; (b-f) antimicrobial activity 
of the gels against E. coli. 
Table 4.7: The drug release kinetics of the gels 
Samples 
Zero order 
(R
2
) 
Higuchi 
(R
2
) 
Weibull 
Best fit  
KP model 
(R
2
) n Type of flow 
CGM10 0.617 0.985 0.983 Weibull 0.50 Non-Fickian 
CGM35 0.363 0.922 0.950 Weibull 0.51 Non-Fickian 
MGM10 0.262 0.913 0.951 Weibull 0.39 Fickian 
MGM35 0.405 0.89 0.988 Weibull 0.36 Fickian 
 
Figure 4.13: Drug release kinetics from the organogels: (a) Zero order, (b) Higuchi 
model, (c) Weibull model, and (d) KP model. 
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Pure cocoa butter and mango butter have shown antimicrobial activity against E. coli (Figure 
4.12b). Polyphenols present in cocoa butter and mango butter were responsible for the 
antimicrobial action [118]. Metronidazole loaded formulations showed very good 
antimicrobial activity. This might be associated with the synergistic activity of the 
polyphenols and the drug. The antimicrobial activity of the cocoa butter and mango butter 
organogels were much higher than Metrogyl
®
 (Figure 4.12d and 4.12e). Difference in the 
antimicrobial activity of the cocoa butter and mango butter organogels against Metrogyl
®
 was 
found to be statistically significant (p < 0.05). The differences in the antimicrobial action of 
the cocoa butter and mango butter organogels were statistically insignificant (p > 0.05). 
4.4. Conclusion 
In conclusion, stable gelatin-based cocoa butter and mango butter organogels were formed by 
a simple hot emulsification method. Cocoa butter incorporated high amounts of aqueous 
fraction (70 % (w/w)) as compared to mango butter (35 % (w/w)). The water droplets were 
dispersed within the fat continuous matrix. Presence of fat around the water droplets imparted 
physical stability to the organogels (evident from the spreadability studies). Since water 
droplets were locked within the crystallized fats, microbial contamination can be arrested. 
Avrami analysis indicated that the rate of fat crystallization was higher in cocoa butter and it 
was decreasing with the increase in water proportion. High fat crystallization rate in cocoa 
butter might be responsible for the high tolerance capacity of the water as compared to 
mango butter. X-ray diffractograms indicated the fats present in the organogels were having 
stable β polymorphic state even after tempering. Effect of tempering was lowered as the 
organogels were prepared by melting the fats at lower temperature (45 ºC). DSC results 
suggested that the organogels showed high percentage of SFC as β polymorphic form and 
intermediary polymorphic forms (β`1 and β`2). As the intermediary polymorphic forms 
possess the melting point at ~ 30 ºC, the organogels may have high chances of consumer 
acceptance if employed in the preparation of chocolates and/or other confectionaries. Increase 
in softness and spreading nature of the organogels with respect to the pure fats also will favor 
the consumer acceptance. Mango butter organogels are found to be softer than the cocoa 
butter organogels, which may be due to the presence of high amounts of liquid-like 
unsaturated fatty acids. Based on the observations, it can be suggested that the mango butter 
organogels can be used as cocoa butter equivalents in food and pharmaceutical industries. 
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Part B: Encapsulation of cocoa butter and mango butter 
organogels in alginate microparticles 
 
 
 
 
 
 
 
 
 
 
 
Overview: 
Cocoa butter and mango butter based gels with 35 % (w/w) aqueous portion were chosen for 
the encapsulation studies. The organogels were encapsulated within the alginate 
microparticles by ionotropic gelation method. Palm oil containing alginate microparticles 
were synthesized for the comparative studies, because, palm oil has been regarded as one of 
the cocoa butter equivalents. Microscopy, XRD and DSC studies confirmed that both kinds 
of the organogels (CG35 and MG35) were successfully encapsulated within the 
microparticles. Confocal micrographs showed the presence of alginate layer around the liquid 
palm oil droplets and semi-solid organogels. Leaching of palm oil was noticed when the 
microparticles were incubated at room-temperature for 2 h. Leaching of palm oil resulted in 
the lower DEE (model drug: metronidazole). In case of fat containing microparticles, 
presence of organogels improved the DEE by preventing the leaching of the drug. 
Biocompatibility studies suggested that the developed microparticles were cytocompatible in 
nature when tested against mammalian L929 fibroblast cells. The organogel containing 
microparticles showed better mucoadhesivity against goat small intestine as compared to 
palm oil containing microparticles. In vitro drug release studies showed super case-II mode of 
drug delivery from the formulations and showed good antimicrobial activity when tested 
against E. coli. 
  
58 
4.5. Introduction 
In general, biopolymeric microparticles are porous in nature which lead to the leaching of the 
encapsulated bioactive agents [151-152]. Over the years, this problem was tried to overcome 
using blended polymers [152]. Additionally, the problem of leaching was negotiated by 
loading higher amount of drugs within the microparticles [153]. Unfortunately, in many cases 
higher drug loading results in severe complications viz., drug toxicity and drug resistance 
[154]. In the recent times, another approach, i.e. core-shell type of microparticles, has been 
employed to overcome the problems. This allowed an improvement in the drug carrying 
capacity of the microparticles [155]. This approach seems to have solved the problem 
associated with the enhancement of the drug encapsulation efficiency. But, difficulty in the 
diffusion of the drugs from the solid shell is another concern associated with the core-shell 
microparticles. In general, core-shell microparticles are being synthesized using synthetic 
polymers or composite polymers [155]. The synthetic polymers remain in the body even after 
the completion of the task [156]. The use of biopolymers for the synthesis of the core-shell 
microparticles may solve the problem. Unfortunately, the leaching of the internal phase from 
the biopolymeric microparticles had prevented the use of the biopolymers for the synthesis of 
core-shell microparticles. In this study, we are proposing an alternative approach to solve the 
problem by encapsulating vegetable fat based organogels. 
Alginate was chosen as the biopolymeric shell material. Alginate has been reported to form 
porous microparticles [105]. Often, the problem of leaching of the internal phase is overcome 
by coating the microparticles with polymers (eg. chitosan and gelatin) [100, 152]. Over the 
years, cocoa butter has been used as topical and transdermal bases in gels, ointments and 
suppositories. The use of cocoa butter in oral delivery of bioactive agents is very limited. 
Keeping this in mind, we intended to explore the use of cocoa butter organogels in oral 
delivery applications. Mango butter formulations were also prepared to use as the cocoa 
butter equivalent. Amongst the stable cocoa butter and mango butter organogels, organogels 
with 35 % (w/w) gelatin solution (CG35 and MG35) were chosen for the encapsulation 
studies. As per the literature, palm oil has been used as cocoa butter equivalent because of its 
high saturated fatty acid content. Palm oil based microparticles were used as the control 
[117]. 
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4.6. Materials and methods 
4.6.1. Preparation of the organogels 
Composition of the cocoa butter and the mango butter based organogels has been given in 
Table 4.8. Organogels were prepared as per the protocol mentioned in chapter 3.2.1. 
Table 4.8: Composition of the organogels. 
Sample 
Cocoa butter 
(% w/w) 
Mango butter 
(% w/w) 
Gelatin solution 
(% w/w) 
Tween 80 
(% w/w) 
Metronidazole 
(% w/w) 
CG 64.0 -- 35.0 1.0 -- 
MG -- 64.0 35.0 1.0 -- 
CGD 63.0 -- 35.0 1.0 1.0 
MGD -- 63.0 35.0 1.0 1.0 
4.6.2. Preparation and characterization of the microparticles. 
Accurately weighed 5 g of the gels or palm oil were used to prepare the primary emulsions 
and they were subsequently processed to synthesize the microparticles by ionotropic elation 
method as explained in chapter 3.2.5. Experimental details for the characterization of the 
microparticles have been explained in chapter 3.3. Bright field microscopy, confocal 
microscopy, XRD, FTIR, DSC, leaching, biocompatiblitbility, mucoadhesivity, in vitro drug 
delivery and antimicrobial studies were conducted during the study. 
4.7. Results and discussion. 
4.7.1. Preparation of the organogels. 
Stable organogels were formed and are shown in Figure 4.14. Mechanism of the formation of 
organogels was explained in part A of this chapter. 
 
Figure 4.14: Pictographs of the organogels: (a) CG and (b) MG. 
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4.7.2. Preparation of the microparticles 
Addition of the primary emulsion to the bulk sunflower oil (external oil phase) (300 rpm and 
4 
o
C) resulted in the formation of internal phase-in-water-in-oil type multiple emulsion. 
Addition of the acidified oil resulted in the gelation of the alginate layer to form 
microparticles. Under acidic conditions, the calcium ions replaced the monovalent sodium 
ions and ionically cross-linked the carboxyl groups of the guluronic monomers (of sodium 
alginate). Cross-linking of the alginate layer resulted in the encapsulation of the internal 
phase. The stability of the microparticles was improved by treating the microparticles with 
0.5 M calcium chloride solution. Sunflower oil was washed from the surface of the 
microparticles with excess water containing 1 % (w/w) Tween 80. Thereafter, the 
microparticles were collected by filtration and subsequently stored at 4 ºC. Stable 
microparticles were also formed when the drug containing organogels and palm oil were 
used. The compositions of the microparticles have been tabulated in Table 4.9. 
Table 4.9: Composition of the microparticles. 
Sample Internal phase 
MPO Palm oil 
MCG CG 
MMG MG 
MPOD Palm oil with drug
* 
MCGD CGD 
MMGD MGD 
*
1% (w/w) metronidazole 
4.7.2. Microscopy 
The bright field micrographs of MCG and MMG were found to be spherical in shape, 
whereas, MPO showed the presence of both spherical and oval shaped microparticles (Figure 
4.15a-c). Formation of oval shaped microparticles may be explained by the presence of liquid 
palm oil (internal phase) in MPO. Since MCG and MMG encapsulated the semi-solid 
organogels, sphericity was retained and resulted in the formation of large sized 
microparticles. Size distribution analysis of the microparticles (Figure 4.16a) indicated that 
the average diameter of the microparticles was in the order of MCG (295.95 ± 8.2 µm) > 
MMG (292.70 ± 6.6 µm) > MPO (266.82 ± 10.6 µm). The differences in the sizes of the 
microparticles can be attributed to their internal compositions. The diameter of the 50 % 
population of the microparticles was determined from the cumulative percentage frequency 
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plot (Figure 4.16b). Results suggested that the diameter of the 50 % of the microparticles was 
nearly equal to the average diameter of the microparticles. Formation of core and shell type 
of microparticles was evaluated by confocal laser scanning microscopy. The confocal images 
showed the presence of black alginate layer around the internal phase of the microparticles 
(Figure 4.15d-f) (indicated by arrow) Confocal images confirmed the formation of core and 
shell type of hybrid microparticles. The confocal images also showed the presence of the oil 
droplets within MPO and uniformly dispersed internal phase within MCG and MMG. This 
confirmed the presence of semi-solid organogels within the microparticles. 
 
Figure 4.15: BFM images of: (a) MPO, (b) MCG, and (c) MMG; CLSM images of (d) 
MPO, (e) MCG, and (f) MMG. 
 
Figure 4.16: Size distribution analysis of the microparticles: (a) % frequency, and (b) 
cumulative % frequency. 
4.7.3. XRD studies 
The X-ray diffraction profiles of the organogels and the prepared microparticles have been 
shown in Figure 4.17a. MCG and MMG showed the peaks corresponding to cocoa butter and 
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mango butter (shown as dotted lines in Figure 4.17a), suggesting the existence of organogels 
within the microparticles. The d-spacings of the peaks of the fats did not vary even after 
encapsulation within the microparticles. This suggested that the polymorphic structure of the 
fats did not change during the preparation of the microparticles. The microparticles retained 
the stable β polymorphic state and the intermediary polymorphic state (β2) of the fats. Results 
indicated that the presence of the stable β polymorphic fats in MCG and MMG. The crystal 
size of the fats within the microparticles was checked by Debey-Sherrer equation (equation 2 
in part A of chapter 3). 
The peak corresponding to the β polymorphic state was chosen for the determination of the 
crystal size. The crystallite sizes of the cocoa butter and the mango butter were found to be 
higher in MCG and MMG as compared to CG and MG, respectively (Table 4.10). This 
suggested that the microparticle processing conditions have altered the crystallite sizes of the 
fats. 
Table 4.10: XRD parameters of microparticles and organogels. 
Sample FWHM
*
 of peak at ~19.3º 2θ  Crystallite size (nm) 
CG 0.25 33.68 
MG 0.26 32.72 
MCG 0.23 35.65 
MMG 0.23 35.60 
The peaks of the fats were superposed over a broad peak (~ 20º 2θ) in MCG and MMG. On 
the other hand, MPO showed only one broad peak with a peak maximum at ~ 20º 2θ. 
Presence of triacylglyerols within the microparticles resulted in the formation of broad peaks 
[157]. This is an indication of the predominant amorphous nature of the microparticles. MPO 
seemed to be more amorphous as compared to MCG and MMG (showed crystalline peaks of 
the vegetable fats). 
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Figure 4.17: a) X-ray diffractograms of organogels and microparticles; FTIR spectra of: 
(b) the organogels and microparticles; (c) drug and drug containing microparticles; and 
(d) DSC thermograms of the organogels and the microparticles. 
4.7.4. FTIR studies 
Figure 4.17b and 4.17c shows the FTIR spectra of the microparticles and metronidazole 
loaded microparticles. All the microparticles showed the characteristic peaks associated with 
the alginate molecules as per the reported literature [158]. The characteristic peaks of alginate 
were observed due to the –COO- and C-O-H stretching vibrations. The peaks at 1620 cm-1and 
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1410 cm
-1
 correspond to the –COO- stretching vibrations. Peak at 3450 cm-1 was due to the 
O-H stretching vibrations of secondary and tertiary alcohols. Presence of secondary and 
tertiary alcohols was confirmed by the presence of C-OH stretching vibrations at 1110 cm
-1
 
and 1150 cm
-1
, respectively [158]. Since palm oil, cocoa butter and mango butter possess 
similar kind of saturated and unsaturated fatty acids in their composition, microparticles and 
organogels showed the characteristic peaks of triacylglycerols/fatty acyl molecules. 
Microparticles showed strong stretching peaks of C-H or C=H bonds at ~2800 cm
-1
 and 1450 
cm
-1
 [137]. These peaks correspond to the fatty acyl chains (tails) of the triglycerides. Pure 
metronidazole showed the characteristic peaks at 3219 cm
-1
 (OH stretching vibrations), 3101 
cm
-1
 (C=CH stretching vibrations), 1535 cm
-1
 (NO2 and NO stretching vibrations) and 1074 
cm
-1
 (C-OH and C-O stretching vibrations) [140]. Since metronidazole was present at very 
low concentration, the peaks associated with the drug molecules were not observed. Though 
the peaks corresponding to the drug were not detected, absence of new peaks and shift in the 
peaks indicated that the drug did not chemically interacted with the components of the 
microparticles [12]. 
4.7.5. Thermal studies 
Figure 4.17d shows the thermograms of the organogels and the microparticles. CG and MG 
showed an endothermic peak at ~37 ºC, indicating the melting of the cocoa butter and the 
mango butter, respectively. In addition to the endothermic peak of the fats, CG and MG also 
showed peaks at ~91 ºC and ~62 ºC, respectively. These peaks correspond to the evaporation 
of the water molecules associated with the organogels. The melting peaks of fat in MCG and 
MMG are associated with shoulder peaks at lower temperatures (showed as an insert in 
Figure 4.17d). Presence of these endothermic peaks indicated the presence of unstable α 
and/or β` polymorphic state(s) of cocoa butter and mango butter in MCG and MMG [129]. 
Presence of unstable polymorphic states of cocoa butter and mango butter was also observed 
in XRD studies. Apart from the peaks at ~37 ºC, MCG and MMG showed another peak at 
~110 ºC. This may be due to the evaporation of water associated with the organogels or 
alginate layer of the microparticles. Since 100 % evaporation of the water is not possible 
from the alginate microparticles, endothermic peak was seen [159]. This confirmed that the 
organogels were present within the microparticles. MPO showed only one broad endothermic 
band. The peak was due to the evaporation of the water molecules associated with the 
alginate layer. 
 
65 
4.7.6. Leaching studies 
MPO showed leaching of palm oil but MCG and MMG did not show leaching of the internal 
phase (Figure 4.18a-c). Leaching of the palm oil was identified by the formation of a dark 
oily zone around MPO after the incubation (Figure 4.18a). Presence of semi-solid organogels 
within MCG and MMG might have prevented the leaching of the internal phase. Absence of 
leaching can also be correlated to the increase in the viscosity of the internal phase of MCG 
and MMG. The increased viscosity might have prevented the leaching of the internal phase 
from MCG and MMG. The leaching of the internal phase was quantified (Figure 4.18d). % 
leaching was found to be very high in MPO as compared to MCG and MMG (p < 0.05). 
Swelling power of the microparticles was higher in MCG and MMG as compared to MPO 
but the difference was not significant (p > 0.05) (Figure 4.18d). 
 
Figure: 4.18: Leaching studies: (a) MPO, (b) MCG, and (c) MMG, and (d) Bar graphs 
showing the swelling power and % leaching of the microparticles. 
4.7.7. Drug encapsulation efficiency 
MCGD (71.3 ± 2.1) and MMGD (70.2 ± 1.6) showed higher % DEE as compared to MPOD 
(44.3 ± 3.4). The results indicated that the % DEE of MCGD and MMGD was nearly twice 
that of MPOD. The difference in % DEE was due to the leaching of the internal phase from 
66 
MPOD. As a result, lower % DEE was observed in MPOD. The results indicated that the 
gelling of the internal phase enhanced the drug carrying capacity of the microparticles. 
4.7.8. Biocompatibility studies 
Fibroblast cells (L929 cell line) showed good growth in the presence of the microparticles 
leachate (Figure 4.19a). The difference in cell viability index of the microparticles against the 
control (cell growth in the absence of leachate) was insignificant (p > 0.05). The results 
suggested that the microparticles are cytocompatible in nature. 
 
Figure 4.19: (a) Biocompatibility studies, and (b) Mucoadhesion times of the 
microparticles. 
4.7.9. Mucoadhesivity studies 
The mucoadhesive properties of the microparticles were evaluated using small intestine of 
goat by wash-off method. The mucoadhesion times were in the order of MCG > MMG >> 
MPO (Figure 4.19b). The difference in the mucoadhesion times of the microparticles was 
significant amongst MPO, MCG and MMG. In general, alginate shows good mucoadhesion 
via non-specific and non-covalent interactions viz., electrostatic interactions, hydrogen and 
hydrophobic bonding [160]. The leaching of the palm oil might have hindered the 
mucoadhesive property of MPO. Absence of leaching in MCG and MMG improved 
mucoadhesion. Observation of higher mucoadhesion times may facilitate the use of MCG and 
MMG for sustained drug release applications. 
4.7.10. In vitro drug delivery studies 
The cumulative percentage drug release (CPDR) profiles of the drug containing 
microparticles have been shown in Figure 4.20a. MPOD showed higher CPDR as compared 
to MCGD and MMGD. Higher CPDR in MPO was due to the leaching of the palm oil. On 
the other hand, presence of semi-solid organogels prevented the free movement of the drug 
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molecules from the microparticles into the dissolution medium. To better understand the drug 
release phenomenon, the drug release profiles of the microparticles were fitted in different 
drug release kinetic models. 
Microparticles showed good fit against zero order and Baker’s Lonsdale (BL) models (Table 
4.11) (Figure 4.21). Zero order release kinetics suggested that the drug release was 
independent of the drug concentration [161]. BL model suggested that the drug release was 
from non-disintegrating spherical formulations [150, 161]. The mechanism of drug diffusion 
was predicted using Korsmeyer-Peppas (KP) model. The Fickian constant (n-value) was 
found to be > 0.89. This indicated that the diffusion of the drug was via anomalous or super 
case-II diffusion [150]. 
The drug release from the microparticles was further evaluated by performing antimicrobial 
studies against E. coli. The drug containing microparticles showed a clear zone of inhibition. 
The blank microparticles did not show any zone of inhibition (Figure 4.20b-d). This indicated 
that metronidazole inhibited the growth of the E. coli. The difference in zone of inhibition 
was insignificant amongst the microparticles (p < 0.05). The antimicrobial studies suggested 
that the drug was released in its active state from the microparticles. 
Table 4.11: The drug release kinetics from the microparticles. 
Samples 
Zero order 
(R
2
) 
Higuchi 
(R
2
) 
BL model 
Best fit  
KP model 
(R
2
) n Type of flow 
MPOD 0.96 0.83 0.98 Zero order 0.90 Super case-II 
MCGD 0.97 0.93 0.95 Zero order 1.26 Super case-II 
MMGD 0.98 0.86 0.95 Zero order 1.02 Super case-II 
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Figure 4.20: (a) CPDR vs. time, and (b-d) Antimicrobial studies of the microparticles. 
 
Figure 4.21: Drug release kinetics: (a) Zero order; (b) Higuchi model; (c) BL model and 
(d) KP model. 
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4.8. Conclusion 
In this study, core (cocoa butter organogels and its equivalents) and shell (alginate) 
microparticles were successfully synthesized using internal gelation method. Presence of 
organogels and palm oil as the core materials of the microparticles were critically evaluated 
by microscopic techniques, X-ray diffraction and differential scanning calorimetric methods. 
Palm oil containing microparticles showed leaching of the internal phase making them 
unsuitable for the controlled delivery applications. Mango butter formulations proved that 
they can be used as alternatives for the cocoa butter formulations. The cocoa butter and 
mango butter containing microparticles showed similar drug encapsulation, CPDR and 
antimicrobial properties. Based on the results, it can be concluded that the microparticles with 
mango butter organogels can be used as equivalents or alternatives to the microparticles with 
cocoa butter organogels. The developed vegetable fat based formulations may be used as 
carriers for the oral delivery of nutraceutical and pharmaceutical bioactive agents. 
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Chapter 5 
Encapsulation of lanolin based organogels in 
alginate microparticles 
Abstract 
Stable semi-solid lanolin-based organogels were prepared using hot-emulsification method. 
The gels were formed when the lanolin: water proportions were maintained at 2:1, 1:1 and 
1:2 (w/w). The gels were characterized by microscopy, XRD, FTIR, DSC and viscosity 
studies. Non-Fickian mode of drug release was identified from the planar gel matrices. Stable 
microparticles were formed when organogel with lanolin:water proportion was-2:1. Blank 
microparticles and microparticles with lanolin were served as the controls. Microparticles 
with lanolin and lanolin based organogel did not leach out any internal components. XRD, 
DSC studies confirmed the encapsulation of organogels within microparticles. Encapsulation 
of organogels improved the DEE of (metronidazole was used as the model drug). 
Formulations showed good biocompatibility and antimicrobial action against L929 fibroblast 
cells and E. coli, respectively.  
Graphical abstract 
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Part A: Preparation and characterization of lanolin-based 
organogels 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overview 
Lanolin-based organogels were prepared by hot emulsification method. Stable semi-solid 
organogels were formed when the lanolin:water proportions were maintained at 2:1, 1:1 and 
1:2 (w/w). Bright-field, phase contrast and fluorescent micrographs showed the circular water 
droplets (red color) in the formulations. Coalescence of water droplets was observed in gels 
containing higher proportion of water. XRD studies suggested an increase in amorphousness 
of the gels with the incorporation of water into the gel structure. The gels showed non-
Newtonian and thixotropic flow behavior. The melting temperatures of the gels were 
identified by DSC thermal analysis. DSC thermograms indicated an increase in thermal 
stability with the increase of water content in the gels. Metronidazole (model drug) was 
released from matrix kind of formulations by non-Fickian mode of diffusion with good 
antimicrobial efficacy against E. coli. 
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5.1. Introduction 
Lanolin (Ln) is an animal wax, devoid of glycerides, which is secreted from the sebaceous 
glands of sheep and other animals [162]. Lanolin coats the hair present on the body of the 
animals. anolin mainly consists of mono-, di- and poly- hydroxyesters of sterols (e.g. 
cholesterol, dihydrocholesteol), trimethyl sterols (lanosterol and dihydrolanosterol), triterpene 
alcohols, aliphatic alcohols (C14-C37) and free hydrocarbons [163]. The biocompatibility of 
lanolin has been attributed to its similar chemical nature as that of human sebum [164]. The 
significant difference between the refined anolin and human sebum is that the former is 
completely devoid of triglycerides and free fatty acids [164]. The increase in permeability of 
the bioactive agents through skin in the presence of lanolin has also been related to the 
similar chemical properties of lanolin as that of human sebum. It has found extensive 
applications in the formulation of moisturizers [165], cosmetics [166], sunscreen lotions 
[166], shaving creams [166-167] and emollient products due to its ability to incorporate large 
amount of water into its structure. Various pharmaceutical products meant for the topical, 
transdermal, subcutaneous and ophthalmic deliveries of drugs have employed anolin due to 
its inherent biocompatibility and water-holding capacity. The water-holding capacity of 
lanolin helps formulating emulsion-based formulations having improved stability [168]. 
Chemical composition of lanolin shows 33 different hydroxy and polyhydroxy esters of 
alcohols (sterols) and 36 free fattyacids which can act as organogelators to form organogels 
when polar phase was added [169-170]. In recent past, it was shown that nanoemulsions 
derived from the lanolin carries potential drug delivery properties [171]. Taking inspiration 
from the above, it seems quite feasible to develop lanolin-based semi-solid topical and 
transdermal formulations. Within this framework, the objective of the current study deals 
with the development of lanolin-based emulsion gels and characterizing them to check their 
suitability to be used as matrices for drug delivery. 
5.2. Experimental section 
5.2.1. Preparation of organogels 
Organogels were prepared as per the protocol given in 3.2.2. The composition of the 
formulations has been shown in Table 5.1. Characterization of the gels (bright field 
microscopy, fluorescent microscopy, XRD, FTIR, DSC, viscosity studies, mechanical studies 
and in vitro drug release studies) was carried out as per the methods described in chapter 3.3. 
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Table 5.1: Composition of the formulations. 
Formulation 
Weight (% w/w) 
Lanolin Water Span 80 Metronidazole 
L1 65.66 33.33 1.0 -- 
LD1 65.66 33.33 1.0 1.0 
L2 50.0 49.0 1.0 -- 
LD2 50.0 49.0 1.0 1.0 
L3 33.33 65.66 1.0 -- 
LD3 33.33 65.66 1.0 1.0 
 
5.3. Results and discussion 
5.3.1. Preparation of the organogels 
 
Figure 5.1: Conversion of Lanolin to emulsified gel. 
Homogenization of lanolin and water resulted in the formation of white colored emulsion. 
The emulsion, so obtained, turned into pale yellow colored gels upon cooling to room-
temperature (RT). Stable semi-solid emulsion gels were formed when the Lanolin:water 
proportions were 1:0.5, 1:1 and 1:2 (w/w) (Figure 5.1). As the proportion of water was 
increased further, the formulations were found to leach water. This may be attributed to the 
water holding capacity of the lanolin, which can absorb water only twice its original weight 
[168]. The metronidazole loaded samples were regarded as LD1, LD2 and LD3 respectively. 
Since the aqueous layer formed the internal phase and lanolin formed a continuous phase, the 
developed gels may be regarded as organogels. The prepared formulations were stable for 
12+ months and stored at room-temperature. 
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5.3.2. Microscopic studies 
 
Figure 5.2: Bright field micrographs of: (a) Lanolin, (b) L1, (c) L2, and (d) L3 (Size bar: 
20 µm); and fluorescent micrographs of: (e) Lanolin, (f) L1, (g) L2, and (h) L3. 
Figure 5.2a-d shows the bright-field light microscopic images of the lanolin and the 
formulations. The micrographs of the lanolin did not show any visible microstructure 
indicating that the composition of lanolin was homogenous. As water was incorporated, the 
micrographs showed a uniform distribution of circular water droplets within the continuous 
phase of lanolin. The size of water droplets increased with the increase in the proportion of 
water in the gels. Similar variation in sizes and distribution of water droplets was observed by 
fluorescent microscope (Figure 5.2d-g). The aqueous phase (containing rhodamine) appeared 
as red colored droplets in the lanolin continuum phase. The L3 micrographs showed the 
tendency of the water droplets to undergo coalescence as the proportion of the water was 
increased in the gels. The coalesced water droplets try to separate out from the continuum 
phase, if the water proportion increases further [172]. This phenomenon may be attributed to 
the phase separation as the Lanolin:water ratio was increased above 1:2 (w/w). 
5.3.3. XRD studies 
Figure 5.3a shows the XRD diffractograms of Lanolin and the organogels. Broad humps in 
the diffractograms may be attributed to the presence of isotropic liquids present within the 
physical structure of the formulations [173]. XRD pattern did not show any sharp diffraction 
peaks suggesting that the gels are amorphous or ultrafine crystalline materials where the 
diffraction peaks cannot be resolved. The diffractogram analysis indicated that there was a 
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decrease in % crystallinity of the organogels as the water content in the emulsion gels 
increased (Table 5.2). The diffractograms of the gels showed a sharp peak at ~21.3
o 2θ as 
compared to 21.67
o
 2θ in lanolin. This slight shift of the peak position may be due to the 
change in the physical properties of the gels at the molecular level. In addition to this, the d-
spacing of Lanolin (4.09 Å) was found to be lower as compared to the emulsion gels (~4.15 
Å). The peak shift and increase in d-spacing in the diffractograms of the gels as against 
Lanolin were due to the incorporation of water [174]. 
 
Figure 5.3: X-ray diffractograms of: (a) lanolin and organogels; FTIR spectra of (b-c) 
lanolin, organogels and metronidazole; and DSC thermograms of (d) lanolin, and L1. 
Table 5.2: Change of % crystallinity of the gels, deduced from the XRD pattern data. 
Formulation Peak position % crystallinity d-spacing (Å) 
Lanolin 21.67 27.0 4.097 
L1 21.38 19.65 4.15 
L2 21.29 18.5 4.168 
L3 21.30 14.23 4.158 
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5.3.4. FTIR studies 
The chemical interactions amongst the organogels were studied using ATR-FTIR 
spectrophotometer (Figure 5.3b). The peaks obtained for the lanolin were in exact match with 
the lanolin FTIR literature data [175]. All the characteristic peaks of lanolin were conserved 
in the formulations. This suggested that there were no significant chemical alterations in the 
lanolin molecular structure, although the other gel components were added. The shallow peak 
at 3361 cm
-1
 may be associated with the –OH stretching of the alcohol hydroxyl groups 
present in lanolin. With the incorporation of water into the gels, the peak at ~ 3361 cm
-1
 
became more prominent in the formulations which may be attributed to the intermolecular 
hydrogen bonding amongst the alcohol group of lanolin and the water molecules [176]. Peaks 
corresponding to the drug were not identified, indicating that the drug was completely 
dispersed within the gel matrix. Absence of additional peaks suggested that the drug was 
present in its native state. 
5.3.5. Thermal analysis 
The differential scanning calorimetric thermogram of lanolin showed a combination of 
exotherm and endotherm peaks [175]. The thermal profiles of the formulations were different 
from that of the lanolin indicating that there has been a complete change in the physical 
properties of the lanolin as water was incorporated into its structure (Figure 5.3d, Table 5.3). 
The melting point (Tm) of formulations was higher than lanolin indicating that the 
formulations were having higher thermal stability than the raw material [170]. The ΔHm 
(change in enthalpy) and ΔSm (change in entropy) values during the melting endotherm 
followed the same trend as that of Tm values. The ΔHm and ΔSm values indicate the cohesive 
energy for packing of the gel structure [170]. The higher ΔHm of L3 and LD3 samples 
suggested the presence of higher gelator (lanolin)- water interactions which may be 
associated to the intermolecular hydrogen bonding. The DSC results may also be correlated 
with the spreadability of the gels. As per the reported literatures, higher Tm values are often 
associated with higher firmness or lower spreadability indices [177]. 
Table 5.3: Thermal properties of the formulations. 
Sample Tm (°C) ΔHm (J/g) ΔSm (mJ/g.K) 
Lanolin 41.1 -6.882 -896.7 
L3 48.7 0.233 5.31 
LD3 47.4 -2.562 -136.3 
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5.3.6.Viscosity studies 
 
Figure 5.4: Shear rate vs. viscosity of lanolin, and the organogels. 
The rheological behaviour of the formulations has been shown in Figure 5.4. Lanolin showed 
an increase in the shear stress as the shear rate was increased. Lanolin showed a gradual 
decrease in the viscosity whereas the gels showed an exponential decrease in the viscosity as 
the shear rate was increased. Lanolin and the formulations showed higher apparent viscosities 
when the shear rate was increased as compared to when the shear rate was lowered. This 
resulted in the formation of hysteresis loop. Decrease in the viscosity as the shear rate was 
increased and formation of hysteresis loop due to closed shear cycle indicate viscoelastic 
properties of the gels (shear thinning and thixotropy, respectively) [106]. Though 100 % 
structural recovery was not there, many of the junction points were recovered. The observed 
hysteresis loop suggested that the total structure recovery did not take place under the 
experimental conditions. Such profiles are very common in pharmaceutical formulations such 
as ointments, creams and gels [178-179]. The non-Newtonian flow behavior of the gels were 
confirmed by analyzing the rheological data using power law or Ostwald-de Waelae 
relationship [110].
 
nK        (5.1) 
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where, τ is the shear stress (Pa) at γ shear rate (s-1), K is the flow consistency index (Pa.s), and n is the flow 
behaviour index.  
The value of n governs the type of rheological behavior. If the value of n is < 1, =1 and > 1, 
then the formulations may be regarded as pseudoplastic, Newtonian and dilatant, respectively 
[110]. In the current study, the n value was determined by plotting the graph between log 
(shear stress) and log (shear rate). All the n values were found to be less than 1, indicating the 
pseudoplastic nature of the gels. The thixotropic behavior of the emulsion gels were 
evaluated by measuring the area enclosed within the hysteresis loop [109]. In general, the 
thixotropy of the gels decreased non-linearly with the addition of water (Figure 5.4). The 
decrease in thixotropy with the increase in the water proportions in the formulations indicated 
that the gels would take more time to regain their initial viscosity once their internal structure 
was disturbed by applying external shear stress. 
5.3.7. Mechanical studies 
Figure 5.5a shows the mechanical profile of lanolin and the organogels after performing the 
cyclic uni-axial compression test. Lanolin showed the maximum hardness and the hardness 
was found to be decreasing with the increase in water proportion of the gels (Table 5.4). 
Decrease in hardness influenced the gumminess of the formulations. As the water proportion 
was enhanced, adhesiveness of the organogels was also decreased, whereas, cohesiveness of 
the formulations seem to be unaffected. The difference between the cohesiveness of the 
organogels was insignificant (p > 0.05). Decrease in hardness of the samples helped in 
increasing the spreadable nature of the organogels (Figure 5.5b and Table 5.4). This property 
may facilitate the use of lanolin in the development of topical formulations. Mechanical 
properties of the formulations were further tested by stress relaxation studies. When force 
was applied, the formulations developed approximately uniform stress (F0). When the stress 
was maintained for 60 seconds, the formulations showed different relaxation behavior (Figure 
5.5c). % relaxation was calculated using the equation 4.8 in chapter 4. Lanolin was found to 
have relaxed more as compared to organogels (Table 5.5). In general, the difference in 
relaxation behavior is associated with the viscoelastic nature of the formulations. The 
viscoelastic nature of the organogels was predicted by fitting the stress relaxation data in 
modified Peleg’s equation (equation 5.2) (R2 > 0.95) (Figure 5.5f). The Stress relaxation 
parameters of the Peleg’s analysis viz., initial rate of relaxation (k1) and extent of relaxation 
(k2) remain unchanged in all the formulations (Table 5.5). In this regard, area (S
*
) and 
asymptotic residual force (F
*
) of the normalized stress relaxation curve were calculated. The 
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obtained S
*
 and F
*
 values were less than 1 (Table 5.5). Since these values are in between 0.0 
and 1.0, the developed organogels are viscoelastic in nature. 
 0
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0
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
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Figure 5.5: Mechanical studies of lanolin and the organogels: (a) Cyclic uni-axial 
compression studies; (b) Spreadability studies; (c) Stress relaxation studies; and (d) 
Stress relaxation profiles (modified Peleg’s analysis). 
Table 5.4: Mechanical properties of lanolin and organogels. 
Sample Hardness 
(N) 
Cohesiveness Adhesiveness 
(N.sec) 
Gumminess 
(N) 
Spreadability 
(N.sec
-1
) 
Lanolin 5.60 1.04 14.14 5.82 0.082 
L1 4.86 1.03 13.69 5.01 0.088 
L2 3.86 1.02 9.51 3.94 0.098 
L3 2.13 1.02 9.64 2.17 0.118 
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Table 5.5: Mechanical parameters of lanolin and the organogels. 
Samples F0 (N) Fr (N) k1 k2 S
* 
F
* 
% relaxation 
Lanolin 0.16 0.04 0.042 0.015 0.92 0.23 76.56 
L1 0.13 0.04 0.045 0.015 0.92 0.30 69.30 
L2 0.18 0.06 0.045 0.015 0.92 0.36 63.83 
L3 0.17 0.06 0.042 0.015 0.92 0.33 66.92 
 
5.3.8. In vitro drug delivery studies 
The release profiles of the drug from the formulations have been shown in figure 8. The 
results indicated that there was 25 %, 36 %, 38 % and 41 % drug release from LD, LD1, LD2 
and LD3 formulations, respectively, suggesting that as the water proportion  was increased in 
formulations the rate of release of the drug was higher. This may be due to the increased 
partition of the drug into aqueous phase of the formulations and subsequent quicker diffusion 
into the dissolution media.  The results can be correlated with the results obtained from the 
XRD and antimicrobial studies, where it was predicted that with the increase in the water 
content in the formulations will result in the increase in the amorphous nature of the gels and 
increased drug release rate [180]. This indicated that the release rate may be tailored by 
altering the composition of the gels. 
Table 5.6: Drug release kinetics of the formulations. 
Sample Zero-order Higuchi model KP model Type of release 
R
2 
value R
2 
value R
2 
value n value Non-Fickian 
LnD 0.761 0.995 0.993 0.557 Non-Fickian 
LD1 0.717 0.998 0.992 0.53 Non-Fickian 
LD2 0.63 0.992 0.991 0.504 Non-Fickian 
LD3 0.85 0.991 0.998 0.576 Non-Fickian 
 
To get an insight into the drug release mechanism, drug release kinetics from the gels was 
evaluated using different drug release kinetics models (Figure 5.6c-d, Table 5.6). The 
formulations followed Higuchi kinetics indicating that the formulations were homogeneous-
planar matrix type and did not lose their structural integrity during the course of the study 
[181]. The Fickian value (n) was calculated from the KP model and was found to be ~ 0.5 for 
all the formulations. This suggested that the release of SA from the gels showed non-Fickian 
release. 
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Figure 5.6: Drug release kinetics: (a) CPDR vs. time; (b) Zero order; (c) Higuchi 
kinetics; and (d) KP kinetics. 
5.3.9 Antimicrobial studies 
The results of the antimicrobial study are shown in Figure 5.7. The results indicated that the 
blank gels did not inhibit the growth of the bacteria. Metronidazole loaded formulations 
showed the antimicrobial activity as the water content in the formulations was increased. The 
results suggested that the antimicrobial activity of the drug loaded gels were due to the 
presence of metronidazole as the blank gels did not show any antimicrobial activity. Also, an 
increase in drug diffusion from the gels containing higher water content may be related to the 
increase in the amorphous nature of the gels, as evident from the XRD studies. 
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Figure 5.7: Antimicrobial studies of lanolin and the organogels against E. coli. 
5.4. Conclusion 
The present study dealt with the successful development of the Lanolin based emulsion gels. 
There were no chemical interactions amongst drug and lanolin molecules, indicating that the 
gel matrices were inert and may be used as carrier for various bioactive agents. The increase 
in amorphousness due to the addition of water has influenced the drug release pattern. The 
developed formulations have shown increased thermal stability compared to the raw material, 
which suggested that the formulations may be stored for a long time. Apart from the flow 
behavior (thixotropic and shear thinning properties), the developed gels showed sufficient 
spreadability and biocompatibility for pharmaceutical applications. This ensures a uniform 
application of the dosage form without any irritation to the skin during topical drug delivery. 
In addition, drug loaded gels showed good antimicrobial activity against E. coli. In short, the 
developed Lanolin based gels may be tried as carrier matrices for topical drug delivery. 
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Part B: Encapsulation of lanolin organogels within alginate 
microparticles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overview 
The developed lanolin-based organogels were tried to encapsulate within the alginate 
microparticles by internal gelation method. Synthesis of the alginate microparticles was 
possible only when L1 (Ln:water-2:1) was used but not with L2 (Ln:water-1:1) and L3 
(Ln:water-1:2). This was due to the unstability of L2 and L3 during thermal processing, 
associated with the preparation of microparticles. Blank microparticles and microparticles 
with lanolin were served as the controls. Ln and L1 components did not leach out of the 
microparticles when incubated at RT for 2h. Microscopy, FTIR, XRD and DSC studies 
confirmed the presence of organogels within the microparticles. Encapsulation of organogels 
improved the DEE (metronidazole was used as the model drug). Non-Fickian mode of drug 
release was seen from the matrix kind of microparticles and showed antimicrobial activity 
against E. coli. The developed microparticles possess good biocompatibility and 
mucoadhesivity against mammalian L929 fibroblast cells and goat small intestine, 
respectively. 
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5.5 Introduction 
The stable lanolin-based organogels (L1, L2 and L3) were tried to encapsulate within the 
alginate microparticles. Lanolin based formulations have been studied in topical and oral 
drug delivery [182-183]. If the organogels gets encapsulated, it is expected that there will be 
reduction in the loss of bioactive agents (associated with leaching) and lanolin organogels 
may be tried for the oral delivery applications. Metronidazole was used as the model drug. 
5.6. Materials and methods 
5.6.1 Preparation of the lanolin-based organogels and microparticles 
Lanolin based organogels were prepared as per the protocol described in chapter 3.2.2. 
Microparticles were prepared as per the protocol given in chapter 3.2.5. Experimental 
procedures for the characterization of microparticles (bright field microscopy, SEM, XRD, 
FTIR, DSC, leaching studies, in vitro biocompatibility, mucoadhesivity and drug delivery 
studies) are given in chapter 3.3. 
5.7. Results and discussion 
5.7.1. Preparation of lanolin based organogels 
The compositions of the organogels used in this study have been tabulated in Table 5.7. 
Mechanism of organogel formation of organogels was explained in part A of this chapter. 
Table 5.7: Composition of the organogels. 
Sample Lanolin:Water 
(% W) 
Span 80 
(% W) 
Metronidazole 
(% W) 
L1 2:1 1.0 -- 
L2 1:1 1.0 -- 
L3 1:2 1.0 -- 
L1MZ 2:1 1.0 1.0 
5.7.2. Preparation of microparticles 
The microparticles were prepared by double emulsification/internal gelation method. Stable 
microparticles were formed when lanolin and L1 organogels were used as the internal phase. 
The use of L2 and L3 organogels did not result in the formation of microparticles. This may 
be associated with the lower stability of L2 and L3 organogels [12]. Due to this reason, L2 
and L3 containing microparticles were not investigated further. The compositions of the 
prepared microparticles have been tabulated in Table 5.8. 
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Table 5.8: Internal phase composition of the microparticles. 
Samples Internal phase Observation 
BM Nil Stable microparticles were formed 
MLn Lanolin  Stable microparticles were formed 
ML1 L1 Stable microparticles were formed 
ML2 L2 Microparticles were not formed 
ML3 L3 Microparticles were not formed 
BMMZ MZ Stable microparticles were formed 
MLnMZ LnMZ Stable microparticles were formed 
ML1MZ L1MZ Stable microparticles were formed 
5.7.3. Microscopy 
BM microparticles were semi-transparent, which may be associated with the absence of any 
internal phase. On the other hand, MLn and ML1 were opaque, which may be accounted to 
the presence of lanolin and L1 within the microparticles (Figure 5.8). As lanolin and L1 are 
semi-solid and opaque at RT, encapsulation resulted in the formation of opaque 
microparticles [162]. 
The size distribution of the microparticles revealed that lanolin and L1 containing 
microparticles showed a broad size distribution compared to BM microparticles (Figure 5.9). 
The average diameter (Davg) of the microparticles was found out by estimating the size of the 
50 % population of the microparticles. The size of the microparticles was in the order of ML1 
(130.14 ± 21.2) > MLn (111.28 ± 17.6) > BM (94.7 ± 10.2). The size distribution analysis of 
the microparticles has been provided in Table 5.9. Since lanolin and L1 are viscous in nature, 
this might have resulted in the formation of non-homogeneous alginate mixture which, in 
turn, resulted in the formation of microparticles of wide size distribution [12]. Apart from the 
physical nature of the internal phase, the homogenization speed also plays an important role 
in governing the size distribution of the microparticles. 
 In general, homogenization at lower speeds exerts lower dispersive forces thereby resulting 
in the formation of larger sized microparticles. Increase in viscosity of the emulsion also 
results in the lower dispersive force. Hence it may be expected that the effective dispersive 
force during the preparation of BM microparticles might have resulted in the formation of 
uniform and small vesicles as compared to lanolin and L1 containing microparticles where 
larger sized particles were formed [92]. The micrographs of the dried microparticles, as 
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observed under SEM, have been shown in Figure 5.8. All types of the microparticles were 
found to be spherical and smooth in nature. 
 
Figure 5.8: The bright field microscopic images of: (a) BM, (b) MLn, and (c) ML1; SEM 
images of: (d) BM, (e) MLn, and (f) ML1; and Size distribution analysis of the 
microparticles: (g) % frequency, and (h) cumulative % frequency. 
5.7.4. Leaching studies 
The leaching of the internal phase from the microparticles was monitored (Figure 5.10). 
Lanolin and L1 containing microparticles did not show any signs of leakage at the end of the 
study (2h). Leakage was checked by monitoring the wetting of the filter paper with the 
internal phase. The absence of leakage of the internal phase may be associated with the 
gelation of the internal phase at RT. This prevented the migration of the internal phase out of 
the polymeric layer. This ensures that the encapsulation of organogels within the 
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microparticles prevents the leakage of bioactive agents which, in turn, can improve the drug 
entrapment efficiency of the microparticles. 
5.7.5 Drug entrapment efficiency 
The dried microparticles were used to calculate the drug entrapment efficiency. The 
encapsulation efficiencies of the microparticles have been tabulated in Table 5.10. The drug 
entrapment efficiency of MLnMZ (82.0 ± 2.5) and ML1MZ (85.0 ± 3.4) were higher than 
BMMZ (46.0 ± 2.7). MLnMZ and ML1MZ have shown %DEE > 85 %, which is nearly the 
1.8 times the drug entrapment efficiency of BM. The restricted movement of the drug within 
the organogels might have yielded higher encapsulation efficiency in MLn and ML1 than in 
BM. In other words, the semisolid nature of the organogels behaved as a barrier for the 
movement of the drugs. MLnMZ and ML1MZ did not show any leaching (Figure 5.9). This 
might have also contributed in the increase drug entrapment efficiency. 
 
Figure 5.9: Leaching studies: (a) BM, (b) MLn, and (c) ML1; and bar graphs of: (d) 
Swelling power and % leaching. 
5.7.6. Molecular interaction studies 
XRD profiles of the microparticles have been shown in Figure 5.10a. BM showed a broad 
hump at ~12
o
 2θ [129]. MLn and ML1 have shown additional peaks corresponding to their 
internal phase apart from the broad peak of the alginate [12]. Microparticles have shown 
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distinct x-ray diffraction profiles, which varied on the composition of the internal phase. The 
characteristic peaks of lanolin and L1 (21.67° and 21.3° 2θ, respectively, given in part A of 
this chapter) were conserved in their respective microparticles, indicating their presence 
without any change in the physical properties. 
 
Figure 5.10: (a) XRD profiles, (b-c) FTIR spectra, and (d) DSC thermograms of the 
microparticles. 
All the microparticles were found to be amorphous in nature as suggested by the presence of 
a broad peak at ~20° 2θ. The change in the amorphousity was compared by calculating full 
width half maximum (FWHM) of the broad peak at ~20º [184]. In general, higher degree of 
amorphousity is associated with higher FWHM [12]. The FWHM of lanolin and L1 was 
found to be 10.76 and 10.00, respectively. BM have shown highest FWHM and may be 
attributed to the presence of water within the microparticles [173]. Results suggested that 
MLn and ML1 have lower amorphousity than BM. 
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The FTIR spectra of the microparticles showed the characteristic peaks of alginate, indicating 
that the addition of lanolin and L1 did not change the chemical nature of the alginate polymer 
(Figure 5.10b-c). L1 showed a narrow peak at 3400 cm
-1
 which was not present in lanolin. 
This may be associated with the intermolecular hydrogen bonding due to the presence of 
water in L1. MLn and ML1 have shown peaks corresponding to lanolin and L1, respectively, 
suggesting their presence within the microparticles. The intensity of the peak at 3400 cm
-1
 for 
L1, as L1 contained water which might have promoted intermolecular hydrogen bonding 
[12]. Absence of additional peaks in the microparticles suggested that there was no chemical 
interaction amongst the drug molecules and the components of the microparticles. 
5.7.7. Thermal studies 
The thermograms of lanolin and L1 have been reported in part A of this chapter. MLn and 
ML1 have shown endothermic peaks at ~38 °C (as shoulder peaks, pointed with arrows in the 
Figure 5.10d), corresponding to the melting endotherms of lanolin and L1. This confirmed 
the encapsulation of lanolin and L1 within the alginate microparticles. As per the literature, 
polysaccharides show high affinity towards water molecules and lose/release water at 
different temperatures depending on the interactions with the water. Water is reported to form 
hydrogen bonds with the –OH groups of the alginate polymers [185]. MLn and ML1 have 
shown peaks at ~67 °C. These endothermic peaks have been reported due to the evaporation 
of the loosely bound water [159]. MLn has shown additional endothermic peak at ~80 
o
C. 
This is due to the evaporation of tightly bound water molecules. ML1 showed a single broad 
endothermic peak for the evaporation of the water molecules. This might have resulted due to 
the evaporation of the water molecules (both loosely bound and tightly bound water) in 
tandem. BM did not contain any internal phase which resulted in the stronger association of 
the water molecules with the –OH groups of alginate. This explains the occurrence of the 
endotherm peak at 100 ºC. No shoulder peak was obtained as there was no gel entrapped 
within the core of the microparticles. 
5.7.8. In vitro Biocompatibility and mucoadhesivity studies 
Biocompatibility of the microparticles was determined by studying the relative proliferation 
of fibroblast cells in the presence of the microparticles extracts. The cell proliferation was 
measured using MTT assay. The results indicated that the cell viability index in presence of 
the leachates of the microparticles were either ~1 or better than 1 indicating the 
biocompatible nature of the microparticles (Figure 5.11a). The change in cell viability index 
was found to be insignificant (p > 0.05) with respect to control. 
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The detachment times of BM, MLn and ML1 from the mucous membranes was found to be 
28.25 ± 2.2 h, 24.5 ± 1.5 h and 25.5 ± 3.25 h, respectively (Figure 5.11b). All the 
microparticles showed high affinity towards the mucousal membrane. This may be associated 
with the anionic nature of the alginate molecules [186]. The statistical analysis suggested that 
the difference in mucoadhesion times was insignificant (p > 0.05). Since there was negligible 
leaching of the internal phase from MLn and ML1, this accounted for their similar 
mucoadhesive behavior as that of BM microparticles. 
 
Figure 5.11: (a) In vitro biocompatibility, and (b) Mucoadhesivity studies of the 
microparticles. 
5.7.9. In vitro drug delivery studies 
The release of the drugs was affected by the physical nature of the microparticles. Under the 
given conditions, BMMZ have shown highest in vitro CPDR value (Figure 5.12a), followed 
by ML1MZ and MLnMZ. The difference in the drug release behavior may be attributed to 
the internal composition of the organogels. Difference in CPDR values was also noticed 
during antimicrobial studies. Higher zone of inhibition was noticed against BMMZ, followed 
by ML1MZ and MLnMZ (Figure 5.12b-d). Presence of water might have facilitated the 
transportation of the drug from the microparticles. 
The speculation of the mechanism of release of the drugs was carried out by fitting the drug 
release profile information in the zero-order, first order, Higuchi, Baker-Lonsdale model and 
Korssmeyer-Peppas models (Figure 5.13). The parameters of the best fit models have been 
tabulated in Table 5.9. All the release patterns followed Higuchi and Baker-Lonsdale models 
(R
2
 > 0.95). The results suggested that the developed microparticles may be considered as 
swollen matrix type as the release profile can be easily described by the Baker-Lonsdale 
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model [187-188]. The Fickian value (n) was calculated from Korssmeyer-Peppas model (R
2
 > 
0.95). As per the n value, MLnMZ and ML1MZ followed non-Fickian kinetics. The non-
Fickian/anomalous behavior of drug release may be due to polymer relaxation, erosion and 
degradation. The non-Fickain and anomalous release behavior of the drugs from the alginate 
microparticles have also been reported [189-190]. 
 
Figure 5.12: (a) CPDR profiles of the microparticles, and (b-d) antimicrobial studies of 
the microparticles against E. coli. 
Table 5.9: Drug release kinetics from the microparticles 
Sample 
Zero order 
R
2
 
Higuchi 
R
2
  
BL model 
R
2
  
Best fit 
KP model 
R
2
 ‘n’  Diffusion 
BMMZ 0.957 0.937 0.983 BL 0.995 0.80 Non-Fickian 
MLnMZ 0.55 0.988 0.996 BL 0.995 0.53 Non-Fickian 
ML1MZ 0.80 0.993 0.993 BL 0.998 0.56 Non-Fickian 
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Figure 5.13: Drug release kinetics: (a) Zero order; (b) Higuchi kinetics; (c) BL model; 
and (f) KP model. 
5.8. Conclusion 
Lanolin-based organogels have been successfully encapsulated within the alginate 
microparticles prepared by ionotropic gelation method. DSC and XRD studies confirmed the 
encapsulation of organogels within the microparticles. Drug entrapment efficiency of the 
organogel containing microparticles was found to be higher than the blank microparticles. 
Encapsulation of the organogels has enhanced the drug carrying capacity of the 
microparticles. The cytocompatibility and mucoadhesivity studies suggested the 
biocompatible and mucoadhesive nature of the microparticles. In vitro drug release studies 
suggested that lanolin and L1 containing microparticles may be tried for controlled delivery 
applications. 
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Chapter 6 
Encapsulation of stearate based organogels in 
alginate microparticles 
Abstract 
Edible oil (sesame oil and soy bean oil) based organogels were synthesized using stearic acid 
as the organogelator. In depth analysis of gel kinetics, gel microstructure, molecular 
interactions, thermal and mechanical behaviors of the organogels was performed. The 
properties of the organogels were dependent on the type of the vegetable oil used and the 
concentration of the stearic acid. Avrami analysis indicated heterogeneous nucleation coupled 
with one-dimensional growth of gelator fibers was the key phenomenon in the formation of 
organogels. Alginate (shell) microparticles were prepared by encapsulating semi-solid 
organogel (core) by ionotropic gelation method. Confocal microscopic studies have shown 
the existence of organogel as the core of the microparticles. The presence of organogel as the 
core material of the microparticle was confirmed by X-ray diffraction and differential 
scanning calorimetric analyses. Entrapment of the organogel within the microparticles has 
improved the drug encapsulation efficiency by preventing the leaching of the internal phase. 
In vitro drug release studies showed sustained release of ciprofloxacin from the organogel 
containing microparticles. The drug loaded microparticles was found to have good 
antimicrobial activity when tested against E. coli. The microparticles were found to be 
mucoadhesive and biocompatible in nature. The preliminary results suggested that the 
developed microparticles hold promise as carriers for controlled delivery applications. 
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Graphical abstract 
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Part A: Preparation and characterization of stearate organogels 
 
 
 
 
 
 
 
 
 
 
Overview: 
Stearic acid based organogels were prepared by hot emulsification method using sesame oil 
and soy bean oil as the organic solvents. Critical gelator concentration (CGC) of stearic acid 
was found to be 16 % (w/w) and 19 % (w/w) for the synthesis of sesame oil and soy bean oil 
organogels, respectively. For further characterization and comparison, sesame oil and soy 
bean organogels with CGC, 22 % (w/w) and 25 % (w/w) gelator concentrations were chosen. 
Organogel microstructure and gelation kinetics indicated that the gels were formed by 
heterogeneous nucleation and one-dimensional growth of gelator fibers. The gelation 
mechanism was confirmed by performing Avrami analysis on DSC thermograms. Based on 
the XRD, FTIR and DSC analyses it was identified that the stearic acid molecules were 
arranged themselves in layered fashion by forming hydrogen bonds amongst their carboxyl 
head groups. The change in the crystallite size of stearic acid in organogels was evaluated by 
XRD studies. Viscoelastic and pseudoplastic nature of the organogels was analyzed in-depth 
by fitting the stress relaxation data in modified Peleg’s model and rheological studies, 
respectively. Textural studies revealed the coexistence of hydrogen bond dissipation and 
formation of new bonds when stress applied on the organogels. Ciprofloxacin (model drug) 
was released from the organogels via diffusion with good antimicrobial activity against E. 
coli. 
 
 
96 
6.1. Introduction 
In general, organogels are grouped as physical gels and chemical gels. Since the chemical 
organogels have wide range of applications beyond biomedical, food and cosmetic 
applications, their mechanism of formation and physical properties have been well 
documented [191]. But limited research has been carried out on the physical organogels, 
especially edible oil organogels (organogels). The gelation mechanism and in-depth analysis 
of physical properties of organogels have not been well explored. 
Stearic acid has several health benefits when consumed orally or applied locally over the 
skin. It is octadecanoic acid, an 18 carbon chain fatty acid. It is the second most naturally 
abundant saturated fatty acid after palmitic acid. Sesame and soy bean oils are edible oils 
obtained from the seeds of Sesamum indicum and Glycine max, respectively. These oils are 
rich in natural antioxidants. Sesame oil contains vitamin E and sesamol whereas phytic acid 
is present in soy bean oil [192-194]. These oils also possess excellent anti-inflammatory 
properties. Although these oils possess intriguing features, limited research has been done on 
these oils for food, cosmetic and pharmaceutical applications. In this study, we report for the 
in-depth analysis of the gelation kinetics, molecular interactions, thermal and mechanical 
properties of the stearic acid based organogels. Sesame oil and soy bean oil were used as the 
representative vegetable oils. In vitro drug release and antimicrobial studies were carried out 
using ciprofloxacin loaded organogels to determine the capability of the organogels as 
carriers for controlled drug delivery. 
6.2. Materials and methods 
Stearate based organogels were prepared as per the protocol given in section 3.2.3 of chapter 
3. Characterization of the organogels, in vitro drug delivery studies and antimicrobial studies 
were performed as per the protocols given in section 3.3 of chapter 3. Characterization 
studies include, bright field microscopy, gelation kinetics, XRD, FTIR, DSC and mechanical 
studies. 
6.3. Results and discussion 
6.3.1. Preparation of the organogels 
Organogels were prepared by dissolving stearic acid in the vegetable oil (sesame oil and soy 
bean oil). At higher temperatures, the stearic acid solution was transparent. As the solution 
was cooled down to room-temperature, the solution became opaque. Formation of organogels 
was confirmed by inverted tube method (Figure 6.1) [107]. Above the critical gelator 
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concentration (CGC), stearic acid induced gelation. The CGCs for sesame oil and soy bean 
oil were different. 16 % (w/w) and 19 % (w/w) of stearic acid was needed to induce the 
gelation of sesame oil and soy bean oil, respectively. CGC of > 15 % is quite common for 
fatty acyl non-ionic organogelators in vegetable oils and organic solvents [106]. At CGC, 
each stearic acid molecule immobilized ~1.7 molecules of sesame oil and ~1.4 molecules of 
soy bean oil. The CGC of the gels did not change even after the addition of 0.5 % (w/w) 
ciprofloxacin. The developed gels were opaque, smooth and semi-solid and their composition 
has been tabulated in Table 6.1. Color of the gels was dependent on the vegetable oil used. 
The organogels are thermoreversible in nature and stable at RT for more than 12 months. 
During this period, syneresis of the oil was not observed. No fungal contamination of the 
samples was found during this period. Sesame oil formed yellow colored gels while white 
colored gels were formed when soy bean oil was used. 
 
Figure 6.1: Pictographs of: (a) Ses1, (b) Ses2, (c) Ses3 (d) Soy1, (e) Soy2, and (f) Soy3. 
The minimum concentration of stearic acid (CGC) to induce gelation was different for the 
oils. This is due to the solvent induced nucleation of the gelator molecules and may be 
attributed to the difference in the polarity of the oils used. The difference in the polarity of the 
oils may be described by the degree of unsaturation of the oils. Sesame oil contains high oleic 
acid fraction whereas soy bean oil contains high linolenic and linoleic acid fraction [195-
196]. These differences lead to the change in polarity of the oils, which in turn, affected the 
gelling ability of stearic acid. This kind of phenomenon was observed in 12-hydroxy stearic 
acid/canola oil organogels [197]. 
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Table 6.1: Composition of the organogels under investigation. 
Sample 
Stearic acid 
(% w/w) 
Sesame oil 
(% w/w) 
Soy bean oil 
(% w/w) 
Ciprofloxacin 
(% w/w) 
Ses1 16.0 84.0 -- -- 
Ses2 22.0 78.0 -- -- 
Ses3 25.0 75.0 -- -- 
Soy1 19.0 -- 81.0 -- 
Soy2 22.0 -- 78.0 -- 
Soy3 25.0 -- 75.0 -- 
Ses1C 16.0 83.5 -- 0.5 
Ses2C 22.0 77.5 -- 0.5 
Ses3C 25.0 76.5 -- 0.5 
Soy1C 19.0 -- 81.5 0.5 
Soy2C 22.0 -- 78.5 0.5 
Soy3C 25.0 -- 75.5 0.5 
6.3.2. Gelation kinetics 
Since the developed formulations were transparent liquids at 70 
o
C, the kinetics of the 
organogelation was studied by measuring the absorbance of the gels when the molten gels 
were cooled to room-temperature. The gel setting time was considered as the time required in 
reaching the equilibrium phase. Equilibrium phase was first achieved by Ses3 and Soy3, 
where the concentration of stearic acid was highest (Figure 6.2). As the stearic acid 
concentration was reduced there was a decrease in the gel setting time. 
The gel setting time was calculated from the measurement of the absorbance  of the molten 
gels during cooling. The shape of the absorption profile was sigmoidal. The gelation time per 
gram of the gel was calculated (Figure 6.2c). The initial slow transformation rate can be 
attributed to the time required for forming the significant number of nuclei. Alteration in the 
gelator concentration resulted in the changes of induction time (Ti), fibrillar growth time (Tf) 
and equilibration time (Te). In comparison to the induction time, fibrillar growth time was 
very fast and was about ~1 min for all the gels. The change in gelator concentration has 
mainly affected the induction time and the equilibration time of the gels. The equilibration 
time (gel setting time) decreased with the increase in the concentration of the stearic acid. 
Sigmoid profile along with long-term equilibrium state signifies that growth of the fiber 
aggregates was may be one-dimensional and followed first-order kinetics [198]. One-
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dimensional growth of the aggregates results in the formation of long fibers having high 
length: width ratio. Formation of fibers with high length: width ratio was confirmed from the 
microscopic studies (Figure 6.3). 
 
Figure 6.2: Gelation kinetics of: (a) sesame oil based organogels, and (b) soy bean oil 
organogels; and (c) Gelation parameters of the organogels. 
The micrographs (bright field microscopy) showed the presence of fibrous network of stearic 
acid in vegetable oils (Figure 6.3). The gelator fibers were dispersed throughout the 
continuous phase and were entangled to form a coherent network. The orientation of the thin 
fibers into discrete fibrillar bundles/aggregates was noticed in all the organogels. This kind of 
phenomenon is commonly associated with physical organogels [199]. The network density 
was higher in gels with higher gelator concentration. Figure 6.3 (g-i) shows the formation of 
gelator network of Ses3 oleogel at different time intervals during cooling. Network formation 
was initiated by random nucleation of stearic acid, followed by fiber growth and subsequent 
branching. Branching and entanglement of fibers has been shown by an arrow in Figure 6.3i. 
Formation of nucleation points were observed during the fiber growth. This suggested that 
the nucleation in the gels was a random and continuous process and not a spontaneous 
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process. The fibers started growing away from the nucleation point. The fibers showed a 
continuous branching at the tips and/or side faces. 
 
Figure 6.3: Microscopic images of: (a) Ses1, (b) Ses2, (c) Ses3, (d) Soy1, (e) Soy2, and (f) 
Soy3 organogels; Formation of Ses3 organogel at: (g) zero sec, (h) 30 sec, and (i) 1 min 
of gelation (Ses3 was shown as the representative). 
The gelator molecules self-assembled as the temperature of the molten organogels was 
reduced (Figure 6.3). Nucleation was governed by the diffusion of stearic acid molecules 
from the molten phase to the solid phase. Phase conversion lead to the formation of fibers 
with low-dimensional or liquid crystalline ordering of stearic acid molecules. This suggested 
heterogeneous nucleation was prevalent in the formation of the stearic acid fibers [200]. 
There was an increase in the fiber growth and branching as the concentration of the gelator 
was increased. The increase in the proportion of stearic acid has resulted in the increase in the 
branching. 
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6.3.3. Molecular interaction studies 
Table 6.2: Peak analysis of stearic acid’s X-ray diffractogram. 
Type of peaks Peak position (º2θ) d-spacing (Å) Interplanar spacing 
Long spacing peaks 6.89 12.82 [003] 
11.5 7.69 [005]  
Short spacing peaks 20.29 4.37 [007] 
21.37 4.15 [110] 
23.7 3.75  
Molecular interactions amongst the gel components were studied by XRD and FTIR studies. 
Stearic acid exists in different polymorphic forms. Based on the peak analysis, the 
polymorphic form of stearic acid was estimated (Figure 6.4, Table 6.2). The peak positions 
and d-spacings of stearic acid diffractograms are closely matching with the C-form of stearic 
acid [157]. The position of the major peaks and the d-spacings of stearic acid were conserved 
in the organogels (Figure 6.4). This suggests that the polymorphic form of stearic acid was 
not altered during the formation of organogels. The diffractograms of both stearic acid and 
the organogels showed the presence of both long-spacing peaks [00l] and short-spacing peaks 
[hk0]. The long spacing and short spacing peaks provide information about the order and the 
lateral packing of the molecular layers, respectively [157]. Although the peak positions of 
long and short spacing peaks were not altered, their intensities were different. The intensity of 
the long spacing peaks was more intense than the short spacing peaks in the stearic acid 
diffractogram. On the other hand, a reverse trend was observed in the prepared organogels, 
i.e. the intensity of the short spacing peaks were higher than the long spacing peaks. This 
suggested that the addition of the vegetable oils in the stearic acid resulted in the 
rearrangement of the molecular packing of stearic acid. 
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Figure 6.4: (a) XRD of organogels; FTIR spectra of: (b) organogels, and (c) CFX and 
CFX containing organogels. 
Previous study using oleanolic acid (a pentacyclic triterpenoid acid) reported that the long 
spacing peaks of stearic acid are not manifested in the X-ray diffractograms. This is due to 
the destruction of the order of molecular layers of stearic acid in the organogels [157]. In the 
present study, inclusion of oils has exposed the crystal planes of long spacing region. This 
resulted in the increase in the peak intensity of the long spacing peaks. Retention of peaks in 
103 
the long spacing region revealed that the order of stearic acid molecular layers was not 
disturbed even in the organogels. As peak positions in the organogels were in match with the 
pure stearic acid, the gelator molecules exist in the same molecular packing arrangement 
[201]. 
Table 6.3: The XRD parameters of SA and organogels. 
Samples d-spacing of [110] plane (Å) FWHM of [110]  peak (º2θ) D (nm) 
SA 4.15 0.157 51.4 
Ses1 4.15 0.324 24.9 
Ses2 4.15 0.195 41.5 
Ses3 4.15 0.192  
Soy1 4.14 0.292 27.7 
Soy2 4.14 0.227 35.6 
Soy3 4.14   
The molecular packing of stearic acid in gelator fibers was determined by the angle ratios or 
Bragg distance ratios. The ratios of position of the 1
st
 (6.89º 2θ), 2nd (11.5º 2θ) and 3rd (21.37º 
2θ) low angle peaks of the gels with respect to lowest angle peak position (6.89º 2θ) was 
studied to identify the packing of the gelator molecules [201]. The XRD profiles of the 
developed gels showed that the ratios were nearly 1:1, 2:1 and 3:1, respectively. This type of 
arrangement supports the layered packing of the stearic acid molecules in the organogels 
[201]. During the preparation of the gels, there is a possibility of the incorporation of the 
vegetable oils within the layers of stearic acid molecules. Association of the vegetable oils 
within the layers of stearic acid has been reported to affect the crystallite size of stearic acid. 
Based on the peak width, average crystallite size (D) was calculated using Debey-Scherrer 
equation (equation 4.2 in chapter 4). 
The estimation and comparison of the average crystallite size was done using the peak at 
21.37º 2θ. Addition of oil resulted in the distinct variation of the crystallite sizes of stearic 
acid (Table 6.3). Decrease in the crystallite size of the gelator molecules leads to the increase 
in the amorphousity (or decrease in the crystallinity) of the organogels and vice versa [136]. 
The amorphous peak (19.5º 2θ) associated with the XRD profiles of the organogels was due 
to the presence of liquid triacylglycerols in sesame oil and soy bean oil [202]. The crystallite 
size values suggested that the organogels with lower proportions of stearic acid were having 
lowest crystallinity. This was attributed to the interactions amongst the stearic acid and the 
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solvents. Presence of oil prevents the crystal growth of stearic acid [203]. This resulted in the 
formation of short stearic acid fibers in the organogels with higher proportions of oils and 
vice versa. During the formation of the organogels, the branching of the gelator fibers 
occurred at the tip and/or the side faces of the gelator fibers (Figure 6.3f). Addition of new 
crystal layers (layered/lamellar arrangement) during crystal growth lead to the structural 
mismatch with the crystallographic orientation of the parent fiber. This crystallographic 
mismatch branching (CMB) was responsible for the splitting of growing fibers. In the 
nucleation-growth mechanism (as predicted earlier), growth was favored by CMB. One-
dimensional growth of fibers is favored when the CMB is very high, which in turn, is 
associated with the high degree of supersaturation of the gelator [197]. 
The possible chemical interactions for the lamellar arrangement of the stearic acid molecules 
were explained by the FTIR studies. FTIR spectrum of stearic acid showed its characteristic 
bands at about 1,710 and 940 cm
-1
 (Figure 6.4). The bands at 1,710 cm
-1
 and 940 cm
-1
 were 
due to the stretching vibration of carbonyl group and bending vibrations of hydrogen bond 
(OH-H) involving carboxylic acid, respectively [204]. The characteristic peaks of stearic acid 
were retained in the FTIR spectra of the organogels. These peaks were shifted towards lower 
wave number in the organogels. This may be due to the involvement of the carboxylic group 
of stearic acid in the non-covalent interactions (hydrogen bonding) during gelation [205]. 
Fatty acids present in sesame oil and soy bean oil have been involved in the formation of 
hydrogen bonds with the stearic acid molecules. This resulted in the incorporation of the 
vegetable oils within the lamellar structure of the stearic acid. Coexistence of stearic acid 
molecules and vegetable oils resulted in the change in the molecular packing of the stearic 
acid in the organogels. Ciprofloxacin showed characteristic bands at 1,610 and 1,260 cm
-1
 
due to the stretching vibration of the phenyl network conjugated to –COOH and of C-F bond, 
respectively [206]. The bands of ciprofloxacin were subsided by the bands of the gel 
components. 
6.3.4. Thermal studies 
Melting and crystallization behavior of stearic acid and organogels was tested below 100 ºC. 
This was done to avoid sublimation of stearic acid. The melting and crystallization events in 
organogels were observed in broad temperature ranges as compared to pure stearic acid 
(Figure 6.5). The occurrence of phase change in the broad temperature range suggested that 
the sol-to-gel and gel-to-sol transitions were not an instantaneous process but a continuous 
process. The Tonset,m (melting onset temperature), Tm (melting temperature), Tonset,c 
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(crystallization onset temperature), Tc (crystallization temperature), ΔHm (melting enthalpy) 
and ΔHc (crystallization enthalpy) of the organogels and stearic acid were tabulated in Table 
6.4. Enthalpy changes involved during the thermal events was measured by integrating the 
area under the curve. The onset temperatures and change in the enthalpies associated with the 
organogels were found to be less than the pure stearic acid (Table 6.4). 
In general, the melting endotherm is a combination of two events, i.e. fiber melting and 
dissolution of the fibers. The effect of the gelator concentration during phase change was 
studied using Schroder-Van Laar equation [207]. 
ln g gX H RT       (6.1) 
where, Xg is the mole fraction of gelator in organogels; ΔHg is the enthalpy involved due to phase change of 
stearic acid during melting; R is the universal gas constant and T is the melting temperature.  
 
Figure 6.5: (a) DSC thermogrms of SA and organogels (arrow in red indicates heating 
and arrow in black indicates cooling); (b) and (c) are the Fitting curves of the Avrami 
equation. 
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The change in the enthalpies (ΔHg) was found to be higher in organogels with the increase in 
the concentration of the stearic acid (Table 6.4). The change in the enthalpies due to the 
gelator melting was found to be less than the total enthalpy of the melting process. The 
excess heat involved during the phase change might have contributed to the dissolution of the 
fibers. This suggested that the fiber melting and the dissolution of the fibers into the solvent 
occurred in tandem, which in turn, resulted in the formation of broad endothermic peaks. 
Microscopic studies suggested that the fiber formation/crystallization in organogels was a 2-
step process, i.e. nucleation and crystal growth. Crystallization at the nucleation site was 
driven by the non-covalent interactions amongst the stearic acid molecules and the stearic 
acid–vegetable oil molecules. This allowed the system to attain a low energy-state by 
releasing heat (exothermic reaction). The released heat was calculated as the crystallization 
enthalpy of the reaction (Table 6.4). This driving force was countered by the entropic forces 
associated with the phase separation/demixing of the gelator fibers from the homogeneous 
solution. The change in the entropies during the crystallization events was calculated by using 
the following equation: 
c cG H T S       (6.2) 
where, ΔG and ΔS are the Gibb’s free energy and change in entropy involved during crystallization.  
Table 6.4: Thermal properties obtained by DSC studies. 
Sample 
Melting, Endotherm Crystallization, Exotherm 
Tonset,m 
(⁰C) 
Tm 
(⁰C) 
ΔHm 
(J/g) 
ΔHg 
(J/g) 
Tonset,c 
(⁰C) 
Tc 
(⁰C) 
ΔHc 
(J/g) 
ΔS 
(J/g/K) 
SA 55.0 58.8 863.55 -- 53.2 49.4 863.55 17.48 
Ses1 35.0 44.5 65.24 33.77 39.6 35.9 236.92 1.82 
Ses2 35.1 44.6 71.55 29.31 38.4 37.3 245.29 1.92 
Ses3 36.7 45.2 106.32 34.16 41.9 38.6 253.08 2.75 
Soy1 34.9 44.5 55.0 28.85 38.5 35.6 226.45 1.54 
Soy2 35.5 44.4 62.58 26.71 38.5 35.7 251.92 1.75 
Soy3 37.0 46.7 107.35 28.23 42.8 39.9 374.32 2.69 
ΔG tends to be zero at the crystallization temperature. The change in the entropies was 
calculated at the crystallization temperature (Table 6.4) [208]. The change in entropy is due 
to the crystal-solvent interfacial tension and forms a key parameter for the nucleus formation 
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during crystallization [209]. The loss of entropy was found to be higher in the organogels 
having higher proportions of stearic acid. Hence, the organogels with higher proportions of 
stearic acid lead to the formation of organogels with higher thermodynamic stability. Increase 
in the loss of entropy indicated a reduction in the crystal-solvent interfacial tension. In other 
words, the crystal-solvent interfacial tension was decreased with the increase in the 
concentration of the stearic acid. 
The results suggested that the rearrangement of the stearic acid molecules happened to 
minimize the interactions amongst the polar head groups of the stearic acid and the apolar 
groups of the vegetable oil. The minimal interfacial interactions lead to the decrease in the 
interfacial tension and hence resulted in the formation of a stable nucleus. This explained the 
thermodynamic stability of the organogels with higher proportions of stearic acid. The 
possible orientation of stearic acid molecules within the organogels has been shown in Figure 
6.6. The polar head groups of stearic acid molecules interact via intermolecular hydrogen 
bonding (as predicted in FTIR studies). This minimizes the interfacial tension by hiding the 
polar groups and exposing the hydrophobic tails to the vegetable oils. This orientation 
resulted in bilayered arrangement of stearic acid molecules during the formation of gelator 
fibers. Layered arrangement of stearic acid molecules was confirmed by the XRD studies. 
 
Figure 6.6: Schematic sketch of the possible orientation of stearic acid molecules in the 
organogels. 
Crystallization studies 
Table 6.5: Crystallization kinetics of organogels. 
Sample 
Avrami analysis 
% crystallinity 
n K, (s
-1
) R
2 
Ses1 1.396 0.984 0.981 7.55 
Ses2 1.568 0.969 0.969 8.28 
Ses3 1.563 0.948 0.95 12.31 
Soy1 1.541 0.981 0.981 6.37 
Soy2 1.583 0.977 0.975 7.25 
Soy3 1.611 0.975 0.97 12.43 
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Gelation/crystallization kinetics of the organogels was evaluated by Avrami equation 
(equation 4.4 in chapter 4). Avrami exponents were obtained from the slopes of the Avrami 
plots (Figure 6.5, Table 6.5). The exponent values were non-integer values and were in 
between 1 and 2. This indicated that the nucleation followed first-order kinetics and the fiber 
formation happened in a linear fashion [210]. In this kind of nucleation mechanism, 
nucleation of the fibers does not occur instantaneously but occurs throughout the gelation 
process. This kind of nucleation is called heterogeneous or simultaneous nucleation [200]. 
Heterogeneous nucleation in the prepared organogels can be visualized in the Figure 6.3h. 
The n value was higher in the organogels with higher concentration of stearic acid (Table 
6.5). The change in the n value suggested a change in the order of the crystal growth. A n 
value nearer to 2.0, suggest that the crystallization process might be approaching towards 
two-dimensional growth of the stearic acid fibers. Change in the order of the crystal growth 
may be associated with the secondary crystallization process occurring during the crystal 
growth. The fractional n values indicate that the secondary crystallization must have occurred 
by heterogeneous nucleation process during gelation. Existence of secondary crystallization 
during gelation can also be proved by observing the regression coefficient (R
2
) values of 
Avrami plots (Table 6.5) [200]. The R
2
 values were found to be decreasing with the increase 
in the concentration of stearic acid. In general, Avrami equation is limited to low degrees of 
crystallinity. At high concentration of stearic acid, impringement of crystals with one another 
and/or secondary crystallization will affect the crystallization kinetics (Avrami equation). 
Secondary crystallization of the gelators must have occurred during the gelation, as was 
evident from the fractional n values. The decrease in the R
2
 values with the increase in the 
concentration of the stearic acid indicated that the secondary crystallization was regulated by 
the change in the concentration of the gelator. Avrami analysis indicated a change in the 
order of crystallization during crystal growth. Hence, it can be inferred that there are high 
chances of secondary crystallization during gelation. Since the crystal growth took place at 
different crystal layers, the occurrence in the structural mismatch lead to the crystallographic 
mismatch and subsequent branching. This kind of branching leads to splitting of fibers and 
results in irregular shaped fibers. The non-integer Avrami exponent values also indicated the 
existence of irregular shaped crystals. 
Based on the organogelation kinetics, XRD, DSC and FTIR studies, the mechanism of 
gelation of stearic acid in vegetable oil organogels was predicted. During gelation, 
heterogeneous nucleation was associated with one dimensional crystal growth and followed 
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by splitting of fibers due to CMB. The stearic acid molecules arrange themselves as bilayers 
to reduce the interfacial tension during fiber growth. Finally, the entanglement of the 
irregularly shaped fibers leads to the formation of the gelator network. 
6.3.5. Mechanical analysis 
 
Figure 6.7: Viscosity studies of organogels: (a, b) Viscosity curves and (c,d) modified 
power law fitting curves. 
The mechanical analyses of the gels were done by small scale deformation (viscosity 
measurement) and large scale deformation (stress relaxation and spreadability using dynamic 
mechanical tester) studies. During small scale deformation studies, the flow behavior of the 
organogels was predicted by applying a cyclic shear rate in the range of 10 s
-1
 to 95 s
-1
. The 
initial apparent viscosity of Ses3 and Soy3 were found to be higher than the other gels 
(Figure 6.7a and 6.7b). With the increase in the gelator concentration, there was an increase 
in viscosity of the organogels thereby indicating the formation of stronger organogels. There 
was an exponential decrease in the viscosity of the organogels when the shear rate was 
increased. When the shear rate was reduced, there was an incomplete structural reversal 
resulting in the formation of an open hysteresis loop. Presence of hysteresis is a common 
feature in gels [179]. 100 % recovery of the initial apparent viscosity was not achieved in any 
of the organogels and may be associated to the complete disruption of the gel architecture. 
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The results have suggested that the apparent viscosities of the organogels were reduced with 
the increase in the shear rate and vice versa. This indicated shear thinning behavior of the 
organogels. The non-Newtonian behavior of the organogels was confirmed by fitting 
obtained data  in the modified power law equation [211]. 
1. mK     (6.3) 
where, τ is the shear stress (Pa) at γ shear rate (s-1); K is the flow consistency index (Pa.s), and m is the flow 
behavior index. 
The flow behaviour indices (Table 6.5) of the organogels were found to be < 1, suggesting 
the pseudoplastic nature of the organogels [211]. The K value (Table 6.5) suggested that the 
organogels with higher proportions of stearic acid have higher consistency. Amongst the 
sesame oil and soy bean oil organogels, apparent viscosity and consistency of the soy bean oil 
organogels was higher. 
Cyclic uni-axial compression test showed that hardness, adhesiveness and gumminess of the 
organogels increased with the increase in stearic acid concentration (Table 6.6). On the other 
hand, cohesiveness was decreased. The same trend was followed in both the kind of 
organogels. Increase in hardness may also be regarded as firmness (F0) and higher firmness 
was observed for Ses3 and Soy3 organogels during stress relaxation studies. In general, 
organogels have been described as viscoelastic semisolids. The viscoelastic nature of the 
organogels was confirmed by stress relaxation studies (Figure 6.8). The stress relaxation 
profiles of the organogels were closely related to the stress relaxation profiles of viscoelastic 
solids [149]. During relaxation, when the strain was kept constant, the recorded force 
decreased quickly and reached a near constant asymptotic value. This value is called residual 
force or resistance encountered by the elastic part of the material [212]. Ses3 and Soy3 have 
shown higher gel strength as initial force and residual force were found to be higher than the 
others. 
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Figure 6.8: Mechanical studies of organogels: (a, b) Stress relaxation studies, (c, d) 
Fitting curves (Modified Peleg’s equation), and (e, f) Spreadability studies. 
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Table 6.6: Mechanical properties of organogels. 
Sample Hardness 
(N) 
Cohesiveness Adhesiveness 
(N.sec) 
Gumminess 
(N) 
Ses1 0.019 1.251 0.083 0.022 
Ses2 0.024 0.955 0.089 0.022 
Ses3 0.167 0.489 0.241 0.082 
Soy1 0.061 0.815 0.123 0.049 
Soy2 0.084 0.727 0.157 0.061 
Soy3 0.468 0.550 0.560 0.257 
The stress relaxation profiles followed an exponential decaying function. The force decay of 
the curve with respect to time (F(t)) of the organogels was analyzed by fitting the data in 
modified Peleg’s equation (Equation 4.6 of chapter 4). Curve fitting (R2 > 0.995) of the 
normalized stress relaxation data using modified Peleg’s equation was shown in Figure 6.8 
and the fitting parameters have been tabulated in Table 6.7. The initial rate of the relaxation 
(k1) was lower in the organogels with higher proportions of stearic acid. The extent of the 
relaxation (k2) of the organogels was almost equal. k1 mainly illustrates the distribution of 
force decay rates and does not represent the whole stress relaxation curve. k2 is the overall 
slope of the normalized stress relaxation data during modified Peleg’s analysis. The slope of 
the modified Peleg’s fitting curve was strongly influenced by the asymptotic residual force 
(Fr). Due to the above reasons, k2 is a good parameter to estimate the complete relaxation 
behavior of the organogels. But the fitting analysis indicated that k2 values were ambiguous 
and very near to each other. Analysis using modified Peleg’s equation is efficient in 
identifying the relaxation behavior but it is unable to quantify the viscoelastic properties of 
the organogels. To quantify the viscoelastic properties, asymptotic residual value in the 
normalized stress relaxation curve (F
*
) and the area under the normalized stress relaxation 
curve (S
*
) are calculated [149]. 
*
0
rFF
F
    (6.4) 
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where, ‘a’ and ‘b’ are the lower and upper limits of the time, respectively.  
Area under the curve (S) is a simple and sensitive estimator of the changes in the relaxation 
behavior of materials. For viscoelastic materials S
* 
varies in the range of 0-1. Materials with 
greater elastic-like behavior possesses S
*
 close to 1.0. In the present study, the area under the 
curves was found to be > 0.5. This indicated that the organogels were viscoelastic semi-solid 
in nature. The organogels with higher stearic acid concentration showed higher S
*
 values, 
which indicated higher elastic strength of the organogels as compared to the organogels with 
lower concentration of stearic acid. The crosslinking density of the organogels might have 
contributed to the differences in the viscoelastic properties of the organogels. 
Table 6.7: Mechanical parameters of organogels. 
Samples 
F0 
(N) 
Fr 
(N) 
k1 k2 S
* 
F
* 
% relaxation 
Spreadability 
(N.sec)
-1
 
Ses1 1.373 0.628 0.111 0.014 0.857 0.457 4.017 4E-2 
Ses2 4.866 1.959 0.097 0.015 0.859 0.403 13.16 1.1E-2 
Ses3 10.12 3.564 0.025 0.016 0.864 0.352 26.49 0.5E-2 
Soy1 3.849 1.504 0.112 0.014 0.858 0.390 9.828 1.9E-2 
Soy2 4.455 1.993 0.086 0.015 0.859 0.387 13.44 1.3E-2 
Soy3 6.351 2.313 0.101 0.014 0.861 0.364 15.63 0.8E-2 
The modified Peleg’s analysis and the calculated parameters (F* and S*) suggested that the 
relaxation behavior of the organogels was dependent on the gelator concentration. The 
difference in the relaxation behavior of the organogels can be attributed to the crosslinking 
density of the stearic acid in the organogels. Higher crosslinking density in the Ses3 and Soy3 
organogels may be associated with the higher intermolecular hydrogen bonding (predicted in 
FTIR studies) amongst the stearic acid and the vegetable oil molecules. Application of the 
force resulted in the breakage of the hydrogen bonds amongst the gelator molecules. 
Disruption of the hydrogen bonds lead to the sudden decrease in the stress applied upon the 
gels (denoted by arrow in Figure 6.8a). The rate of decay was higher in Ses3/Soy3, followed 
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by Ses2/Soy2 and Ses1/Soy1. The rate of decay was also dependent on the gelator 
concentration. Since the hydrogen bonding was more pronounced in Ses3 and Soy3 than the 
other gels, disruption of bonds resulted in the greater decay of the applied stress. Force 
induced unbinding lead to the local gelator network rearrangement in the organogels. 
Interestingly though the hydrogen bonds were disrupted, the gelator network retained its 
elasticity even under plastic flow conditions. This has lead to the availability of residual 
stress at the end of relaxation. More amount of residual stress was retained in the organogels 
with higher gelator concentration. Retaining of residual stress was due to the formation of 
new hydrogen bonds amongst the gelator molecules during relaxation [213]. This suggests 
that the hydrogen bond disruption due to the application of stress is subsequently associated 
with the formation of new bonds. The coexistence of bond dissipation and the elastic 
recovery due to the formation of new bonds is possible if the gelator molecule can readily 
undergo crosslinking [213]. Based on the stress relaxation studies, the relaxation behavior of 
the organogels can be ranked as Ses3 > Ses2 > Ses1 and Soy3 > Soy2 > Soy1. 
The ranking of the relaxation behavior was also predicted by calculating the % relaxation. % 
relaxation was calculated using equation 6.8 [214]. 
0
0
% e *100r
F F
r laxation
F
 
  
 
  (6.8) 
% relaxation indicated that the relaxation was higher in oleogels with higher proportions of 
stearic acid. % relaxation information further confirmed the viscoelastic nature of the 
oleogels. 
The spreadable nature of the organogels was checked and shown in Figure 6.8e and 6.8f. 
Spreadability of Ses3 and Soy3 was very low, i.e. a very high force was needed to spread the 
gels. Gels with lower concentration of stearic acid showed better spreadability. The 
spreadability of the organogels was predicted by calculating the inverse of the area under the 
positive curve (Table 6.7). Lower spreadability of Ses3 and Soy3 may be associated with the 
higher elastic nature of the organogels (confirmed by stress relaxation studies) as compared 
to the others. The mechanical parameters followed a similar trend for both sesame oil and soy 
bean oil organogels. The results only varied quantitatively. This was due to the gelator-
solvent interactions. 
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6.3.6. In vitro drug delivery studies 
 
Figure 6.9: Drug release kinetics from the organogels: (a, b) CPDR vs. time; (c, d) Zero 
order, (e, f) Higuchi model, and (g, h) KP model. 
The CPDR was higher in the gels with lower proportions of stearic acid (Figure 6.9). 
Presence of dense network of gelator fibers in organogels with higher stearic acid 
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concentration  might have prevented the movement of the drug molecules. The drug release 
from the organogels followed zero-order kinetics (R
2
 > 0.95) (Table 6.8). Traditionally, zero-
order kinetics is followed by poorly water-soluble drugs [150]. The slope (n) or Fickian value 
(KP kinetics) was found to be in between 0.45 and 0.89 for Ses1C, suggesting non-Fickian 
diffusion [150]. In general, non-Fickian diffusion is followed when the release mechanism is 
not well known or when more than one mechanism is involved. The ‘n’ value was found to 
be 0.89 for Ses2C and Soy1C, suggesting case-II diffusion transport mechanism [150]. The n 
value for Soy2C is near 0.89, which can be considered as case-II transportation of drugs. 
Case-II transport mechanism has been associated with the zero order release, i.e. time 
independent release of the drugs [150]. Fickian value exceeded 1.0 in Ses3C and Soy3C, 
indicating super case-II transport of drugs. 
Table 6.8: Drug release kinetics from the organogels. 
Samples 
Zero order 
(R
2
) 
Higuchi 
(R
2
) 
Best fit  
KP model 
n Type of flow 
Ses1C 0.97 0.93 Zero order 0.86 Non-Fickian 
Ses2C 0.99 0.87 Zero order 0.89 Case-II transport 
Ses3C 0.99 0.90 Zero order 1.02 Super case-II transport 
Soy1C 0.97 0.93 Zero order 0.89 Case-II transport 
Soy2C 0.99 0.87 Zero order 0.91 Case-II transport 
Soy3C 0.99 0.82 Zero order 1.02 Super case-II transport 
The release of the drug in its active form was checked by performing antimicrobial studies. 
Presence of clear zones around the wells of the drug loaded organogels indicated that 
ciprofloxacin was released in its active form (Figure 6.10). Higher drug release from Ses1C 
and Soy1C resulted in larger zone of inhibition. The antimicrobial efficiency of the drug 
loaded organogels was much better than the Ciplox
®
 formulation. This may be due to the 
sustained release of the drug from the organogels over a prolonged period of time. The in 
vitro release studies suggested that the release of the drugs can be controlled by tailoring the 
concentration of stearic acid in the organogels. 
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Figure 6.10: Antimicrobial studies of organogels against E. coli. 
6.4. Conclusion 
Stearic acid was able to induce gelation of sesame oil and soy bean oil. The CGC for both the 
oils was different and was attributed to the differences in the chemical composition of the 
oils. The gelator-solvent interactions have significantly influenced the gelation and 
viscoelastic properties of the organogels. The physicochemical properties of the organogels 
were altered as the compositions of the organogels were changed. Gel kinetics, XRD and 
thermal analyses indicated that the formation of organogels was accompanied with the 
heterogeneous nucleation coupled with one-dimensional growth of the gelator fibers. The 
predicted gelation mechanism in stearic acid-edible oil organogels was via nucleation-CMB-
crystal growth-nucleation-. The in vitro drug release studies have suggested that the 
developed organogels may be tried as topical controlled drug delivery vehicles. 
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Part B: Encapsulation of stearate organogels in alginate 
microparticles 
 
 
 
 
 
 
 
 
 
Overview: 
Alginate microparticles were synthesized by encapsulating sesame oil and soy bean oil 
organogels with 22 % (w/w) stearic acid concentration (core) by ionotropic gelation method. 
Vegetable oil (sesame oil and soy bean oil) containing microparticles were used as the 
controls. Confocal microscopic studies showed the existence of distinct shell material around 
the organogel core. This was confirmed by XRD and DSC analyses. Control microparticles 
showed leaching, whereas, organogel containing microparticles did not show any leaching. 
Semi-solid nature of organogels prevented the leaching internal phase which in turn improved 
the drug encapsulation efficiency of microparticles (ciprofloxacin was used as the model 
drug). In vitro drug release studies showed the controlled release of ciprofloxacin from the 
organogel containing microparticles with significant antimicrobial activity against E. coli. 
Further, microparticles showed good mucoadhesivity and cytocompatibility against goat 
small intestine and mammalian L929 fibroblast cells, respectively. 
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6.5. Introduction 
Stearic acid-based sesame oil and soy bean oil organogels are tried to encapsulate within the 
alginate microparticles. These oils have antioxidant properties which may improve the shelf-
life of the formulations. Oral consumption of stearic acid has been reported to lower the LDL 
cholesterol [215]. These health benefits of microparticulate components will help improving 
the efficiency of the formulations. Ciprofloxacin (CFX) was chosen as the model drug to 
study the drug release kinetics from the developed microparticles. It is a 2
nd
 generation 
fluoroquinolone antibiotic with broad spectrum of activity against bacterial infections viz., 
urinary tract, gastrointestinal, abdomen and respiratory infections [216]. The drug has been 
recommended to treat the infections especially caused by Gram negative bacteria. In this 
regard, antimicrobial efficiency of the developed formulations was tested against E. coli. In 
general, systemic administration of ciprofloxacin is being done via oral (tablets or 
suspension) or intravenous (solution) routes. In oral drug delivery, for the immediate release, 
ciprofloxacin hydrochloride salt and for the extended release, ciprofloxacin base have been 
employed. Since attempts were made to design controlled release dosage forms, ciprofloxacin 
base was chosen. Ciprofloxacin therapy often includes nausea (2.5% of patients) and 
vomiting (1% of patients) [217]. These problems can be overcome by taste masking the 
antibiotic via the developed microparticles. 
In nut shell, this chapter describes the synthesis and characterization of alginate-based 
microparticles containing organogels as the internal phase (core). Sesame oil and soy bean oil 
containing microparticles were used as controls.  
6.6. Materials and methods 
Stearate organogels were prepared as per the protocol described in section 3.2.3 of chapter 3. 
Ses2 and Soy2 were chosen for the encapsulation studies and they were labeled as OG1 and 
OG2, respectively. 2.5 g of OG1/OG2 or sesame oil/soy bean oil were encapsulated within 
the microparticles as mentioned in section 3.2.5 of chapter 3. Sesame oil and soy bean oil 
containing microparticles served as the controls for OG1 and OG2 containing microparticles, 
respectively. Bright field microscopy, SEM, confocal microscopy, XRD, FTIR, DSC, 
biocompatibility studies, mucoadhesivity studies, in vitro drug delivery studies and 
antimicrobial studies were conducted as per the methods described in section 3.3 of chapter 3. 
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6.7. Results and discussion 
6.7.1. Preparation of organogels 
Stable organogels were prepared and the composition was given in Table 6.9. The 
mechanism of organogel formation has been explained in part A of this chapter. 
Table 6.9: Composition of the organogels. 
Sample 
Stearic acid 
(% w/w) 
Sesame oil 
(% w/w) 
Soy bean oil 
(% w/w) 
Ciprofloxacin 
(% w/w) 
OG1 22.0 88.0 -- -- 
OG2 22.0 -- 88.0 -- 
OG1C 22.0 87.5 -- 0.5 
OG2C 22.0 -- 87.5 0.5 
6.7.2. Preparation of the microparticles 
Stable microparticles were formed when organogels and vegetable oils were used as the 
internal phases. Table 6.10 illustrates the composition of the microparticles. 
Table 6.10: Composition of the microparticles. 
Sample Internal phase Ciprofloxacin (% w/w) 
MSes Sesame oil -- 
MSoy Soybean oil -- 
MOG1 OG1 -- 
MOG2 OG2 -- 
MSesC Sesame oil + CFX 0.5 
MSoyC Soybean oil + CFX 0.5 
MOG1C OG1 + CFX 0.5 
MOG2C OG2 + CFX 0.5 
6.7.3. Microscopy 
The structural analysis of the microparticles was investigated in detailed by different 
microscopic techniques. BFM images of MSes, MSoy showed droplets as the internal phase, 
whereas, MOG1 and MOG2 are opaque in nature (Figure 6.11a-d). Micrographs suggested 
the formation of spherical microparticles. The size distribution analysis of the microparticles 
suggested a broad size distribution profile for the vegetable oil containing microparticles, 
whereas, organogel containing microparticles showed a narrow size distribution profile 
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(Figure 6.12a). The average diameter (Davg) of the microparticles was calculated as the size of 
the 50% of the total microparticles population (shown as dotted lines in Figure 6.12b). The 
average diameter of the organogel containing microparticles was higher (MOG1: 210.24 ± 
5.8 µm; MOG2: 226.10 ± 4.7 µm) than the vegetable oil (MSes: 130.52 ± 3.5 µm; MSoy: 178 
± 3.8 µm) containing microparticles. Increase in the sizes of the organogel containing 
microparticles was due to the higher viscosity of the organogels. Due to this reason, large 
droplets of primary emulsion were formed during the formation of the multiple emulsions 
when organogels were used as the internal phase. 
 
Figure 6.11: BFM images (size bar: 200 µm) of: (a) MSes, (b) MSoy, (c) MOG1, and (d) 
MOG2; SEM images (size bar: 500 µm) of: (e) MSes, (f) MSoy, (g) MOG1, and (h) 
MOG2; and confocal images (size bar: 50 µm) of: (i) MSes, (j) MSoy, (k) MOG1, and (l) 
MOG2. 
The scanning electron micrographs showed that the microparticles were spherical in nature 
and had a smooth surface after drying (Figure 6.11e-h). The organogel entrapped 
microparticles were nearly spherical, whereas, the spherical nature of the oil containing 
microparticles was lost to a great extent. This can be explained by the physical nature of the 
internal phase of the microparticles. The presence of semi-solid organogels within the core 
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prevented deformation of the microparticle architecture during drying. On the other hand, the 
vegetable oils were not able to resist the inward force of the alginate layer when the 
microparticles were dried. This resulted in the formation of the deformed structures. 
 
Figure 6.12: Size distribution analysis of the microparticles: (a) % frequency and (b) 
Cumulative % frequency. 
The internal structure of the microparticles was investigated using confocal micrographs. 
Confocal images of MSes and MSoy showed the presence of oil globules (green in color) in 
different sizes (Figure 6.11i and 6.11j). On the other hand, MOG1 and MOG2 have shown 
homogeneous globular structures of uniform sizes of the internal phase (Figure 6.11k and 
6.11l). The difference can be attributed to the structuring of oils by the gelator (stearic acid) 
molecules in MOG1 and MOG2 [218]. Some of the oil globules in MSes and MSoy seemed 
to be closer to the alginate boundary layer. This kind of microstructure may promote leaching 
of the internal phase oil. On the other hand, MOG1 and MOG2 showed globular structures 
uniformly surrounded by an alginate layer. This kind of encapsulated structure is preferred to 
prevent the leaching so as to enhance the encapsulation efficiency. Confocal images of 
MOG1 and MOG2 showed the presence of the black alginate layer surrounding the internal 
phase (indicated by an arrow). Encapsulation of the organogels within the alginate 
microparticles was further confirmed by thermal (DSC) studies. 
6.7.4. Leaching studies 
The results of the leaching studies (filter paper method) indicated that the vegetable oil 
containing microparticles showed extensive leaching of the internal phase (marked by the 
formation of a dark zone) from the dried microparticles as against the organogel containing 
microparticles (Figure 6.13a and 6.13b). This may be accounted to the porous nature of the 
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alginate microparticles [151]. The dark zone was not observed for the organogel containing 
microparticles (Figure 6.13c and 6.13d). Absence of leaching from the organogel containing 
microparticles can be attributed to the gelation of the vegetable oils using stearic acid; due to 
which apparent viscosity of the oils was increased. This in turn, prevented the leaching of the 
internal phase due to the immobilization of the oil within the fibrous matrix of stearic acid. 
 
Figure 6.13: Leaching studies: (a) MSes, (b) MSoy, (c) MOG1, and (d) MOG2; and bar 
graphs showing the (e) Swelling power, and % leaching of the microparticles. 
The leaching of the internal phase was quantified by incubating the microparticles in 
phosphate buffer (pH 7.4) (Figure 6.13e). The studies indicated higher leaching of the 
internal phase from the vegetable oil containing microparticles (> 25 %) as compared to the 
organogel containing microparticles which showed much lower leaching (~5 %). The results 
were significantly different (p < 0.05) and supported the observation of the qualitative 
leaching studies. The swelling power of the microparticles was in the range 2.0 -2.7. Though 
not much difference was observed in the swelling power of the microparticles, organogel 
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containing microparticles have shown slightly higher swelling power (Figure 6.13e). This 
may be accounted to the ability of the fatty acid organogels to accommodate water within 
their architecture [219]. But the back pressure created by the alginate layer on to the internal 
phase might have been a limiting factor for the organogels to accommodate higher 
proportions of water molecules within them. 
6.7.5. Drug encapsulation efficiency 
Drug encapsulation efficiency of the organogel containing microparticles (MOG1C: 77.0 ± 
2.9, MOG2C: 82.0 ± 2.5) was much higher as compared to the vegetable oil containing 
microparticles (MSesC: 48.0 ± 2.8, MSoyC: 45.0 ± 3.2). This may be explained by the 
increased viscosity of the organogels which decreased the diffusion of the drug molecules 
(evident from the in vitro drug release studies). This reduced the loss of the drug from the 
microparticles during the preparation and washing stages. Also, leaching of the internal phase 
from the microparticles played an important role. 
6.7.6. Molecular characterization studies 
X-ray diffraction analysis of sodium alginate, stearic acid, organogels (OG1, OG2) and the 
developed microparticles was performed (Figure 6.14a and 6.14b). Presence of vegetable oil 
in MSes and MSoy changed the diffraction pattern of sodium alginate (Na-Alg) to show a 
single broad peak. The fatty acyl molecules in the vegetable oils were responsible for the 
appearance of the hump at ~20º 2θ [157]. Even though, the organogels were amorphous in 
nature the crystalline peaks of stearic acid were observed. These peaks were also found in the 
diffractograms of MOG1 and MOG2. This indicated that MSes and MSoy were 
comparatively more amorphous than MOG1 and MOG2. The crystalline peaks in MOG1 and 
MOG2 indicated the existence of stearic acid molecules within the microparticles. The 
crystalline peaks of stearic acid were conserved and retained at almost the same 2θ (Bragg’s 
angle) in MOG1 and MOG2. This suggested the presence of the stearic acid without any 
changes in the physical nature of the organogels [157]. MOG1 and MOG2 showed “Long 
spacing” (6.8º and 11.4º 2θ) and “short spacing” (21.37º and 23.7º 2θ) peaks of stearic acid. 
Although the peaks of stearic acid were conserved in MOG1 and MOG2, their intensities 
were poor when compared with stearic acid and OG1 and OG2, respectively. Presence of 
alginate layer around the organogels might have reduced the peak intensity in MOG1 and 
MOG2. This suggested that stearate organogels were encapsulated within the alginate 
microparticles without any major alterations in the organogel structure. 
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Figure 6.14: (a-b) X-ray diffractograms, and (c-d) FTIR spectra of the microparticles. 
Figure 6.14b shows the interplanar spacings [hkl] of the peaks and their corresponding d-
values have been listed in the Table 6.11. In general, intensities of all the peaks of the 
organogels were decreased after encapsulation, but the effect was more pronounced in long 
spacing peaks. The major changes in the pattern of the peaks revealed that the order of the 
molecular layers was significantly altered due to the presence of the other components of the 
microparticles [157]. There were negligible changes in the d-values of the short spacing 
peaks in microparticles as compared to the organogels. Along with the decrease in the peak 
intensity and changes in d-value; crystallite size (D) of the stearic acid was also changed 
when the organogels were incorporated within the microparticles. d-value of the crystalline 
peaks in microparticles was not in actual match with that of the pure stearic acid and 
organogels (Table 6.11). The crystallite size was calculated based on the [110] crystal plane 
(at 2θ 21.37º) of stearic acid. The crystal size was calculated using Debey-Scherrer equation 
(equation 4.2 in chapter 4). 
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Crystallite size (D) of stearic acid was found to be higher when it was in pure form, followed 
by encapsulated organogels and organogels, respectively. This suggested that the stearic acid 
in microparticles was structurally closer to its native form than in the organogels. Increase in 
the crystallite size also suggested an increase in the crystallinity of the stearic acid in 
microparticles than in the organogels. This was supported by the FWHM values which 
showed that the FWHM values were lower in the organogel encapsulated microparticles as 
compared to organogels. 
Table 6.11: XRD analysis of the organogels and the microparticles. 
Sample 
d-value of peaks (Å) 
FWHM of 
21.3º 2θ 
D (nm) [003] or 
6.8º 2θ 
[005] or 
11.4º 2θ 
[110] or 
21.3º 2θ 
[112] or 
23.7º 2θ 
SA 12.82 7.69 4.15 3.75 0.157 51.4 
OG1 12.89 7.74 4.15 3.74 0.195 41.5 
OG2 12.53 7.60 4.13 3.73 0.227 35.6 
MOG1 11.83 -- 4.05 3.66 0.162 49.8 
MOG2 13.01 8.09 4.49 3.63 0.194 41.4 
The FTIR spectra of the prepared microparticles have been shown in Figure 6.14c and 6.14d. 
The microparticles have shown the characteristic peaks associated with the alginate. The 
characteristic peaks of stearic acid were observed at ~1,710 and ~940 cm
-1
. The peak at 1,710 
cm
-1
 overlapped with the –COO- vibrations of the alginate. Co-existence of the stearic acid 
and alginate peaks suggested that the stearic acid based organogels might have been 
encapsulated within the alginate microparticles. In drug containing microparticles, peaks 
corresponding to ciprofloxacin (1,610 and 1,260 cm
-1
, due to phenolic groups conjugated to –
COO
-
 and CF bond, respectively) were observed apart from the peaks associated with the 
alginate and stearic acid molecules. There was no shift in the absorption bands of 
ciprofloxacin indicating that the drug molecules were present in its native state. 
6.7.7. Thermal studies 
Vegetable oil containing microparticles showed a broad endothermic peak at ~70 ºC (Figure 
6.15a). This may be due to the evaporation of the bound water from the alginate layer. 
Though dried microparticles were used for the thermal analysis, 100 % removal of water 
from the alginate microparticles was not possible [159]. The organogels showed endothermic 
peaks, associated with the melting of the organogels, at ~44 ºC. The melting endotherms of 
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Figure 6.15: (a) DSC curves of the microparticles and organogels, (b) Melting point of 
organogels, (c) Cell viability index, and (d) Mucoadhesion times of the microparticles. 
the organogels were also observed in the thermograms of the organogel containing 
microparticles, suggesting the presence of organogels within the microparticles. The 
differences in the melting temperatures between OG1, OG2 and MOG1, MOG2, respectively 
were found to be significant (p < 0.05) (Figure 6.15b). This indicates that encapsulation has 
improved the stability of the organogels. In addition to the melting peaks of the organogels, 
microparticles showed additional peaks at ~70 ºC and ~100 
o
C. The peak at ~70 ºC was due 
to the evaporation of the bound water in the alginate layer, whereas, the peak at ~100 ºC was 
due to the evaporation of the water molecules absorbed by the organogels (within the 
microparticles) during microparticle preparation [220]. Literature suggests that it is quite 
possible that the water molecules can exist within the dynamic and transient microstructures 
of the fatty acyl organogels [219]. Evaporation of water over a range of 60-120 ºC, suggested 
the involvement of dipole-dipole interactions amongst the –OH groups of the water 
molecules and the fatty acid molecules. There is a high probability of dipole-dipole 
interactions amongst the water molecules and the alginate molecules [185]. Thermal analysis 
revealed that the organogels have been successfully entrapped within the alginate 
microparticles. 
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6.7.8. Biocompatibility and mucoadhesivity studies 
Cytocompatibility of the microparticles was checked using L929 fibroblast cells. The 
leachants of the microparticles were used in the study. MTT assay indicated that the relative 
proliferation of the cells in the presence of the leachants and the control was statistically 
insignificant (p > 0.05) thereby suggesting the cytocompatibility of the prepared 
microparticles (Figure 6.15c). In vitro cell cytocompatibility studies have confirmed that the 
developed formulations were biocompatible in nature and may be employed for the in vivo 
applications. 
In addition to the biocompatibility studies, mucoadhesivity of the microparticles was checked 
using goat small intestine. Microparticles showed different adhesion times (depending on the 
composition) from the mucosal surface of the small intestine. Detaching times/mucoadhesion 
times were found to be more in organogel containing microparticles (Figure 6.15d). Leaching 
of oil from the MSes and MSoy might have reduced these interactions between the alginate 
layer and the mucosal surface. This has lead to the quick detachment of MSes and MSoy as 
compared to MOG1 and MOG2. Higher mucoadhesive nature is expected to promote the 
residence time of MOG1 and MOG2 in the gastrointestinal tract and lead to the lower dosage 
administration frequency. Statistical analysis suggested that the mucoadhesion times varied 
significantly when the internal phase was changed from oil to organogel (p < 0.05). This 
suggested an improved mucoadhesive efficiency of the microparticles when organogels were 
encapsulated. 
6.7.9. In vitro drug delivery studies 
In vitro drug release was higher from MSesC and MSoyC as compared to MOG1C and 
MOG2C (Figure 6.16a). This might be associated with the leaching of oils from MSesC and 
MSoyC. The drug release kinetics from the microparticles was estimated (Figure 6.16b-e). 
MSesC and MSoyC followed zero order kinetics, whereas MOG1C and MOG2C followed 
Higuchian kinetics (Table 6.12). It indicated that drug release from MSes and MSoy was 
concentration dependent. But in case of MOG1C and MOG2C, drug release was 
affected/controlled by the presence of organogel as the core of the microparticles. The drug 
release from the microparticles followed the Baker’s Lonsdale (BL) model. The results 
suggested that the developed formulations may be regarded as spherical matrices [150]. From 
the Korsmeyer-Peppas (KP) model, it was found that the release of the drug was diffusion 
mediated and followed non-Fickian (0.4 > n > 0.89) diffusion mechanism. The ’n’ value of 
MSesC and MSoyC is near 0.89, which in general associates with the case-II diffusion or 
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zero order kinetics [150]. In vitro drug release studies suggested that the drug release 
behavior was altered due to the incorporation of organogels within the microparticles. 
 
Figure 6.16: Drug release kinetics from the microparticles: (a) CPDR vs. time, (b) Zero 
order, (c) Higuchi model, (d) BL model, and (e) KP model. 
Table 6.12: The drug release kinetics from the microparticles 
Samples 
Zero order 
(R
2
) 
Higuchi 
(R
2
) 
BL model 
(R
2
) 
Best fit  
KP model 
n Type of flow 
MSesC 0.96 0.90 0.98 BL 0.80 Non-Fickian 
MSoyC 0.95 0.91 0.99 BL 0.85 Non-Fickian 
MOG1C 0.83 0.98 0.99 BL 0.67 Non-Fickian 
MOG2C 0.71 0.95 0.97 BL 0.68 Non-Fickian 
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6.7.10. Antimicrobial studies 
Ciprofloxacin is a quinolene antibiotic, found to be active against E. coli. After an overnight 
incubation of nutrient agar plates, zone of inhibition was found around the drug loaded 
microparticles but not around the microparticles without drugs (Figure 6.17). This suggested 
that the zone of inhibition was due to the release of ciprofloxacin from the microparticles. 
Zone of inhibition was found to be more against MSesC and MSoyC than MOG1C and 
MOG2C, respectively. This may be due to the leaching of the oils from the microparticles at 
37 ºC which in turn increased the availability of drug and hence larger zone of inhibition. 
This was also evident from the in vitro drug release studies. Antimicrobial studies indicate 
that the drug was releasing in its active state from the microparticles. 
 
Figure 6.17: Antimicrobial studies of the microparticles against E. coli. 
6.8. Conclusion 
Ionotropic gelation method was successfully employed to synthesize organogel entrapped 
microparticles using alginate as the polymer matrix. The organogel entrapped microparticles 
showed improved drug entrapment efficiency by preventing the leaching of the internal 
phase. Controlled release of ciprofloxacin from the microparticles was noticed and the release 
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was super case-II diffusion transport mediated. The developed microparticles seem to have 
huge potential in controlled delivery applications. 
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Chapter 7 
Encapsulation of Span 80-Tween 80 based 
organogels in alginate microparticles 
Abstract 
Sunflower oil based organogels were prepared using a gelator mixture containing Span 80 
and Tween 80 (1:2 (w/w)). The organogel composition involves 52.5 % (w/w) of gelator 
mixture, 35.0 % (w/w) of water and 12.5 % (w/w) of sunflower oil. The organogel was 
characterized by microscopic, FTIR, thermal and mechanical studies. Drug release kinetics 
suggested that metronidazole (model drug) was released from organogel matrices in non-
Fickian fashion and the drug was found to be active against E. coli. The synthesized 
organogel was encapsulated within the alginate microparticles by ionotropic gelation method. 
Blank microparticles and sunflower oil containing microparticles were synthesized as the 
controls. The microparticles were characterized by microscopy, XRD, FTIR and DSC 
studies. Microscopic studies revealed that oil droplets were present within sunflower oil 
containing microparticles whereas, organogel containing microparticles were opaque in 
nature. The difference in microstructure can be attributed to the gelation of sunflower oil by 
organogelators which in turn, prevented the oil leaching. Prevention of oil has improved the 
DEE, biocompatibility (against mammalian L929 fibroblasts) and mucoadhesivity (against 
goat small intestine) of the microparticles. The release of drugs from the microparticles 
followed non-Fickian diffusion and showed good antimicrobial activity against E. coli. 
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Graphical abstract 
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Part A: Preparation and characterization of Span 80-Tween 80 
based organogels 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overview 
Span 80-Tween 80 based organogels were prepared by mixing the surfactants in the ratio of 
1:2 (w/w), sunflower oil and water. Microscopic studies revealed the presence of circular 
emulsion droplets within the organogel matrix. FTIR studies indicated that intermolecular 
hydrogen bonding between the organogelators (surfactants) and water molecules might be 
responsible for the formation of organogels. Since the water molecules are associated with 
the organogel components, thermal studies yielded a single large endotherm. This was 
resulted due to the gel-to-sol transition at lower temperature and evaporation of water at 
higher temperature. Mechanical properties of the organogel were identified by performing 
mechanical studies. Stress relaxation studies indicated that the developed organogel is a 
viscoelastic semi-solid. Drug release kinetics showed that metronidazole was released in non-
Fickian mode from organogel matrices. The released drug was found to be effective against 
E. coli. 
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7.1. Introduction 
In general, the mechanism of organogelation may be achieved by forming 3D networked 
structures either by solid fibre or by fluid filled fibre structures. The organogelation has been 
achieved by using ionic surfactants (e.g. sodium lauryl sulphate, sodium stearate etc) and 
non-ionic surfactants (e.g. polysorbates, sorbitan esters, poloxamer etc) [221]. Unlike ionic 
surfactants, non-ionic surfactants are non-irritant in nature. This property of the non-ionic 
surfactants has facilitated the exploitation of non-ionic surfactants for the development of 
organogels. A broad category of sorbitan esters based non-ionic surfactants have gained wide 
applications in pharmaceutical and food industries [222-224]. This may be associated with 
the versatility and biocompatibility of these organogels [32]. 
7.2. Materials and methods 
Span 80 and Tween 80 based organogels were prepared as per the protocol given in section 
3.2.4 of chapter 3, characterization of the organogels (microscopy, FTIR studies, thermal 
studies and mechanical studies), in vitro drug release studies and antimicrobial studies were 
explained in detail in section 3.3 of chapter 3. 
7.3. Results and discussion 
7.3.1. Preparation of organogels 
 
Figure 7.1: Schematic representation of the preparation of organogels. 
A clear and homogeneous solution was formed after mixing Span 80: Tween 80 in the ratio 
of 1:2 (w/w) (surfactant mixture) and sunflower oil. Drop-wise addition of water (under 
constant stirring) has lead to the transformation of the clear solution to turbid. Formation of 
organogel was confirmed by inverted test-tube method (Figure 7.1) [221]. The organogel was 
labelled as “OG”. Metronidazole (1 % w/w) containing organogels were found to be stable at 
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room-temperature and labelled as “OGMZ”. The organogels were stable for more than 12 
months at room-temperature. Dilution test revealed that the formed organogels are oil-in-
water (O/W) type of organogels. This indicated that the oil was dispersed in the organogels. 
Microstructure of the organogel was analyzed in bright field microscope. The microscopic 
analysis revealed the presence of uniformly dispersed emulsion droplets within the 
continuous matrix of organogel (Figure 7.2). 
7.3.2. Microscopic studies 
Microstructure of the organogel was analyzed in bright field microscope. The microscopic 
analysis revealed the presence of uniformly dispersed emulsion droplets within the 
continuous matrix of organogel (Figure 7.2). 
 
Figure 7.2: Microstructure of the organogel. 
7.3.3. FTIR studies 
FTIR spectra of organogels and organogel components have been shown in Figure 7.3a. 
FTIR spectra of organogels and the surfactant mixture are similar to each other with some 
variations. Difference in peak intensity was found for the FTIR band at ~3,300 cm
-1
. In 
general, peak at ~3,300 cm
-1
 corresponds to the –OH stretching vibrations. Increase in peak 
intensity was due to the presence of water within the organogels. Incorporation of water 
might have lead to the intermolecular hydrogen bonding between the water molecules and 
surfactant molecules [176]. It has been established that gelation mechanism in fluid-type 
organogels involves hydrogen bonds and hydrophobic interactions amongst the gel 
components [176]. Addition of drug to the organogel did not alter the position of the peaks in 
the FTIR spectrum of organogel. Absence of new peaks indicated that the drug was 
completely dispersed in the organogel. This also indicated that no chemical interactions exist 
between the organogel components and drug molecules. 
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Figure 7.3: (a) FTIR spectra of the organogels, surfactant mixture and drug 
(metronidazole); and (b) DSC thermogram of the organogel. 
7.3.4. Thermal studies 
Organogel was heated from 20 
o
C to 150 
o
C at a scan rate of 1 
o
C/min. When heated, 
organogel yielded a single large endotherm with a peak maximum at ~95 
o
C. Endotherm was 
resulted due to the combination of two evens namely, gel-to-sol transition of the organogel 
and evaporation of water associated with the organogel. FTIR studies also indicated that the 
water molecules are associated with the organogel components. In general, gel-to-sol 
transition temperature of the Span 80-Tween 80-type of organogel is present at ~ 55 
o
C. Since 
gel-to-sol transition of the organogel was associated with the evaporation of water, no 
separate peak was identified. 
7.3.5. Mechanical studies 
Figure 7.4a shows the two cycled uni-axial compression test of the organogel. The mechanical 
parameters calculated from the compression test have been tabulated in Table 7.1. 
Spreadability studies indicated that OG possesses good spreadability. The viscoelastic nature 
of the organogel was investigated by stress relaxation studies. When the applied stress was 
released, a sudden decrease in force was noticed and reached a constant force during the 
relaxation time. This indicated that when stress was applied, OG released the stress in quick 
time. % relaxation of the organogel was calculated using equation 1. It was found to be 86.52 
%. Higher % relaxation indicated the liquid-like nature of the organogel. This was confirmed 
by calculating the viscoelastic properties (F
*
 and S
*
) of the organogel. 
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where, F0 and Fr are the maximum load after the application of stress and the residual force after the relaxation, 
respectively. 
 
Figure 7.4: Mechanical studies: (a) Cyclic compression; (b) Spreadability; (c) Stress 
relaxation curves and (d) Normalized stress relaxation curve (modified Peleg’s 
analysis). 
The viscoelastic properties, asymptotic residual value in the normalized stress relaxation 
curve (F
*
) and the area under the normalized stress relaxation curve (S
*
) are calculated using 
the following equations [149]. 
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where, ‘s’ is the area under the stress relaxation curve; ‘a’ and ‘b’ are the lower and upper limits of the time, 
respectively.  
Area under the curve (S) is a simple and sensitive estimator of the changes in the relaxation 
behavior of materials. For viscoelastic materials S
* 
varies in the range of 0 to1. Elastic-like 
materials possesses S
*
 close to 1.0. On the other hand, if S
*
 is near to zero, then the materials 
can be regarded as viscous materials. Since S
*
 was found to be in between 0 to 1 (Table 7.1), 
OG can be regarded as viscoelastic semi-solid. 
Table 7.1: Mechanical properties of the organogel. 
Sample Hardness 
(N) 
Cohesiveness Adhesiveness 
(N.sec) 
Gumminess 
(N) 
Spreadability 
(N.sec
-1
) 
S
* 
OG 0.087 0.855 0.25 0.074 0.002 0.347 
7.3.6. In vitro drug delivery studies 
In vitro drug release studies showed that ~ 54 % of metronidazole was released from OGMZ 
(Figure 7.5a). To predict the drug release behaviour, the drug release data was fitted in 
different drug kinetic models (Figure 7.5b-d). After fitting, it was found that the drug release 
pattern was not following zero order kinetics (R
2
 > 0.95), but following Higuchi kinetics (R
2
 
> 0.95) (Table 7.2). Following Higuchi kinetics suggested that the drug was released from 
planar matrices. The drug release behaviour was further investigated by fitting the data in KP 
kinetics (R
2
 > 0.95). The Fickian value (n) was found to be in between 0.4 and 0.85 which 
suggested that non-Fickian mode of drug release was observed (Table 7.2). Based on the drug 
release kinetic models, it was inferred that metronidazole was released in non-Fickian mode 
from matrix-kind of organogel. 
Table 7.2: Drug release kinetics. 
Sample Zero-order Higuchi model Best fit KP model 
R
2 
 R
2 
 R
2
 n value Type of release 
OGMZ 0.915 0.973 Higuchi 0.99 0.667 Non-Fickian 
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Figure 7.5: Drug release kinetics: (a) CPDR vs. time, (b) Zero order, (c) Higuchi model, 
and (d) KP model. 
7.3.7. Antimicrobial studies 
Antimicrobial nature of the organogel and release of the drug from OGMZ was confirmed by 
testing the gels against E. coli. A clear zone of inhibition was noticed around OGMZ, but the 
zone of inhibition was not found for OG. This indicated that metronidazole has been released 
in its active form and antimicrobial activity was only due to the action of the drug. Zone of 
inhibition (diameter: ~1.7 cm) due to OGMZ was found to be almost same as that of 
metrogyl
®
 (diameter: ~1.6 cm). Difference in zone of inhibition was found to insignificant (p 
> 0.05). 
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Figure 7.6: Antimicrobial studies of the organogels against E. coli. 
7.4. Conclusion 
Stable organogel was prepared using Span 80-Tween 80 in the ratio of 1:2 (w/w), sunflower 
oil and water. Microscopic, FTIR and thermal studies were conducted to characterize the 
organogel. Mechanical properties of the organogel were elucidated by conducting uni-axial 
compression studies, spreadability studies and stress relaxation studies. Stress relaxation 
studies revealed that the organogel is viscoelastic semisolid in nature. Drug release kinetics 
suggested that metronidazole was released in non-Fickian mode from organogel matrices. 
The organogel showed good antimicrobial activity against E. coli as that of metrogyl
®
. 
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Part B: Encapsulation of Span 80-Tween 80 based organogels in 
alginate microparticles 
 
 
 
 
 
 
 
 
 
Abstract 
Sunflower oil based organogels were prepared using a gelator mixture containing Span 80 
and Tween 80 (1:2 (w/w)). The organogel composition involves 52.5 % (w/w) of gelator 
mixture, 35.0 % (w/w) of water and 12.5 % (w/w) of sunflower oil. The synthesized 
organogel (core) was encapsulated within the alginate microparticles by internal gelation 
method. Blank microparticles and sunflower oil containing microparticles were also 
synthesized as the controls. The microparticles were characterized by microscopy, XRD, 
FTIR and DSC studies. Microscopic studies revealed that oil droplets were present within 
sunflower oil containing microparticles whereas, organogel containing microparticles were 
opaque in nature. The difference in microstructure can be attributed to the gelation of 
sunflower oil by organogelators which in turn, prevented the oil leaching. Prevention of oil 
has improved the DEE (metronidazole), biocompatibility (against mammalian L929 
fibroblasts) and mucoadhesivity (against goat small intestine) of the microparticles. The 
release of drugs from the microparticles followed non-Fickian diffusion and showed good 
antimicrobial activity against E. coli. 
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7.5. Introduction 
In this chapter, we tried to encapsulate sunflower oil via polysorbates-based organogels. All 
the components used in this study are GRAS (Generally Regarded As Safe) materials and 
FDA approved for oral administration [225-226]. Blank microparticles (microparticles 
without any internal phase) and microparticles with sunflower oil served as controls.  
7.6. Materials and methods 
7.6.1. Preparation and characterization of the microparticles 
Microparticles were prepared as per the protocol given in section 3.2.5 of chapter 3. 5 g of 
Span 80-Tween 80-based organogel and sunflower oil were used during the preparation of 
organogel and sunflower oil containing microparticles, respectively. Blank microparticles and 
sunflower oil containing microparticles were used as the controls of the study. 
Experimental details for the characterization of the microparticles are given in section 3.3 of 
chapter 3. 
7.7. Results and discussion 
7.7.1. Preparation of the microparticles 
The composition of the internal phase of the microparticles has been listed in Table 7.3. 
Primary emulsions were prepared by dispersing either sunflower oil or organogel in alginate 
solution. Addition of the primary emulsion to the external phase sunflower oil resulted in the 
formation of oil-in-water-in-oil multiple emulsion. Crosslinking of the alginate molecules 
under acidic conditions resulted in the formation of stable microparticles. 
Table 7.3: The internal phase composition of the microparticles. 
Samples Internal phase 
BM No internal phase 
MSO Sunflower oil 
MOG Organogel 
BMMZ Blank microparticles with 1 % (w/w) metronidazole 
MSOMZ Sunflower oil containing 1 % (w/w) metronidazole 
MOGMZ Organogel containing 1 % (w/w) metronidazole 
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7.7.2. Microscopy 
Figure 7.7: Bright field microscopic images (scale bar: 100 µm) of: (a) BM, (b) MSO, 
and (c) MOG; SEM images (scale bar: 500 µm) of: (d) BM, (e) MSO, and (f) MOG; and 
Confocal images of: (g) MSO, and (h) MOG. 
The microparticles have shown distinct variation in their internal structure (Figure 7.7). BM 
was semi-transparent due to the absence of any internal phase within the microparticles. MSO 
showed globular droplets suggesting the entrapment of sunflower oil within the alginate 
particles. Oil droplets were clearly seen in confocal image of MSO (Figure 7.7g). MOG were 
more opaque than BM and MSO as was evident from the darker nature of the microparticles 
(Figure 7.7c). This may be associated with the presence of the semi-solid organogel, which 
prevented the transmission of the light through the microparticles [227]. Confocal image of 
MOG showed uniformly dispersed organogel matrix (Figure 7.7h). Sunflower oil was 
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dispersed within the organogel matrix. Absence of large oil droplets helps in preventing the 
oil leaching. 
The average diameter of the microparticles was found to be highest for MOG followed by 
MSO and BM (Figure 7.8a). MOG had broad size distribution over MSO and BM (Figure 
7.8a and 7.8b). Presence of viscous organogels in the primary emulsions might have lead to 
the larger and wide size distribution of MOG microparticles. SEM studies suggested that the 
microparticles are circular but are having polydispersity (Figure 7.7d-f). The sizes of the 
microparticles were smaller as compared to the particle size obtained from light microscopy. 
This is due to the fact that the microparticles for SEM analysis were completely dried. The 
evaporation of water has lead to the shrinkage of the microparticles which resulted in loss of 
spherical nature to a certain extent. The extent of loss of sphericity was more in BM and 
MSO as compared to MOG. The microscopic studies indicated that the physical nature of the 
internal phase was affecting the appearance of the microparticles. 
 
Figure 7.8: Size distribution analysis: (a) % frequency and (b) Cumulative % frequency 
of the microparticles. 
7.7.3. Leaching studies 
Leaching of internal phase from the MSO showed a darker region surrounding the 
microparticles (Figure 7.9). This indicated that sunflower oil was leaking out of the 
microparticles. On the other hand, MOG did not show any signs of leakage until the end of 
the experiment (2 h). This may be attributed to the gelation of the sunflower oil due to which 
apparent viscosity was increased. The increase in viscosity might have prevented the leaching 
of the internal phase. Quantification of oil leaching by another study also demonstrated the 
similar kind of results. % leaching was very high in MSO (~ 45 %) as compared to MOG 
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(~10 %). This study shows that the leakage of oil from microparticles may be overcome by 
inducing gelation of the internal phase. 
 
Figure 7.9: Leaching studies: (a) BM, (b) MSO, and (c) MOG; and bar graphs showing 
the: (d) Swelling power and % leaching of the microparticles. 
7.7.4. Drug entrapment efficiency 
The percentage of drug encapsulation efficiency (% DEE) of microparticles was varying with 
nature of the internal phase. The lowest % DEE of BMMZ (44.0 ± 2.7) may be associated 
with the absence of the internal phase. Drug might have diffused out of the porous alginate 
microparticles by diffusion during the preparation of the microparticles [92]. The % DEE of 
MSOMZ (49.0 ± 2.5) was slightly better than BMMZ and may be associated with the 
partitioning effect. The %DEE was highest in MOGMZ (74.0 ± 3.4) which may be due to the 
combined effect of partitioning and increased viscosity of the internal phase. The semi-solid 
organogels might have restricted the diffusion of drugs and resulted in higher % DEE. 
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7.7.5. Molecular interaction studies 
 
Figure 7.10: (a-b) FTIR spectra, (c) XRD profiles, and (d) DSC thermograms of the 
microparticles. 
The FTIR spectra of the microparticles showed peaks corresponding to calcium alginate 
(Figure 7.10a-b). The peak at ~3370 cm
-1 
was broadened and shifted towards lower wave 
numbers in MSO and MOG, suggesting an increase in hydrogen bonding [228]. The drug 
containing microparticles showed characteristic peaks of metronidazole, in addition to the 
peaks associated with calcium alginate. The peaks at 1238 cm
−1
 (ester carbonyl peak), 1747 
cm
-1
 (carbonyl stretching) and 1593 cm
-1
 (asymmetric nitro stretch), associated with 
metronidazole, were observed in drug containing microparticles [229]. Though the peaks of 
the drugs were conserved in the microparticles, the characteristic peaks of the alginate 
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backbone (1200–950 cm−1) were shifted slightly towards lower wave number. This suggested 
a strong association of the drugs with the components of the microparticles [230]. At the 
same time, absence of any new characteristic peak in the spectra suggested that the drugs are 
in their native state and there were no chemical interactions between the drugs and the 
microparticles. 
The X-ray diffractogram of BM showed two peaks at 13.7º 2θ and 23º 2θ, whereas the 
diffractograms of MSO and MOG showed only one peak at 23º 2θ (Figure 7.10c). The peak 
at 13.7º 2θ of BM was not visible in MSO and MOG. On the other hand, the peak at 23º 2θ 
was intensified. This may be due to the interactions amongst the alginate and the internal 
phase molecules, which resulted in the alteration in the molecular packing of the alginate 
molecules. 
7.7.6. Thermal studies 
Figure 7.10d shows the thermograms of the organogel and developed microparticles. The 
thermogram of sunflower oil showed an endothermic peak at ~34ºC. The organogel showed a 
broad endothermic peak at ~95 ºC. This is due to the combined effect of melting of the 
organogel and evaporation of water present in the organogel [231]. BM showed an 
endothermic peak at ~100ºC which may be attributed to the evaporation of the bound water 
associated with the alginate. Although dried microparticles were used, the thermal profile 
suggested that it was not possible to remove the bound water completely. MSO and MOG 
have shown endothermic peaks at ~60ºC. This endothermic peak may be associated with the 
heating of sunflower oil. Gel to sol transition temperature of the span 80 and tween 80 
organogels was found to be 55 to 70 ºC [107]. The endothermic peak of MOG was broader 
than MSO. This can be explained by the simultaneous evaporation of the water present in the 
organogel. Thermal analysis suggests that the organogels were successfully encapsulated 
within the microparticles. 
7.7.7. Biocompatibility and physical interaction studies 
Biocompatibility of the microparticles was determined by studying the relative proliferation 
of MG63 cells in the presence of the microparticles extracts. The cell proliferation was 
measured using MTT assay. The results indicated that the cell viability index in presence of 
the leachates of the microparticles were either ~1 or better than 1 indicating the 
biocompatible nature of the microparticles (Figure 7.11a). The change in cell viability index 
was found to be insignificant (p > 0.05) with respect to control. 
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Figure 7.11: (a) Biocompatibility and (b) Mucoadhesion times of the microparticles. 
Physical interaction of microparticles with mucous membrane was studied by in vitro wash-
off method (Figure 7.11b). In general, alginate constructs possess high affinity towards 
intestinal mucousal layer. Under the experimental conditions, MSO (3.45 ± 0.5) detached 
quicker than MOG (22.5 ± 2.5) and BM (28.25 ± 2.2). This may be accounted to the leaching 
of sunflower oil from MSO which was evident from the leaching studies. The mucoadhesive 
time of MOG was increased almost by 7 fold as compared to MSO. This is due to the 
prevention of oil leaching from MOG, due to the gelation of the internal phase. The 
differences in mucoadhesivity of microparticles were found to be significant (p < 0.05) as per 
paired t-test analysis. The significant rise in the mucoadhesive nature of MOG is self-
explanatory about the importance of the structuring of the edible oil within the microparticles. 
The results suggested that the MOG may be tried as mucoadhesive microparticulate delivery 
vehicle. 
7.7.8. In vitro drug release studies 
Figure 7.12 shows the in vitro cumulative percentage drug release (CPDR) profiles of the 
microparticles. The drug release from BMMZ and MSOMZ was higher than MOGMZ. This 
may be associated with the leaching of the drugs from BMMZ and MSOMZ.  
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Figure 7.12: (a) CPDR profiles of the microparticles, and (b-d) antimicrobial studies of 
the microparticles against E. coli. 
The drug release kinetics was studied by finding the best-fit release model after fitting in 
zero-order, First-order, Higuchi and Baker-Lonsdale models. The diffusion of the drugs was 
figured out by calculating ‘n’ value using KP model. The acceptable regression coefficient 
for fitting of the models was > 0.95 and the best fit models have been tabulated in Table 7.4 
and shown in Figure 7.13. The results suggested that the drug release from the microparticles 
followed Higuchian and BL kinetic models, indicating that the developed microparticles were 
spherical matrix type. The release behavior of the drugs from the microparticles followed 
non-Fickian diffusion. The non-Fickian diffusion of the drugs may be attributed to the 
polymer relaxation, erosion and degradation [232]. 
The drug containing microparticles have shown considerable antimicrobial activity thereby 
suggesting that that the incorporated drugs were bioactive even after encapsulation (Figure 
7.12b-d). Comparatively, BMMZ (diameter of the zone of inhibition: 2.2 cm) and MSOMZ 
(diameter of the zone of inhibition: 1.9 cm) microparticles showed higher zone of inhibition 
over MOGMZ (diameter of the zone of inhibition: 1.6 cm). This may be attributed to the 
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quick release of the drugs from BMMZ and MSOMZ microparticles. Similar results were 
also evident from the in vitro drug release studies. The results suggested that the organogels 
containing microparticles may be tried for the controlled delivery applications. 
 
Figure 7.13: The drug release kinetics from the microparticles: (a) Zero order; (b) 
Higuchi model; (c) BL model and (d) KP model. 
Table 7.4: Drug release kinetics from the microparticles. 
Sample 
Zero order 
R
2
 
Higuchi 
model 
R
2
 
BL 
model 
R
2
 
Best fit 
model 
KP model 
n 
Type of 
diffusion 
BMMZ 0.95 0.92 0.96 BL 0.84 Non-Fickian 
MSOMZ 0.92 0.95 0.99 BL 0.75 Non-Fickian 
MOGMZ 0.89 0.95 0.99 BL 0.84 Non-Fickian 
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7.8. Conclusion 
Encapsulation of the organogels prevented leaching of the internal phase of the 
microparticles, a common phenomenon when oil is encapsulated. The encapsulation 
efficiency of the drugs was improved after the encapsulation of organogels. The 
mucoadhesivity of the microparticles was improved by many-fold when the oil was 
encapsulated via organogel. Based on the preliminary results, the developed organogel 
containing microparticles are best suited to prevent the leakage of the internal phase and 
controlled delivery applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
153 
Chapter 8 
Comparison of the organogel loaded microparticles 
8.1. Preparation and characterization of the microparticles 
Organogels of different nature (plant-based, animal-based, plant and animal-based and 
synthetic polysorbates-based) were successfully encapsulated within the alginate 
microparticles by ionotropic gelation method (Table 8.1). The comparative account of the 
microparticles is provided in Table 8.2. All the microparticles were found to be stable at 
room-temperature. Microscopic studies revealed that the microparticles are spherical in 
nature with broad size distribution. Broad size distribution of the microparticles can be 
attributed to the increased viscosity of the primary emulsion (due to the addition of 
organogels) and the method used for the preparation of microparticles. The average size 
(Davg) of the microparticles differed from each other. The difference in sizes can be attributed 
to the internal composition of the microparticles. Average size was highest for MCG (cocoa 
butter organogel containing microparticles) and lowest for ML1 (lanolin organogel 
containing microparticles. The order of average sizes is MCG > MMG > MOG2 > MOG1 > 
MOG and ML1. Encapsulation of organogels within the microparticles was confirmed by 
DSC, FTIR and XRD studies. DSC thermograms of the microparticles showed endothermic 
peaks corresponding to the melting point of the encapsulated organogels. This indicated that 
the organogels were encapsulated within the microparticles. XRD studies also showed the 
peaks corresponding to the gelators of the organogels. It was found that the stable 
polymorphic state of vegetable fats (cocoa butter and mango butter) and stearic acid was 
retained in the microparticles. The characterization studies confirmed that the encapsulated 
organogels are present in their native state within the microparticles. 
Table 8.1: Description of the microparticles 
Sample Description 
MCG Cocoa butter organogel (CG35) containing microparticles 
MMG Mango butter organogel (MG35) containing microparticles 
ML1 Lanolin organogel (L1) containing microparticles 
MOG1 Sesame oil/stearate-based organogel (Ses2) containing microparticles 
MOG2 Soy bean oil/stearate-based organogel (Soy2) containing microparticles 
MOG Span 80-Tween 80-based organogel (OG) containing microparticles 
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Table 8.2: Comparison of the organogel loaded microparticles
*
. 
Sample Davg (µm) % leaching % DEE Cell viability index Mucoadhesive 
time (h) 
In vitro drug delivery Zone of inhibition (cm) 
MCG 295.95 11.74 71.3 1.05 18.2 Super case-II 1.9 
MMG 292.70 12.12 70.2 1.06 17.4 Super case-II 2.0 
ML1 130.14 2.82 85.0 0.93 25.5 Non-Fickian 1.0 
MOG1 210.24 5.20 77.0 1.01 26.0 Super case-II 1.7 
MOG2 226.10 4.20 82.0 1.03 22.15 Super case-II 1.7 
MOG 142.0 9.40 74.0 1.01 22.5 Non-Fickian 1.2 
*average values are provided
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8.2. Leaching studies 
The microparticles showed significant variation in leaching of the internal phase (Table 8.2). 
Higher % leaching was found in vegetable fat containing organogels (MCG and MMG). This 
was may be due to the melting of cocoa butter and mango butter. DSC studies of the CG35 and 
MG35 showed that these organogels can melt (partially) at room-temperature. Molten solid fat 
content of the organogels might have leached out of MCG and MMG and resulted in higher % 
leaching. Next to MCG and MMG, % leaching was higher from MOG. This can be explained 
with respect to the strength of the gels. Mechanical studies revealed that OG (Span 80-Tween 80 
based organogel) was having lowest gel strength and higher spreadability than the others. In 
general, lower gel strength and higher spreadable nature reduces the immobilization capacity of 
the microparticles. Since MOG possesses lower immobilization capacity, there is a high chance 
for the leaching. MOG1 and MOG2 showed lower % leaching as compared to MOG. Since 
stearate organogels are having higher gel strength and lower spreadability, MOG1 and MOG2 
showed less amount of leaching. % leaching was found to be lowest in ML1 which can be 
attributed to the higher viscosity and stickiness of the lanolin-based organogels than the other 
organogels. The difference in % leaching has directly influenced the drug encapsulation 
efficiency of the microparticles. % drug encapsulation efficiency was in the order of ML1 > 
MOG2 > MOG1 > MOG > MCG > MMG. 
8.3. In vitro biocompatibility studies 
The cell viability index of all microparticles was found to be near one (the cell viability index of 
the control) (Table 8.2). This suggests that the microparticles are supporting the growth of the 
L929 fibroblast cells. The organogel containing microparticles showed higher mucoadhesivity. 
Leaching of the internal phase affected the mucoadhesivity of the microparticles. Lowest 
mucoadhesive time was observed for vegetable fat containing organogels and highest for the 
lanolin containing organogels (Table 8.2). Since these microparticles showed longer 
mucoadhesion times, these microparticles may be used as the controlled drug delivery vehicles. 
8.4. In vitro drug delivery studies 
The microparticles showed two kinds of drug diffusion. KP kinetics was used to predict the type 
of diffusion from the microparticles. Non-Fickian mode of drug diffusion was present in ML1 
and MOG, whereas, super case-II type of diffusion was associated with MCG, MMG and MOG1 
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and MOG2. Super case-II mode of diffusion resulted in higher CPDR from the microparticles 
than the others. 
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Chapter 9 
Conclusion 
The present work was aimed at developing a new strategy in negotiating the problem of leaching 
from the microparticles. To achieve this, hydrophobicity of the microparticles was improved by 
encapsulating semi-solid organogels within the alginate microparticles. Semi-solid organogels 
were prepared using plant-derived cocoa butter, mango butter, animal-derived lanolin, stearic 
acid having both plant and animal origin and synthetic polysorbates (Mixture of Span 80 and 
Tween 80 in the ratio of 1:2 w/w). The microscopic, physicochemical, thermal and mechanical 
properties of the organogels were studied. Gelation mechanism in vegetable fat and stearate-
based organogels was predicted. Instantaneous nucleation coupled with one or two dimensional 
growth of the fat crystals was followed by cocoa butter and mango butter organogels. On the 
other hand, stearate organogels followed heterogeneous nucleation coupled with one-
dimensional growth of organogelators. In vitro drug release studies were carried out from the 
organogels using metronidazole and cirprofloxacin (in stearate organogels) as the model drugs. 
Antimicrobial properties of the organogels were evaluated by checking against E. coli.  
The developed organogels were successfully encapsulated within the alginate microparticles by 
ionnotropic/internal gelation method. The presence of organogels as the core material of the 
microparticles was confirmed by microscopic, XRD and DSC studies. To check the efficiency of 
the microparticles in preventing the leaching of internal phase, leaching studies were carried out 
qualitatively and quantitatively. Both the studies showed that the leaching of internal phase from 
the developed microparticles was found to be negligible when compared with controls. Presence 
of semi-solid organogels prevented the leaching of the internal phase at room-temperature, which 
in turn improved the drug encapsulation efficiency of the microparticles. Increase in drug 
encapsulation efficiency was found to be almost 2-fold as compared to the controls. Prevention 
of leaching has enhanced the mucoadhesivity of the organogel containing microparticles by 
almost 2 to 3-fold with respect to the controls. The microparticles showed controlled release of 
the drugs under in vitro conditions and they showed antimicrobial property when tested against 
E. coli. The biocompatibility of the microparticles was checked by incubating their leachates 
with mammalian fibroblast cells. Based on the results, it was concluded that the developed 
formulations (organogels and microparticles) may be tried as the controlled delivery vehicles for 
in vivo applications. 
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